≡ Risteys
R14

Documentation Changelog GitHub Contact & Feedback

Other specified/unspecified inflammatory spondylopathies

DOID EFO Endpoint Browser PheWeb

M13_SPONDYLINFLAMNAS

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps

FinnGen

Phenotype data

519870

1. Apply sex-specific rule

None

519870

2. Check conditions

None

519870

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Hospital discharge: ICD-10 — M46.8, M46.9
  • Hospital discharge: ICD-9 — 720[8-9]
  • Cause of death: ICD-10 — M46.8, M46.9
  • Cause of death: ICD-9 — 720[8-9]

2 out of 7 registries used, show all original rules.

2130

4. Check minimum number of events

None

2130

5. Include endpoints

None

2130

6. Filter based on genotype QC (FinnGen only)

2062

Control definitions (FinnGen only)

Control exclude
M13_DORSOPATHY

Extra metadata

Level in the ICD hierarchy
4
First used in FinnGen datafreeze
DF2

Case counts by codes

↥

FinnGen case counts by registry codes:

generic upset plot

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

All Female Male
Number of individuals
Whole population 11100 6611 4434
Only index persons 10586 6400 4186
Unadjusted period prevalence (%)
Whole population 0.16 0.19 0.12
Only index persons 0.21 0.24 0.16
Median age at first event (years)
Whole population 43.02 42.94 43.03
Only index persons 42.21 42.34 42.01

-FinnGen-

Key figures

All Female Male
Number of individuals 2062 1390 672
Unadjusted period prevalence (%) 0.43 0.49 0.31
Median age at first event (years) 43.76 43.02 45.29

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
2130
Matched controls
21300
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
NA3AA
NOMESCO Finland
Lumbar spine X-ray examination without contrast
13.2
310.9
314
275
H02AB06
ATC
prednisolone; systemic
5.5
307.9
1501
6409
TNX10
NOMESCO Finland
Arthrocentesis, unspecified region, unspecified region
14.2
307.7
581
547
281
Kela drug reimbursment
Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab and tocilizumab
51.5
307.7
696
199
L04AB06
ATC
golimumab; parenteral
72.7
307.7
198
30
H20.0
ICD-10 Finland
Acute and subacute iridocyclitis
16.5
307.7
413
306
L04AX03
ATC
methotrexate; systemic
22.5
307.7
1093
952
M48.0
ICD-10 Finland
Spinal stenosis
34.3
307.7
208
67
M45
ICD-10 Finland
Ankylosing spondylitis
955.5
307.7
822
14
202
Kela drug reimbursment
Connective tissue diseases, rheumatoid arthritis and comparable disease
51.1
307.7
1521
993
NK4XE
NOMESCO Finland
Joint ultrasound examination not elsewhere classified
16.2
307.7
681
600
NA3BG
NOMESCO Finland
Lumbar spine MRI examination with high intensity magnet
30.4
307.7
438
180
M46.9
ICD-10 Finland
Inflammatory spondylopathy, unspecified
4503599627370496.0
307.7
1910
5
M51.3
ICD-10 Finland
Other specified intervertebral disc degeneration
24.4
307.7
302
143
A07EC01
ATC
sulfasalazine; oral, rectal
73.7
307.7
1462
614
L01BA01
ATC
methotrexate; systemic
19.1
307.7
378
238
M13.9
ICD-10 Finland
Arthritis, unspecified
11.7
307.7
567
643
NA6BG
NOMESCO Finland
Sacro-iliac joint MRI examination with high intensity magnet
147.2
307.7
356
29
M51.1
ICD-10 Finland
Lumbar and other intervertebral disc disorders with radiculopathy
27.5
307.7
404
180
L04AB01
ATC
etanercept; parenteral
37.2
307.7
321
101
M47.2
ICD-10 Finland
Other spondylosis with radiculopathy
71.0
307.7
176
27
L88
ICPC
Rheumatoid/seropositive arthritis
21.8
307.7
510
303
313
Kela drug reimbursment
Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab, tocilizumab and ustekinumab (rheumatoid diseases)
49.0
307.7
712
216
L04AB04
ATC
adalimumab; parenteral
30.0
307.7
439
183
M46.1
ICD-10 Finland
Sacroiliitis, not elsewhere classified
471.2
307.7
476
13
P01BA02
ATC
hydroxychloroquine; oral
8.6
307.7
507
745
NA3CG
NOMESCO Finland
Lumbar spine extensive MRI examination with high intensity magnet
47.0
307.1
181
42
M46.8
ICD-10 Finland
Other specified inflammatory spondylopathies
+∞
266.4
250
*
M54.9
ICD-10 Finland
Dorsalgia, unspecified
6.6
240.7
447
825
M79.0
ICD-10 Finland
Rheumatism, unspecified
16.3
227.3
198
133
N03AX16
ATC
[U] pregabalin
5.1
227.1
603
1534
M54.5
ICD-10 Finland
Low back pain
4.1
224.8
1013
3837
L04AA13
ATC
[U] leflunomide
14.9
222.8
204
150
N03AX12
ATC
[U] gabapentin; oral
6.3
221.9
431
828
M01AH01
ATC
celecoxib; oral
5.1
218.0
576
1455
L04AC10
ATC
secukinumab; parenteral
56.7
217.7
123
23
M01AC06
ATC
meloxicam; systemic, rectal
3.9
210.2
1053
4247
N02AE01
ATC
buprenorphine; parenteral, sublingual, transdermal
7.7
207.3
318
477
M54.4
ICD-10 Finland
Lumbago with sciatica
5.4
202.4
471
1063
N02AX02
ATC
tramadol; systemic, rectal
3.8
201.2
1061
4400
L04AB05
ATC
certolizumab pegol; parenteral
45.0
200.4
119
28
NA1BG
NOMESCO Finland
Cervical spine MRI examination with high intensity magnet
12.7
195.9
197
169
M01AH05
ATC
etoricoxib; oral
4.5
187.3
1697
9887
NA2BG
NOMESCO Finland
Thoracal spine MRI examination with high intensity magnet
22.3
185.4
138
66
M47.82
ICD-10 Finland
Other spondylosis, cervical region
25.8
183.9
129
53
NF1AE
NOMESCO Finland
Hip joint ultrasound examination
16.1
183.6
160
107
M06.0
ICD-10 Finland
Seronegative rheumatoid arthritis
11.3
178.7
195
189
M06.9
ICD-10 Finland
Rheumatoid arthritis, unspecified
10.0
167.0
199
218
M47.9
ICD-10 Finland
Spondylosis, unspecified
65.5
159.9
88
14
M25.5
ICD-10 Finland
Pain in joint
3.3
154.8
1013
4626
WZA10
NOMESCO Finland
Extensive medical or dental certificate
15.4
149.5
133
92
GD1AA
NOMESCO Finland
Thorax X-ray examination
3.1
144.4
1127
5638
M50.1
ICD-10 Finland
Cervical disc disorder with radiculopathy
18.8
142.4
114
64
ABC36
NOMESCO Finland
Decompression of lumbar nerve roots
70.6
137.8
75
11
H20.1
ICD-10 Finland
Chronic iridocyclitis
17.9
133.2
109
64
M47.80
ICD-10 Finland
Other spondylosis, multiple sites in spine
21.6
131.9
99
48
N06AX21
ATC
duloxetine; oral
4.5
131.0
366
941
TNX00
NOMESCO Finland
Puncture and needle biopsy of soft tissue, unspecified region
14.2
130.5
121
90
M07.3*L40.5
ICD-10 Finland
Other psoriatic arthropathies
10.2
127.6
147
153
NA1AA
NOMESCO Finland
Cervical spine X-ray examination without contrast
13.8
126.2
119
91
N02AA59
ATC
codeine, combinations excl. psycholeptics; systemic
2.9
125.5
1090
5656
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
3.0
124.6
814
3620
UJF32
NOMESCO Finland
Coloscopy
3.2
121.4
645
2544
NA1EA
NOMESCO Finland
Cervical spine X-ray examination with flexion
33.2
119.9
77
24
M43.1
ICD-10 Finland
Spondylolisthesis
20.8
112.9
86
43
H20.9
ICD-10 Finland
Iridocyclitis, unspecified
14.9
112.3
101
71
L03
ICPC
Low back symptom/complaint
2.9
110.3
740
3301
A02BC02
ATC
pantoprazole; systemic
3.0
109.2
1577
10374
M79.7
ICD-10 Finland
Fibromyalgia
7.8
104.3
149
203
M02.9
ICD-10 Finland
Reactive arthropathy, unspecified
9.9
103.0
121
129
M54.6
ICD-10 Finland
Pain in thoracic spine
4.9
102.9
246
554
NH3EA
NOMESCO Finland
Feet X-ray examination with load
9.9
100.3
118
126
A02BC03
ATC
lansoprazole; oral
2.8
97.7
662
2939
M54.2
ICD-10 Finland
Cervicalgia
5.0
97.6
225
491
M03BX02
ATC
tizanidine; oral
2.7
97.5
1504
9945
M03BC01
ATC
orphenadrine (citrate); systemic
2.9
96.5
598
2530
ND2AA
NOMESCO Finland
Hand and fingers X-ray examination
3.8
96.4
330
974
N06AA09
ATC
amitriptyline; systemic
4.6
89.9
230
546
M35.7
ICD-10 Finland
Hypermobility syndrome
12.3
89.7
90
76
M01AH02
ATC
rofecoxib; oral
4.0
89.1
285
800
N02BF01
ATC
gabapentin; oral
4.3
88.7
249
635
M05.8
ICD-10 Finland
Other seropositive rheumatoid arthritis
5.0
86.9
197
423
NA2AA
NOMESCO Finland
Thoracal spine X-ray examination without contrast
10.9
86.2
94
90
NG1DA
NOMESCO Finland
X-ray of knees
12.4
86.1
86
72
M54.3
ICD-10 Finland
Sciatica
7.0
85.1
134
203
NA6AA
NOMESCO Finland
Sacro-iliac joint X-ray examination
50.1
84.5
49
10
S01BA04
ATC
prednisolone; ophthalmic
8.8
82.9
106
126
M70.6
ICD-10 Finland
Trochanteric bursitis
3.5
81.6
319
1023
M54.1
ICD-10 Finland
Radiculopathy
10.4
81.0
91
91
S01BA01
ATC
dexamethasone; ophthalmic
6.2
77.5
138
237
WZC30
NOMESCO Finland
Teaching
2.9
77.2
450
1819
ZY020
NOMESCO Finland
Telephone, letter or other consultation without direct patient contact
4.5
76.2
200
483
M01AX01
ATC
nabumetone; oral
6.5
73.4
124
202
ABC16
NOMESCO Finland
Microsurgical excision of lumbar intervertebral disc displacement
+∞
73.4
70
*
M01AB05
ATC
diclofenac; systemic, rectal
2.4
73.2
1493
10523
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
2.5
72.5
616
2992
NAG40
NOMESCO Finland
Anterior fusion of cervical spine without fixation
+∞
72.3
69
*
M01AB55
ATC
diclofenac, combinations; oral
5.1
72.2
158
328
N02AJ06
ATC
codeine and paracetamol; systemic
2.3
71.6
977
5814
NG1AE
NOMESCO Finland
Knee joint ultrasound exmination
11.4
70.4
74
67
F45.4
ICD-10 Finland
Persistent somatoform pain disorder
13.9
70.1
65
48
L40.5
ICD-10 Finland
Arthropathic psoriasis
8.5
70.0
92
113
XX9XE
NOMESCO Finland
Other ultrasound examination
14.4
69.2
63
45
A02BC01
ATC
omeprazole; systemic
2.5
68.9
587
2845
NB1AE
NOMESCO Finland
Shoulder ultrasound examination
10.6
68.8
76
74
NA1BA
NOMESCO Finland
Cervical spine extensive X-ray examination without contrast
25.8
68.8
48
19
M01AE03
ATC
ketoprofen; systemic, rectal
2.3
68.5
770
4211
M01AE02
ATC
naproxen; oral, rectal
2.2
68.4
1334
9106
L86
ICPC
Back syndrome with radiating pain
5.3
68.0
141
279
M13.8
ICD-10 Finland
Other specified arthritis
11.5
66.8
70
63
NH3AA
NOMESCO Finland
Foot and toes X-ray examination
3.4
66.5
265
855
M79.6
ICD-10 Finland
Pain in limb
2.2
65.7
1002
6172
L04AC13
ATC
ixekizumab; parenteral
32.9
65.1
42
13
NA1CG
NOMESCO Finland
Cervical spine extensive MRI examination with high intensity magnet
11.3
64.3
68
62
TNH11
NOMESCO Finland
Injection of diagnostic or therapeutic substance in ankle joint or foot joint
11.3
64.3
68
62
M03BA52
ATC
carisoprodol, combinations excl. psycholeptics; oral
7.0
64.3
100
149
M50.3
ICD-10 Finland
Other cervical disc degeneration
17.0
63.5
53
32
M53.1
ICD-10 Finland
Cervicobrachial syndrome
3.1
63.5
305
1100
A02BC05
ATC
esomeprazole; systemic
2.2
62.6
876
5192
G55.1*M51.1
ICD-10 Finland
Compression of nerve roots and nerve plexus in disc diseases in the lumbar region and other regions
13.9
61.5
57
42
NA3EA
NOMESCO Finland
Lumbar spine X-ray examination with flexion
87.8
61.3
68
8
H02AB07
ATC
prednisone; oral
2.9
60.9
330
1271
M54
ICD-10 Finland
Dorsalgia
2.8
60.3
340
1338
M01CB01
ATC
sodium aurothiomalate; parenteral
12.0
60.3
61
52
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
2.1
60.1
867
5180
H22.1*M45
ICD-10 Finland
Iridocyclitis in ankylosing spondylitis
+∞
59.7
57
*
L04AA11
ATC
[U] etanercept
25.2
59.6
42
17
N02BE01
ATC
paracetamol; systemic, rectal
3.3
58.9
1934
15993
SPAT1223
SPAT
Implementation of physical therapy rehabilitation plan
2.4
58.9
546
2724
ZXX01
NOMESCO Finland
Extent of proceudre, 1 unit
12.4
58.4
58
48
L04AX01
ATC
azathioprine; systemic
4.4
58.2
155
377
NH1AE
NOMESCO Finland
Ankle joint ultrasound examination
14.8
58.0
52
36
TNG10
NOMESCO Finland
Puncture of knee
10.0
57.4
66
68
ND2BA
NOMESCO Finland
Hand and fingers extensive X-ray examination
6.0
56.9
102
176
S01XA20
ATC
artificial tears and other indifferent preparations; ophthalmic
2.1
56.6
905
5588
NK5AT
NOMESCO Finland
Joint injection with ultrasound guidance not elsewhere classified
11.2
56.5
60
55
M01AX17
ATC
nimesulide; oral
2.4
56.0
452
2115
TND11
NOMESCO Finland
Injection of diagnostic or therapeutic substance in joint, wrist or hand
9.1
56.0
69
78
A01
ICPC
Pain general/multiple sites
3.3
55.8
233
771
7209X
ICD-9 Finland
Ankylosing spondylitis and other inflammatory spondylopathies, Unspecified inflammatory spondylopathy
+∞
55.5
53
*
R51.80
ICD-10 Finland
Headache
2.5
54.7
418
1906
NG1AA
NOMESCO Finland
Knee X-ray examination without contrast
2.9
54.7
280
1043
R4110
NOMESCO Finland
Physiotherapy
2.2
54.5
595
3163
H57.1
ICD-10 Finland
Ocular pain
4.1
54.3
154
393
M06.8
ICD-10 Finland
Other specified rheumatoid arthritis
13.8
53.7
50
37
S01FA04
ATC
cyclopentolate; ophthalmic
10.6
53.6
59
57
TPH04
NOMESCO Finland
Cathetrisation of vein
2.3
53.3
484
2381
L04AB02
ATC
infliximab; parenteral
12.7
53.1
52
42
M13.0
ICD-10 Finland
Polyarthritis, unspecified
8.5
52.8
69
84
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
2.0
52.7
961
6176
SPAT1253
SPAT
Initiation, adjustment, discontinuation or repetition of medication
2.1
52.7
661
3705
N02BF02
ATC
pregabalin; oral
3.9
52.6
163
443
M15.0
ICD-10 Finland
Primary generalized (osteo)arthrosis
6.8
52.0
83
127
SPAT1230
SPAT
Aid fitting and borrowing and monitoring of use
2.7
51.4
309
1251
M46.0
ICD-10 Finland
Spinal enthesopathy
266.9
51.3
52
*
TNG11
NOMESCO Finland
Injection of diagnostic or therapeutic substance in knee
10.4
51.2
57
56
M75.1
ICD-10 Finland
Rotator cuff syndrome
2.2
51.1
526
2721
S01CA02
ATC
prednisolone and antiinfectives; ophthalmic
11.8
50.8
52
45
NF1AA
NOMESCO Finland
Hip X-ray examination
3.7
50.6
173
503
SPAT1301
SPAT
No procedures
2.1
50.6
621
3442
Z01.8
ICD-10 Finland
Other specified special examinations
2.3
50.5
506
2587
J01AA02
ATC
doxycycline; systemic
2.2
50.0
1651
12994
Z01.0
ICD-10 Finland
Examination of eyes and vision
2.4
49.8
418
1981
ZX120
NOMESCO Finland
Intravenous
3.0
49.3
241
873
J01FF01
ATC
clindamycin; systemic
2.1
49.0
604
3347
NE1BG
NOMESCO Finland
Pelvic, hip and femur MRI examination with high intensity magnet
5.7
48.8
93
170
A07EC02
ATC
mesalazine; oral, rectal
3.6
48.6
172
512
NA6CG
NOMESCO Finland
Sacro-iliac joint extensive MRI examination with high intensity magnet
90.6
48.0
53
6
M54.8
ICD-10 Finland
Other dorsalgia
4.6
47.8
118
270
R52.2
ICD-10 Finland
Other chronic pain
5.2
47.5
100
200
M46.4
ICD-10 Finland
Discitis, unspecified
478.2
47.5
47
*
ZXM10
NOMESCO Finland
Intraoperative use of conventional X-ray imaging
3.7
46.4
152
429
A02BA02
ATC
ranitidine; systemic
2.4
46.4
359
1637
J01.0
ICD-10 Finland
Acute maxillary sinusitis
2.0
46.1
660
3852
M03BC51
ATC
orphenadrine, combinations; systemic
2.1
45.7
598
3376
A07EA06
ATC
budesonide; oral, local oral
4.1
45.4
129
329
Z50.8
ICD-10 Finland
Care involving use of other rehabilitation procedures
3.4
45.3
171
530
ZYC01
NOMESCO Finland
Remote contact by phone
3.3
45.1
185
604
N02AC04
ATC
dextropropoxyphene; oral
7.2
45.0
67
95
SPAT1249
SPAT
Treatment-related counselling outside office
1.9
44.6
842
5392
M01AH03
ATC
valdecoxib; oral
3.8
43.2
137
378
ZX140
NOMESCO Finland
Intra articular
10.4
43.2
48
47
NA7BG
NOMESCO Finland
Spine and spinal cord MRI examination with high intensity magnet
17.8
42.9
35
20
WZB00
NOMESCO Finland
Telephone prescription or other care instructions
1.9
42.8
720
4423
G44.2
ICD-10 Finland
Tension-type headache
2.4
42.7
336
1540
M01CB03
ATC
auranofin; oral
14.9
42.6
38
26
R06.0
ICD-10 Finland
Dyspnoea
2.1
42.6
518
2836
L20
ICPC
Joint symptom/complaint NOS
4.1
42.3
119
301
H20
ICD-10 Finland
Iridocyclitis
12.6
41.9
41
33
H15.1
ICD-10 Finland
Episcleritis
6.5
41.5
68
107
G56.0
ICD-10 Finland
Carpal tunnel syndrome
2.5
41.2
304
1351
7227C
ICD-9 Finland
Intervertebral disk disorders, Intervertebral disk disorder with myelopathy[SYNDROMA ISCHIADICUM]
+∞
40.8
39
*
L84
ICPC
Back syndrome without radiat pain
3.9
40.6
122
324
S01FA02
ATC
scopolamine; ophthalmic
12.3
40.2
40
33
G54.0
ICD-10 Finland
Brachial plexus disorders
5.6
40.0
77
142
ZXX02
NOMESCO Finland
Extent of procedure, 2 units
7.7
40.0
56
74
208
Kela drug reimbursment
Ulcerative colitis and Crohn's disease
3.4
39.9
151
468
J01DB01
ATC
cefalexin; oral
2.2
39.6
1793
15029
L01
ICPC
Neck symptom/complaint
2.2
39.5
380
1892
NE1AA
NOMESCO Finland
Pelvis X-ray examination
3.6
39.5
135
392
L28
ICPC
Limited function/disability (L)
2.4
39.4
300
1351
NA2CG
NOMESCO Finland
Thoracal spine extensive MRI examination with high intensity magnet
12.4
39.3
39
32
O99.89
ICD-10 Finland
Other specified diseases and conditions complicating pregnancy, childbirth and the puerperium
4.8
39.2
90
194
R29.8
ICD-10 Finland
Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems
3.0
39.2
185
655
N06CA01
ATC
amitriptyline and psycholeptics; systemic
2.8
39.2
210
797
N06AX16
ATC
venlafaxine; oral
2.3
39.0
350
1694
Z3226
NOMESCO Finland
Physiotherapist
2.3
38.7
356
1739
R10.3
ICD-10 Finland
Pain localized to other parts of lower abdomen
2.0
38.4
580
3413
4AB02, ,
NOMESCO Finland
14.2
38.3
35
25
NB1AA
NOMESCO Finland
Shoulder X-ray examination without contrast
3.2
38.2
161
533
NA7CG
NOMESCO Finland
Spine and spinal cord extensive MRI examination with high intensity magnet
9.6
38.1
45
48
L17
ICPC
Foot/toe symptom/complaint
1.9
37.9
626
3794
SPAT1202
SPAT
Intra-articular injection
6.0
37.9
67
114
M01AB08
ATC
etodolac; oral
3.1
37.6
163
549
R50.9
ICD-10 Finland
Fever, unspecified
2.2
37.5
350
1719
NF1DA
NOMESCO Finland
X-ray of hips
7.2
37.4
56
80
R07.4
ICD-10 Finland
Chest pain, unspecified
2.0
37.0
516
2948
SHB00
NOMESCO Finland
Preparing and fitting the occlusal splint in the mouth
2.3
36.7
309
1453
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
2.0
36.4
453
2485
Z71.8
ICD-10 Finland
Other specified counselling
1.8
36.3
780
5123
J01MA02
ATC
ciprofloxacin; systemic
1.8
36.2
733
4728
A06AC01
ATC
ispaghula (psylla seeds); oral
2.0
36.1
498
2831
R52.9
ICD-10 Finland
Pain, unspecified
2.6
35.9
230
954
SPAT1263
SPAT
Sampling
1.8
35.8
850
5746
J45.9
ICD-10 Finland
Asthma, unspecified
2.1
35.7
395
2071
ABC30
NOMESCO Finland
Decompression of cervical nerve roots
+∞
35.5
34
*
NGF15
NOMESCO Finland
Total synovectomy of knee, arthroscopic
7.8
35.3
49
64
M02AA07
ATC
piroxicam; topical
1.9
35.3
635
3939
M02.8
ICD-10 Finland
Other reactive arthropathies
11.8
35.2
36
31
M06
ICD-10 Finland
Other rheumatoid arthritis
10.4
35.2
39
38
Z50.1
ICD-10 Finland
Other physical therapy
3.6
34.7
117
336
S18
ICPC
Laceration/cut
1.8
34.5
890
6145
M46.3
ICD-10 Finland
Infection of intervertebral disc (pyogenic)
+∞
34.5
33
*
M07.3
ICD-10 Finland
Other psoriatic arthropathies
7.6
34.4
49
66
L13
ICPC
Hip symptom/complaint
2.2
34.1
347
1759
XA402
NOMESCO Finland
ENMG
6.6
34.1
55
85
R03AC02
ATC
salbutamol; inhalant
1.7
34.0
1177
8820
M35.3
ICD-10 Finland
Polymyalgia rheumatica
4.7
34.0
79
172
M06.4
ICD-10 Finland
Inflammatory polyarthropathy
13.5
34.0
32
24
ZXH09, ,
SPAT
4.0
33.8
99
258
L99
ICPC
Musculoskeletal disease other
5.1
33.7
72
146
ZYC05
NOMESCO Finland
Non-real-time text-based remote communication
6.3
33.6
57
93
L02
ICPC
Back symptom/complaint
2.4
33.5
250
1113
7200A
ICD-9 Finland
Ankylosing spondylitis and other inflammatory spondylopathies, Ankylosing spondylitis
+∞
33.4
32
*
NH3BA
NOMESCO Finland
Foot and toes extensive X-ray examination
3.8
33.1
103
280
R42
ICD-10 Finland
Dizziness and giddiness
2.0
33.1
414
2267
ZYC01, ,
SPAT
2.3
32.9
281
1326
T81.4
ICD-10 Finland
Infection following a procedure, not elsewhere classified
2.5
32.9
234
1019
H04.10
ICD-10 Finland
Dry eye syndrome
2.3
32.9
291
1394
N02AA05
ATC
oxycodone; systemic
2.3
32.6
266
1231
K02.1
ICD-10 Finland
Caries of dentine
1.8
32.6
1358
10666
M76.6
ICD-10 Finland
Achilles tendinitis
3.5
32.5
115
341
SPAT1153
SPAT
Removal of sutures
1.9
32.5
549
3325
M01AE52
ATC
naproxen and esomeprazole; oral
4.2
32.2
86
209
M02AA10
ATC
ketoprofen; topical
2.2
32.2
306
1509
ND2DA
NOMESCO Finland
Bilateral hand X-ray examination
5.8
32.2
59
104
L30.9
ICD-10 Finland
Dermatitis, unspecified
1.9
32.0
489
2864
NA7DG
NOMESCO Finland
Spine and spinal cord very extensive MRI examination with high intensity magnet
8.8
32.0
40
46
H02AB04
ATC
methylprednisolone; systemic
2.2
31.8
292
1419
P01AB01
ATC
metronidazole; oral, rectal
1.7
31.5
854
5940
7208A
ICD-9 Finland
Ankylosing spondylitis and other inflammatory spondylopathies, Other inflammatory spondylopathies
+∞
31.3
30
*
NH3DA
NOMESCO Finland
Bilateral foot X-ray examination
5.5
31.2
61
114
N06AX11
ATC
mirtazapine; oral
1.8
31.2
686
4494
C07AB07
ATC
bisoprolol; oral
1.7
31.0
767
5193
K57.3
ICD-10 Finland
Diverticular disease of large intestine without perforation or abscess
2.2
30.9
296
1462
ZXH06, ,
SPAT
3.1
30.4
133
450
K07.60
ICD-10 Finland
Snapping jaw
2.9
30.2
149
539
SPAT1260
SPAT
Consultation of another employee
2.1
30.1
333
1738
D07AC01
ATC
betamethasone; topical
1.7
30.0
745
5038
WZC00, ,
SPAT
2.1
29.9
329
1713
NAG62
NOMESCO Finland
Posterior fusion of lumbar spine with fixation, 2-3 vertebraea
157.2
29.7
31
*
N02AJ13
ATC
tramadol and paracetamol; systemic
5.9
29.7
53
91
E0000UV, ,
ATC
1.7
29.5
897
6403
M15.9
ICD-10 Finland
Polyarthrosis, unspecified
3.2
29.4
119
384
NE1CG
NOMESCO Finland
Pelvic, hip and femur extensive MRI examination with high intensity magnet
6.1
29.4
51
85
ZY010, ,
SPAT
6.1
29.4
51
85
M47.1
ICD-10 Finland
Other spondylosis with myelopathy
+∞
29.2
28
*
SFA20
NOMESCO Finland
Two-surface restoration
1.7
28.9
1321
10467
M51.9
ICD-10 Finland
Intervertebral disc disorder, unspecified
28.3
28.9
39
14
J01FA10
ATC
azithromycin; systemic
1.7
28.9
1280
10060
R20.2
ICD-10 Finland
Paraesthesia of skin
2.7
28.7
165
647
ABC56
NOMESCO Finland
Decompression of lumbar spinal canal and nerve roots
104.8
28.7
31
*
L04AA01
ATC
[U] ciclosporin
6.6
28.6
46
71
J02AC01
ATC
fluconazole; systemic
1.7
28.6
889
6370
SAA02
NOMESCO Finland
Basic examination of mouth
1.7
28.4
1517
12504
L40.3
ICD-10 Finland
Pustulosis palmaris et plantaris
5.5
28.4
55
102
R10.1
ICD-10 Finland
Pain localized to upper abdomen
2.0
28.3
366
2019
R03DC03
ATC
montelukast; oral
2.0
28.2
370
2051
WX110
NOMESCO Finland
Infiltration anesthesia
1.8
28.1
1561
12987
G47.3
ICD-10 Finland
Sleep apnoea
1.9
28.0
462
2760
K52.9
ICD-10 Finland
Noninfective gastroenteritis and colitis, unspecified
3.5
28.0
97
284
R4120
NOMESCO Finland
Occupational therapy
2.7
27.8
152
581
SPAT1310
SPAT
Counselling related to known health issue
1.8
27.8
605
3927
M13.1
ICD-10 Finland
Monoarthritis, not elsewhere classified
6.5
27.8
45
70
ACC51
NOMESCO Finland
Release of median nerve
2.6
27.8
165
658
UJF92
NOMESCO Finland
Capsular endoscopy
4.7
27.6
64
139
R03AC03
ATC
terbutaline; inhalant
2.1
27.6
307
1602
B01AB05
ATC
enoxaparin; parenteral
1.8
27.5
558
3546
M54.0
ICD-10 Finland
Panniculitis affecting regions of neck and back
7.6
26.8
38
51
M01AC01
ATC
piroxicam; systemic, rectal
2.3
26.8
226
1058
L40.0
ICD-10 Finland
Psoriasis vulgaris
3.1
26.5
115
387
M25.9
ICD-10 Finland
Joint disorder, unspecified
6.2
26.3
45
74
J01DA01
ATC
[U] cefalexin
1.6
26.2
1257
9967
M79.1
ICD-10 Finland
Myalgia
2.0
26.2
338
1859
M19.0
ICD-10 Finland
Primary arthrosis of other joints
2.4
26.1
187
815
M17.0
ICD-10 Finland
Primary gonarthrosis, bilateral
2.2
25.9
227
1078
ZXA05
NOMESCO Finland
Left side
1.9
25.7
394
2294
L04AK01
ATC
leflunomide; oral
8.2
25.7
34
42
J01FA06
ATC
roxithromycin; oral
1.7
25.6
777
5490
H05BA01
ATC
calcitonin (salmon synthetic); nasal, parenteral
6.6
25.6
41
63
K50.8
ICD-10 Finland
Other Crohn disease
4.9
25.6
56
116
M43.0
ICD-10 Finland
Spondylolysis
33.5
25.6
33
10
M51.8
ICD-10 Finland
Other specified intervertebral disc disorders
33.5
25.6
33
10
K50.0
ICD-10 Finland
Crohn disease of small intestine
4.9
25.3
56
117
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
2.3
25.3
208
962
SPAT1229
SPAT
Assessment of need for aid
3.0
25.3
118
414
Z50.9
ICD-10 Finland
Care involving use of rehabilitation procedure, unspecified
3.6
25.3
85
244
ZXE10
NOMESCO Finland
More than one and less than three hours
1.7
25.1
642
4335
ABC26
NOMESCO Finland
Open discectomy of lumbar spine
+∞
25.0
24
*
R01AD09
ATC
mometasone; nasal
1.6
25.0
997
7522
NH1CG
NOMESCO Finland
Ankle and foot extensive MRI examination with high intensity magnet
5.7
24.8
46
82
203
Kela drug reimbursment
Chronic asthma and similar chronic obstructive pulmonary diseases
1.9
24.7
374
2167
J01CA04
ATC
amoxicillin; systemic
1.9
24.6
1771
15486
SPAT1256
SPAT
Intramuscular and subcutaneous injection
1.6
24.6
746
5259
M05BA04
ATC
alendronic acid; oral
2.7
24.5
135
518
SAA01
NOMESCO Finland
Simple examination of mouth
1.7
24.4
1579
13377
M76.8
ICD-10 Finland
Other enthesopathies of lower limb, excluding foot
5.2
24.3
50
98
WZC30, ,
SPAT
2.4
24.3
179
789
Z04.8
ICD-10 Finland
Examination and observation for other specified reasons
2.0
24.1
274
1439
TQX10
NOMESCO Finland
Biopsy of skin and subcutaneous tissue
2.4
24.0
170
736
K50.9
ICD-10 Finland
Crohn disease, unspecified
4.9
23.9
53
111
R4180
NOMESCO Finland
Podiatric therapy
6.0
23.9
42
71
R07.3
ICD-10 Finland
Other chest pain
2.3
23.8
196
907
J20.9
ICD-10 Finland
Acute bronchitis, unspecified
1.9
23.8
380
2237
ZXA00
NOMESCO Finland
Right side
1.8
23.8
416
2518
X59
ICD-10 Finland
Exposure to unspecified factor
1.8
23.8
384
2268
SFA10
NOMESCO Finland
One-surface restoration
1.6
23.6
1197
9513
SAA03
NOMESCO Finland
Extended examination of mouth
1.6
23.4
853
6267
L15
ICPC
Knee symptom/complaint
1.7
23.3
485
3086
UJF30
NOMESCO Finland
Ileoscopy through colon
2.2
23.2
219
1070
WZA90
NOMESCO Finland
Other medical or dental certificate
1.7
23.1
481
3060
M01AB01
ATC
indometacin; systemic, rectal
2.9
23.1
109
385
K51.9
ICD-10 Finland
Ulcerative colitis, unspecified
3.4
23.1
86
264
M53.0
ICD-10 Finland
Cervicocranial syndrome
2.2
23.0
202
959
9211
FHL
Exploration or removal of diskusprolapse
+∞
23.0
22
*
NK6QA
NOMESCO Finland
Measurement of bone density from two or more locations with X-ray
2.6
22.7
142
580
FP1B5
NOMESCO Finland
Resting ECG, 12 leads
4.7
22.7
52
112
L16
ICPC
Ankle symptom/complaint
2.0
22.6
263
1390
NA3AD
NOMESCO Finland
Lumbar spine and sacrum CT examination
6.6
22.6
36
55
R03AK06
ATC
salmeterol and fluticasone; inhalant
2.0
22.6
254
1327
M35.0
ICD-10 Finland
Sicca syndrome [Sjögren]
5.0
22.6
48
97
N05BA01
ATC
diazepam; systemic, rectal
2.1
22.3
236
1205
SPAT1203
SPAT
Injection therapy, other than intramuscular or subcutaneous
3.7
22.0
71
198
C01DA08
ATC
isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal
2.0
22.0
284
1556
K03.82
ICD-10 Finland
Split tooth for reasons other than trauma
1.6
21.7
628
4346
R06AE07
ATC
cetirizine; oral
1.6
21.6
936
7118
Z01.2
ICD-10 Finland
Dental examination
1.6
21.6
1017
7881
C08CA01
ATC
amlodipine; oral
1.7
21.6
564
3804
WZC00
NOMESCO Finland
Treatment plan or consultation
1.6
21.5
751
5436
M01AE01
ATC
ibuprofen; systemic, rectal
2.2
21.4
1954
17837
NDL52
NOMESCO Finland
Tenosynovectomy of hand
8.3
21.4
28
34
H02BX01
ATC
methylprednisolone, combinations; systemic
3.3
21.3
80
247
XCW99
NOMESCO Finland
Other investigative procedure of eye
2.2
21.2
189
902
J01CR02
ATC
amoxicillin and beta-lactamase inhibitor; systemic
1.5
21.2
1096
8657
TNF11
NOMESCO Finland
Injection of diagnostic or therapeutic substance in hip joint
34.2
21.1
27
8
M75.4
ICD-10 Finland
Impingement syndrome of shoulder
2.7
21.0
120
469
NF2AT
NOMESCO Finland
Injection to hip joint with ultrasound guidance
16.7
20.9
33
20
J45.1
ICD-10 Finland
Nonallergic asthma
2.5
20.9
136
566
M46
ICD-10 Finland
Other inflammatory spondylopathies
+∞
20.9
20
*
M07.4*K50.9
ICD-10 Finland
Arthropathy in Crohn's disease [regional enteritis]
24.5
20.9
29
12
L04AA17
ATC
[U] adalimumab
21.7
20.8
30
14
M53.2
ICD-10 Finland
Spinal instabilities
77.6
20.7
23
*
NA6BM
NOMESCO Finland
Sacro-iliac joint MRI examination with 3 Tesla magnet
77.6
20.7
23
*
AA1AD
NOMESCO Finland
CT of head and brain
1.7
20.5
428
2714
D50.9
ICD-10 Finland
Iron deficiency anaemia, unspecified
2.3
20.5
155
691
K21.9
ICD-10 Finland
Gastro-oesophageal reflux disease without oesophagitis
2.1
20.5
203
1011
J04AB02
ATC
rifampicin; systemic
6.3
20.2
34
55
R1240
NOMESCO Finland
Social assessment of need and possibilities of rehabilitation
6.3
20.2
34
55
SFA30
NOMESCO Finland
Three-surface restoration
1.5
20.0
865
6545
G55.2*M47.9
ICD-10 Finland
Nerve root and plexus compressions in spondylosis
19.0
20.0
30
16
M77.9
ICD-10 Finland
Enthesopathy, unspecified
3.1
19.9
86
289
SPAT1028
SPAT
Ultrasound examination of paranasal sinuses
2.5
19.9
133
561
71240
ICD-8 Finland
Rheumatoid arthritis and allied conditions, Spondylitis ankylopoietica
+∞
19.8
19
*
M35.9
ICD-10 Finland
Systemic involvement of connective tissue, unspecified
5.8
19.8
36
63
N06AA10
ATC
nortriptyline; systemic
4.6
19.7
47
105
H20.8
ICD-10 Finland
Other iridocyclitis
8.2
19.6
26
32
ZXE00
NOMESCO Finland
One hour or less
1.6
19.5
747
5494
I49.9
ICD-10 Finland
Cardiac arrhythmia, unspecified
1.9
19.4
257
1418
R03BA02
ATC
budesonide; inhalant
1.8
19.4
363
2229
TQW40, ,
SPAT
2.1
19.3
205
1046
EB1AA
NOMESCO Finland
Intraoral radiographic dental examination
1.5
19.3
1155
9336
OAB42, ,
SPAT
1.9
19.3
280
1591
M19.2
ICD-10 Finland
Other secondary arthrosis
5.8
19.3
35
61
Z3231
NOMESCO Finland
Registered nurse
1.7
19.3
476
3150
R2130
NOMESCO Finland
Counselling and guidance which enhance independent living
2.2
19.1
165
778
NHL50
NOMESCO Finland
Tenolysis or tenosynovectomy of foot
22.8
19.1
27
12
N05CF01
ATC
zopiclone; oral
1.6
19.0
533
3641
ZXA10
NOMESCO Finland
Bilateral
1.8
19.0
295
1713
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
1.9
19.0
241
1311
L04AC21
ATC
bimekizumab; systemic
55.5
18.9
22
*
NGB20
NOMESCO Finland
Primary total prosthetic replacement of knee joint without patellar part
2.3
18.9
152
695
UDQ12
NOMESCO Finland
Flexible laryngoscopy
2.6
18.9
114
458
ZY010
NOMESCO Finland
Hospital outpatient
2.4
18.9
131
562
X58
ICD-10 Finland
Exposure to other specified factors
1.8
18.8
310
1832
Z01.5
ICD-10 Finland
Diagnostic skin and sensitization tests
2.0
18.8
208
1078
M17.5
ICD-10 Finland
Other secondary gonarthrosis
5.0
18.8
40
81
M17.1
ICD-10 Finland
Other primary gonarthrosis
1.8
18.7
309
1828
A03FA01
ATC
metoclopramide; systemic, rectal
1.7
18.7
426
2760
T84.0
ICD-10 Finland
Mechanical complication of internal joint prosthesis
4.0
18.6
52
131
D01AC20
ATC
imidazoles/triazoles in combination with corticosteroids; topical
1.7
18.6
433
2821
NB2AT
NOMESCO Finland
Intra artrial injection of shoulder with ultrasound guidance
5.4
18.6
36
67
W01
ICD-10 Finland
Fall on same level from slipping, tripping and stumbling
1.6
18.6
506
3430
R02
ICPC
Shortness of breath/dyspnoea
2.0
18.5
220
1169
N05BA04
ATC
oxazepam; oral
1.6
18.5
484
3246
R01AD12
ATC
fluticasone furoate; nasal
1.5
18.5
714
5246
J06.9
ICD-10 Finland
Acute upper respiratory infection, unspecified
1.5
18.4
1197
9804
D07AB02
ATC
hydrocortisone butyrate; topical
1.6
18.4
584
4103
R74
ICPC
Upper respiratory infection acute
1.5
18.4
781
5855
JN3BD
NOMESCO Finland
Extensive abdominal CT
2.2
18.4
170
823
SHA03
NOMESCO Finland
Stomatognathic treatment, demanding
2.9
18.3
86
303
L08
ICPC
Shoulder symptom/complaint
1.7
18.3
420
2725
NA2BG, ,
SPAT
7.2
18.2
27
38
NGF25
NOMESCO Finland
Operation for osteochondritis of knee, arthroscopic
2.5
18.2
118
490
WYA05
NOMESCO Finland
Emergency visit or other similar visit involving procedures
1.5
18.2
959
7517
A01AB09
ATC
miconazole; local oral
2.3
18.2
149
687
G43.9
ICD-10 Finland
Migraine, unspecified
2.2
18.1
162
774
XKD00
NOMESCO Finland
Uroflowmetry
2.1
17.9
175
865
Z96.6
ICD-10 Finland
Presence of orthopaedic joint implants
3.0
17.9
80
274
R01BA52
ATC
pseudoephedrine, combinations; oral
1.6
17.9
571
4012
K07.69
ICD-10 Finland
Dislocation of the jaw joint UNS
4.4
17.8
45
105
NA3DG
NOMESCO Finland
Lumbar spine very extensive MRI examination with high intensity magnet
26.9
17.8
24
9
7890A
ICD-9 Finland
Other symptoms involving abdomen and pelvis, Abdominal pain
2.6
17.8
104
411
M07.5*K51.9
ICD-10 Finland
Arthropathy in ulcerative colitis
18.2
17.8
27
15
SHA02
NOMESCO Finland
Stomatognathic treatment, basic
2.1
17.8
171
841
SPAT1250
SPAT
Comprehensive monitoring of chronic illness
1.7
17.7
356
2228
M70.7
ICD-10 Finland
Other bursitis of hip
3.9
17.6
52
137
AB5CT
NOMESCO Finland
Blockage of nerv root with CT guidance
181.5
17.5
18
*
C03CA01
ATC
furosemide; systemic
1.7
17.4
337
2085
F01
ICPC
Eye pain
3.1
17.4
72
236
NH3FA
NOMESCO Finland
Weight-bearing X-ray of foot
3.8
17.4
52
138
L04AD01
ATC
ciclosporin; systemic
3.9
17.4
50
129
NG1EA
NOMESCO Finland
Knee X-ray examination with wrench
5.4
17.3
34
64
WX290
NOMESCO Finland
Other blockage of nerve
1.5
17.3
1078
8708
J45.0
ICD-10 Finland
Predominantly allergic asthma
2.0
17.3
190
982
F32.2
ICD-10 Finland
Severe depressive episode without psychotic symptoms
2.2
17.3
146
682
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
1.9
17.2
255
1458
D07AD01
ATC
clobetasol; topical
1.7
17.2
323
1982
D01
ICPC
Abdominal pain/cramps general
1.8
17.2
256
1466
N03AE01
ATC
clonazepam; systemic
2.6
17.1
100
395
NA1AD
NOMESCO Finland
Cervical spine CT examination
2.9
17.1
81
287
SPAT1255
SPAT
Intravenous administration of medicine
2.4
17.1
116
493
NA7EA
NOMESCO Finland
Scoliosis X-ray examination
31.7
17.0
22
7
Z87.1
ICD-10 Finland
Personal history of diseases of the digestive system
1.5
17.0
838
6452
M02.1
ICD-10 Finland
Postdysenteric arthropathy
16.1
17.0
27
17
ACC59
NOMESCO Finland
Decompression and freeing of adhesions of peripheral nerve: other or unspecified
3.0
17.0
74
250
R70.0
ICD-10 Finland
Elevated erythrocyte sedimentation rate
4.3
17.0
44
105
G43.0
ICD-10 Finland
Migraine without aura [common migraine]
2.2
16.9
156
754
R1250
NOMESCO Finland
Evaluation of functional capability
3.7
16.9
54
150
NB1BG
NOMESCO Finland
Shoulder and humerus MRI examination with high intensity magnet
3.6
16.9
55
155
NHG80
NOMESCO Finland
Fusion of first tarsometatarsal joint
3.1
16.9
70
230
K07.65
ICD-10 Finland
Temporomandibular joint-pain-dysfunction syndrome
5.4
16.8
33
62
C01CA24
ATC
epinephrine; parenteral
2.1
16.8
156
756
L03.0
ICD-10 Finland
Cellulitis of finger and toe
2.0
16.8
186
963
L12
ICPC
Hand/finger symptom/complaint
1.7
16.8
338
2113
UKC02
NOMESCO Finland
Cystoscopy
2.0
16.8
202
1078
AB5BT
NOMESCO Finland
Blockage of nerv root with X-ray guidance
63.8
16.7
19
*
M05.9
ICD-10 Finland
Seropositive rheumatoid arthritis, unspecified
3.9
16.7
49
128
K30
ICD-10 Finland
Functional dyspepsia
1.9
16.7
225
1247
M05
ICD-10 Finland
Seropositive rheumatoid arthritis
5.5
16.7
32
59
SPAT1325
SPAT
Vaccination
1.6
16.7
520
3627
RF120, ,
NOMESCO Finland
6.5
16.7
27
42
R06AX27
ATC
desloratadine; oral
1.5
16.6
646
4731
N04BC05
ATC
pramipexole; oral
2.4
16.6
114
487
R21
ICPC
Throat symptom/complaint
1.6
16.5
488
3361
R5599
NOMESCO Finland
Other rehabilitation service
3.8
16.4
49
130
J01FA09
ATC
clarithromycin; systemic
1.5
16.4
610
4423
R00.2
ICD-10 Finland
Palpitations
2.0
16.4
177
909
FM1EE
NOMESCO Finland
Extensive structural and functional ultrasound examination of heart
1.7
16.4
353
2247
M65.9
ICD-10 Finland
Synovitis and tenosynovitis, unspecified
2.9
16.3
77
272
A02BX02
ATC
sucralfate; oral
3.2
16.3
64
203
L29
ICPC
Musculoskeletal sympt/complt other
2.1
16.3
161
799
WX408
NOMESCO Finland
General anesthesy, balanced
1.6
16.3
432
2897
F32.11
ICD-10 Finland
Moderate depressive episode with somatic syndrome
3.2
16.3
66
214
R01AD08
ATC
fluticasone; nasal
1.5
16.2
599
4333
XFP96
NOMESCO Finland
Other intraoperative electrophysiological investigation in arhythmia or disturbance of impulse propagation
5.1
16.2
34
68
J31.0
ICD-10 Finland
Chronic rhinitis
2.0
16.2
183
955
C07AB02
ATC
metoprolol; systemic
1.8
16.1
261
1531
A41.0
ICD-10 Finland
Sepsis due to Staphylococcus aureus
4.7
16.1
37
80
D05AX52
ATC
calcipotriol, combinations; topical
2.4
16.1
112
481
K51.5
ICD-10 Finland
Left sided colitis
2.9
16.1
76
269
R53
ICD-10 Finland
Malaise and fatigue
1.6
16.1
481
3319
R51
ICD-10 Finland
Headache
2.2
16.0
134
623
NDG60
NOMESCO Finland
Arthroplasty of first CMC joint
5.0
15.9
34
69
A07AA02
ATC
nystatin; oral
2.5
15.9
98
398
N02CC01
ATC
sumatriptan; nasal, systemic, rectal
1.7
15.9
329
2071
EB1VA, ,
NOMESCO Finland
1.6
15.9
381
2492
F32.9
ICD-10 Finland
Depressive episode, unspecified
1.8
15.8
273
1633
SHA01
NOMESCO Finland
Stomatognathic treatment, simple
1.8
15.8
251
1465
NBG15
NOMESCO Finland
Acromioplastia, arthroscopic
2.5
15.7
101
418
C01DA14
ATC
isosorbide mononitrate; oral
2.2
15.7
142
681
R10.0
ICD-10 Finland
Acute abdomen
2.9
15.7
73
256
C07AA05
ATC
propranolol; systemic
1.6
15.7
409
2729
Z76.0
ICD-10 Finland
Issue of repeat prescription
1.5
15.7
553
3956
M17.9
ICD-10 Finland
Gonarthrosis, unspecified
1.9
15.7
194
1045
D07XC01
ATC
betamethasone; topical
1.9
15.6
221
1243
72880
ICD-8 Finland
Vertebrogenic pain syndrome, Radicula syndrome of lower limbs
+∞
15.6
15
*
C10AC01
ATC
colestyramine; oral
3.3
15.6
58
178
WX402
NOMESCO Finland
General anaesthesia
1.6
15.6
438
2975
J20
ICD-10 Finland
Acute bronchitis
1.9
15.6
206
1134
R5140
NOMESCO Finland
Monitoring the use of the aid
1.9
15.5
194
1049
S01CA01
ATC
dexamethasone and antiinfectives; ophthalmic
1.5
15.4
521
3690
K44.9
ICD-10 Finland
Diaphragmatic hernia without obstruction or gangrene
2.3
15.4
123
561
SPAT1295
SPAT
Other function in accordance with physical therapy nomenclature
2.8
15.4
80
298
WX002
NOMESCO Finland
Sedation and analgesia
1.7
15.4
302
1872
NHL16
NOMESCO Finland
Tenolysis or tenosynovectomy of achilles tendon
38.3
15.4
19
5
A03
ICPC
Fever
1.6
15.3
381
2511
XX9AW
NOMESCO Finland
Production of copy from X-ray picture
3.0
15.3
66
222
R01AD58
ATC
fluticasone, combinations; nasal
1.5
15.3
574
4160
L18
ICPC
Muscle pain
2.6
15.2
86
335
N06AB04
ATC
citalopram; systemic
1.6
15.2
369
2419
S30.0
ICD-10 Finland
Contusion of lower back and pelvis
2.6
15.2
90
359
T88.7
ICD-10 Finland
Unspecified adverse effect of drug or medicament
4.2
15.1
40
97
JN3AD
NOMESCO Finland
Abdominal CT examination
1.8
15.1
221
1257
D64.9
ICD-10 Finland
Anaemia, unspecified
2.1
15.1
151
754
K50.1
ICD-10 Finland
Crohn disease of large intestine
4.3
15.0
38
89
J01CF05
ATC
flucloxacillin; systemic
2.1
15.0
150
748
NH1AA
NOMESCO Finland
Ankle X-ray examination without contrast
2.1
15.0
139
674
NGD05
NOMESCO Finland
Partial excision of meniscus of knee, arthroscopic
2.0
14.9
180
962
UDC00
NOMESCO Finland
Ear microscopy
2.1
14.9
144
710
R09
ICPC
Sinus symptom/complaint
1.9
14.8
184
991
WW200
NOMESCO Finland
Immunization
3.0
14.8
66
226
Y83
ICD-10 Finland
Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
2.3
14.8
112
499
S01BC03
ATC
diclofenac; ophthalmic
3.4
14.8
52
154
QDB10
NOMESCO Finland
Major dressing of wound of skin of lower limb
2.7
14.8
77
287
UJF45
NOMESCO Finland
Flexible sigmoidoscopy with biopsy
2.1
14.8
136
657
M53.3
ICD-10 Finland
Sacrococcygeal disorders, not elsewhere classified
5.1
14.8
31
62
NJ2MA
NOMESCO Finland
Measurement of mechanical axis of lower leg with X-ray
2.5
14.8
97
406
F32.10
ICD-10 Finland
Moderate depressive episode without somatic syndrome
1.9
14.8
183
986
ZZH21
NOMESCO Finland
Graft of patients own bone, small pieces
4.8
14.7
33
70
M47.81
ICD-10 Finland
Other spondylosis, occipito-atlanto-axial region
18.5
14.7
22
12
K52.88
ICD-10 Finland
Other specified noninfective gastroenteritis and colitis
3.6
14.7
47
131
FP1C5
NOMESCO Finland
Resting ECG, 15 leads
5.3
14.7
29
55
RF420, ,
NOMESCO Finland
5.3
14.7
29
55
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
2.0
14.6
176
939
4AB0M, ,
NOMESCO Finland
+∞
14.6
14
*
R05
ICPC
Cough
1.6
14.6
464
3239
J45
ICD-10 Finland
Asthma
1.9
14.5
205
1152
S13.4
ICD-10 Finland
Sprain and strain of cervical spine
2.4
14.5
96
403
NGA30
NOMESCO Finland
Exploration of knee joint, arthroscopic
2.5
14.4
93
386
M65.8
ICD-10 Finland
Other synovitis and tenosynovitis
3.0
14.4
64
219
R03BA01
ATC
beclometasone; inhalant
1.8
14.4
239
1412
SPAT1312
SPAT
General health counselling
1.5
14.4
581
4266
K21.0
ICD-10 Finland
Gastro-oesophageal reflux disease with oesophagitis
2.0
14.3
156
803
TAB00
NOMESCO Finland
Lumbar puncture
2.5
14.3
90
369
J35.0
ICD-10 Finland
Chronic tonsillitis
2.1
14.2
136
667
F33.2
ICD-10 Finland
Recurrent depressive disorder, current episode severe without psychotic symptoms
2.3
14.2
104
457
SFC01
NOMESCO Finland
Additional procedure necessary for restorative treatment
1.5
14.2
534
3862
SDA03
NOMESCO Finland
Periodontal treatment
1.4
14.2
879
7004
R13
ICD-10 Finland
Dysphagia
2.2
14.1
114
523
R03AC12
ATC
salmeterol; inhalant
2.8
14.1
70
255
L40.8
ICD-10 Finland
Other psoriasis
6.7
14.0
22
33
J46
ICD-10 Finland
Status asthmaticus
3.2
14.0
55
175
M16.7
ICD-10 Finland
Other secondary coxarthrosis
5.9
14.0
25
43
SBB10
NOMESCO Finland
Dental impressions
2.1
13.9
140
700
J05AB01
ATC
aciclovir; systemic
1.6
13.9
427
2954
LCA06
NOMESCO Finland
Biopsy of endometrium
1.7
13.9
252
1527
OAB25, ,
SPAT
6.1
13.9
24
40
I10
ICD-10 Finland
Essential (primary) hypertension
1.4
13.9
901
7231
Z3229
NOMESCO Finland
Other healthcare associate professional
2.1
13.7
136
676
SPAT1148
SPAT
Treatment of chronic ulcer or burn
1.9
13.7
174
944
R07.0
ICD-10 Finland
Pain in throat
1.9
13.7
167
894
A46
ICD-10 Finland
Erysipelas
1.8
13.7
215
1248
SDA01
NOMESCO Finland
Periodontal treatment, very brief
1.5
13.7
574
4239
M01AX05
ATC
glucosamine; oral
1.8
13.7
221
1295
XA800
NOMESCO Finland
Neuropsychological investigation
2.5
13.6
89
372
M76.9
ICD-10 Finland
Enthesopathy of lower limb, unspecified
5.0
13.6
29
59
7245A
ICD-9 Finland
Other and unspecified disorders of back, Backache, unspecified
+∞
13.6
13
*
72510
ICD-8 Finland
Displacement of intervertebral disk, Lumbalis cum prolapsu disci
+∞
13.6
13
*
G99.2*M47.1
ICD-10 Finland
Spondylogenic compression of spinal cord
+∞
13.6
13
*
R61.9
ICD-10 Finland
Hyperhidrosis, unspecified
4.7
13.5
31
67
A07EA02
ATC
hydrocortisone; rectal
3.2
13.5
54
174
TNB11
NOMESCO Finland
Injection of diagnostic or therapeutic substance in shoulder joint
10.1
13.5
26
26
M46.2
ICD-10 Finland
Osteomyelitis of vertebra
140.9
13.5
14
*
NFB30
NOMESCO Finland
Primary total prosthetic replacement of hip joint not using cement
2.4
13.4
93
399
O99.1
ICD-10 Finland
Other diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism complicating pregnancy, childbirth and the puerperium
5.1
13.4
28
56
M00.9
ICD-10 Finland
Pyogenic arthritis, unspecified
5.6
13.4
25
45
M02.3
ICD-10 Finland
Reiter disease
21.3
13.3
19
9
SPAT1215
SPAT
Assessment of need for medical rehabilitation
2.6
13.3
75
292
R03BA08
ATC
ciclesonide; inhalant
1.9
13.2
169
919
298, ,
Kela drug reimbursment
10.5
13.2
25
24
SPAT1058
SPAT
PEF monitoring instruction
2.1
13.2
124
604
K59.1
ICD-10 Finland
Functional diarrhoea
2.2
13.2
108
498
M79.2
ICD-10 Finland
Neuralgia and neuritis, unspecified
3.7
13.2
41
112
SPAT1097
SPAT
Recording of ECG
1.8
13.1
199
1144
R1210
NOMESCO Finland
Medical assessment of need and possibilities to rehabilitation
4.5
13.1
31
69
RF410, ,
NOMESCO Finland
5.5
13.1
25
46
R1220
NOMESCO Finland
Psychological examination of need and possibilities to rehabilitation
5.5
13.1
25
46
E66.01
ICD-10 Finland
Obesity due to excess calories
1.8
13.1
212
1243
J01EE02
ATC
sulfadiazine and trimethoprim; systemic
1.5
13.0
511
3717
J32.0
ICD-10 Finland
Chronic maxillary sinusitis
2.0
13.0
155
823
S06.0
ICD-10 Finland
Concussion
1.8
13.0
192
1095
NA3BG, ,
SPAT
2.5
12.9
80
326
D06
ICPC
Abdominal pain localized other
1.9
12.9
173
956
J01MA12
ATC
levofloxacin; systemic
1.7
12.9
278
1763
C03EA01
ATC
hydrochlorothiazide and potassium-sparing agents; oral
1.9
12.9
182
1023
M20.4
ICD-10 Finland
Other hammer toe(s) (acquired)
2.7
12.9
69
262
R03AK07
ATC
formoterol and budesonide; inhalant
1.5
12.8
429
3017
SPAT1131
SPAT
Colonoscopy
3.1
12.8
53
174
A49.9
ICD-10 Finland
Bacterial infection, unspecified
1.9
12.8
158
849
J05AB11
ATC
valaciclovir; oral
1.7
12.8
276
1751
R83
ICPC
Respiratory infection other
1.5
12.7
606
4576
M05BB03
ATC
alendronic acid and colecalciferol; oral
4.2
12.7
33
79
WX320
NOMESCO Finland
Spinalanesthesy
1.5
12.7
405
2819
SPAT1292
SPAT
Other function in accordance with SHToL (Finnish classification of nursing interventions)
2.1
12.7
123
607
K08.80
ICD-10 Finland
Toothache NOS
1.8
12.6
202
1179
M48.1
ICD-10 Finland
Ankylosing hyperostosis [Forestier]
70.3
12.6
14
*
M65.3
ICD-10 Finland
Trigger finger
2.3
12.6
93
411
OAA65, ,
SPAT
1.5
12.5
497
3620
OAB47, ,
SPAT
2.0
12.5
145
763
M46.5
ICD-10 Finland
Other infective spondylopathies
+∞
12.5
12
*
SCA01
NOMESCO Finland
Preventive oral health care, short
1.5
12.5
592
4464
3029
Kela drug reimbursment
Upadacitinib
9.4
12.5
25
27
NHU20
NOMESCO Finland
Removal of internal fixation device from ankle or foot
2.5
12.4
76
308
R60.9
ICD-10 Finland
Oedema, unspecified
2.4
12.4
89
388
1220
FHL
Arthroscopy
2.8
12.4
62
227
P06
ICPC
Sleep disturbance
1.7
12.4
260
1637
M81.9
ICD-10 Finland
Osteoporosis, unspecified
2.7
12.4
66
250
OAB93, ,
SPAT
1.8
12.4
177
999
Z02.7
ICD-10 Finland
Issue of medical certificate
2.0
12.3
134
690
N07CA01
ATC
betahistine; oral
2.2
12.3
109
520
NBA30
NOMESCO Finland
Exploration of joint of shoulder or upper arm, arthroscopic
3.5
12.3
41
118
N05CF02
ATC
zolpidem; oral
1.6
12.2
309
2038
NDM40
NOMESCO Finland
Discission of sheath of tendon of wrist or hand
2.9
12.2
57
201
NA3BM
NOMESCO Finland
Lumbar spine MRI examination with 3 Tesla magnet
37.8
12.2
15
*
NH1BG
NOMESCO Finland
Ankle and foot MRI examination with high intensity magnet
3.3
12.2
45
138
G43.1
ICD-10 Finland
Migraine with aura [classical migraine]
1.9
12.2
161
886
J01MA14
ATC
moxifloxacin; systemic
1.9
12.2
147
785
GX2D5
NOMESCO Finland
Sleep oximetry
5.5
12.1
23
42
R52.1
ICD-10 Finland
Chronic intractable pain
12.5
12.1
21
17
K80
ICPC
Cardiac arrhythmia NOS
2.0
12.1
142
751
NG2CA
NOMESCO Finland
X-ray of patella with specialised projection
8.7
12.0
25
29
Y88.3
ICD-10 Finland
Sequelae of surgical and medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
3.1
12.0
49
160
UDH02
NOMESCO Finland
Rhinopharyngoscopy
2.0
12.0
126
641
M05BX04
ATC
denosumab; parenteral
2.4
12.0
84
363
M25.4
ICD-10 Finland
Effusion of joint
3.9
11.9
35
92
NA3CG, ,
SPAT
4.4
11.9
29
66
EB1SA
NOMESCO Finland
Dental X-ray, bite-wing X-ray on one side of the mouth
1.4
11.9
1140
9682
A04
ICPC
Weakness/tiredness general
1.6
11.9
273
1758
M48.9
ICD-10 Finland
Spondylopathy, unspecified
46.9
11.9
14
*
ZXE20
NOMESCO Finland
More than three and less than five hours
1.8
11.9
195
1147
R5110
NOMESCO Finland
Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it
1.7
11.9
207
1239
M72.2
ICD-10 Finland
Plantar fascial fibromatosis
1.8
11.9
173
982
R60.0
ICD-10 Finland
Localized oedema
1.8
11.8
176
1005
C08CA13
ATC
lercanidipine; oral
1.8
11.8
196
1157
D07AC13
ATC
mometasone; topical
1.5
11.8
531
3959
TND10
NOMESCO Finland
Joint puncture, wrist or finger joint
10.6
11.8
22
21
J01FA01
ATC
erythromycin; systemic
1.6
11.7
293
1927
SPAT1212
SPAT
Extensive examination of musculoskeletal system
2.0
11.7
121
612
FM1AE
NOMESCO Finland
Standard cardiac ultrasound examination
1.7
11.7
251
1589
M04AA01
ATC
allopurinol; systemic
1.9
11.6
150
819
M07.4
ICD-10 Finland
Arthropathy in Crohn disease [regional enteritis]
65.3
11.6
13
*
C08DA01
ATC
verapamil; systemic
2.6
11.6
64
247
NBG10
NOMESCO Finland
Acromioplastia
3.9
11.6
33
85
SPAT1081
SPAT
Cardiorespiratory global assessment
2.5
11.5
72
295
M76.0
ICD-10 Finland
Gluteal tendinitis
3.7
11.5
36
99
J18.9
ICD-10 Finland
Pneumonia, unspecified
1.5
11.5
361
2500
K04.5
ICD-10 Finland
Chronic apical periodontitis
1.5
11.5
503
3727
TDM10
NOMESCO Finland
Puncture of maxillary antrum
2.4
11.5
77
326
S01GX01
ATC
cromoglicic acid; ophthalmic
1.5
11.5
426
3055
M05BA06
ATC
ibandronic acid; systemic
4.0
11.5
32
81
E000006, ,
ATC
2.1
11.5
115
575
72870
ICD-8 Finland
Vertebrogenic pain syndrome, Lumbalgia
+∞
11.5
11
*
R03BB01
ATC
ipratropium bromide; inhalant
3.1
11.5
47
154
NA7BT
NOMESCO Finland
Injection to spinal facet joint with radiological guidance
120.7
11.4
12
*
K59.09
ICD-10 Finland
Constipation, unspecified
2.3
11.4
90
409
S21
ICPC
Skin texture symptom/complaint
1.6
11.4
248
1576
M75.9
ICD-10 Finland
Shoulder lesion, unspecified
2.2
11.4
92
423
M23.2
ICD-10 Finland
Derangement of meniscus due to old tear or injury
1.8
11.3
173
996
Z2446
NOMESCO Finland
Social worker
2.0
11.3
117
592
K51.8
ICD-10 Finland
Other ulcerative colitis
3.5
11.3
38
110
L34
ICPC
Musculoskeletal, Blood test
35.2
11.3
14
*
L04AF03
ATC
upadacitinib; oral
8.9
11.3
23
26
G44.8
ICD-10 Finland
Other specified headache syndromes
3.3
11.2
41
125
KMAK, ,
NOMESCO Finland
1.4
11.2
1055
8900
D94
ICPC
Chronic enteritis/ulcerative colitis
4.8
11.2
25
53
FN1AC
NOMESCO Finland
Angiography of heart and/or coronary arteries
1.6
11.2
250
1599
A03FA02
ATC
cisapride; oral, rectal
2.1
11.2
100
479
RF210, ,
NOMESCO Finland
2.9
11.2
51
178
TQW80
NOMESCO Finland
Local dermatologic skincare
2.9
11.2
51
178
H53.1
ICD-10 Finland
Subjective visual disturbances
2.0
11.1
128
672
G56.2
ICD-10 Finland
Lesion of ulnar nerve
2.7
11.1
59
223
NA1BG, ,
SPAT
3.2
11.1
43
136
R03BA05
ATC
fluticasone; inhalant
1.5
11.0
329
2251
WX780
NOMESCO Finland
Remote monitoring CPAP
2.2
11.0
95
448
TDW99
NOMESCO Finland
Other minor procedure in surgery of ear, nose and larynx
2.6
11.0
61
236
Z03.89
ICD-10 Finland
Observation for other suspected diseases and conditions
1.7
10.9
230
1448
R49.01
ICD-10 Finland
Functional dysphonia
2.6
10.9
60
231
G06.1
ICD-10 Finland
Intraspinal abscess and granuloma
43.5
10.9
13
*
ZXD05
NOMESCO Finland
Urgent procedure
1.4
10.9
540
4091
SPAT1284
SPAT
Extensive health certificate
2.8
10.9
55
203
XF600
NOMESCO Finland
Bloodpressure measurement
2.2
10.9
95
451
SPAT1226
SPAT
Implementation of occupational therapy rehabilitation plan
3.5
10.9
37
108
RS221, ,
NOMESCO Finland
3.9
10.8
31
80
N83.2
ICD-10 Finland
Other and unspecified ovarian cysts
1.7
10.8
209
1286
N10
ICD-10 Finland
Acute tubulo-interstitial nephritis
1.7
10.8
185
1101
K51.3
ICD-10 Finland
Ulcerative (chronic) rectosigmoiditis
3.0
10.8
48
165
L27.0
ICD-10 Finland
Generalized skin eruption due to drugs and medicaments
3.8
10.8
32
85
H40.5
ICD-10 Finland
Glaucoma secondary to other eye disorders
4.9
10.7
23
47
36400
ICD-8 Finland
Iritis, Iridocyclitis acuta
17.9
10.7
16
9
J01FA15
ATC
telithromycin; oral
1.7
10.7
182
1081
C10AA03
ATC
pravastatin; oral
2.3
10.7
83
375
S46.0
ICD-10 Finland
Injury of muscle(s) and tendon(s) of the rotator cuff of shoulder
1.9
10.7
126
668
W19
ICD-10 Finland
Unspecified fall
1.8
10.7
152
857
C09CA01
ATC
losartan; oral
1.5
10.6
363
2556
M22.4
ICD-10 Finland
Chondromalacia patellae
2.5
10.6
66
270
M09AX01
ATC
hyaluronic acid; parenteral
2.8
10.6
51
183
H01
ICPC
Ear pain/earache
1.6
10.6
228
1443
SDA02
NOMESCO Finland
Periodontal treatment, brief
1.4
10.6
709
5648
K58.0
ICD-10 Finland
Irritable bowel syndrome with diarrhoea
2.0
10.6
108
544
H81.1
ICD-10 Finland
Benign paroxysmal vertigo
1.8
10.6
172
1009
CJB10
NOMESCO Finland
Laser discission of secondary cataract
2.2
10.6
92
436
D47.2
ICD-10 Finland
Monoclonal gammopathy of undetermined significance (MGUS)
5.0
10.5
22
44
M01AE51
ATC
ibuprofen, combinations; systemic
5.0
10.5
22
44
S01
ICPC
Pain/tenderness of skin
2.3
10.5
79
353
WX204
NOMESCO Finland
Axillary plexus blockaced
2.5
10.5
65
266
-1, ,
NOMESCO Finland
1.4
10.5
654
5150
SPAT1254
SPAT
Administration of medicine
1.7
10.4
204
1259
R4110, ,
SPAT
1.7
10.4
200
1228
M17
ICD-10 Finland
Gonarthrosis [arthrosis of knee]
1.8
10.4
167
975
ABC60
NOMESCO Finland
Decompression of cervical spinal cord
+∞
10.4
10
*
M03.2*A04.6
ICD-10 Finland
Postinfectious arthropathy in enteritis due to Yersinia enterocolitica
+∞
10.4
10
*
N01
ICPC
Headache
1.6
10.4
225
1426
L11
ICPC
Wrist symptom/complaint
1.7
10.4
184
1106
DM1AA
NOMESCO Finland
Paranasal sinuses X-ray examination without contrast
2.5
10.4
63
255
U07
ICPC
Urine symptom/complaint other
1.9
10.4
127
682
D02
ICPC
Abdominal pain epigastric
2.0
10.4
115
597
UGC12
NOMESCO Finland
Flexible bronchoscopy
2.1
10.3
98
480
D07AB08
ATC
desonide; topical
1.7
10.3
198
1217
M23.9
ICD-10 Finland
Internal derangement of knee, unspecified
1.7
10.3
173
1025
71599
ICD-8 Finland
Arthritis, unspecified
18.9
10.3
15
8
P01
ICPC
Feeling anxious/nervous/tense
1.6
10.2
290
1960
SPAT1156
SPAT
Guidance concerning treatment of rash and skin
1.7
10.2
182
1095
R03AC13
ATC
formoterol; inhalant
2.3
10.2
80
363
L92
ICPC
Shoulder syndrome
3.1
10.2
42
138
A08.4
ICD-10 Finland
Viral intestinal infection, unspecified
2.3
10.2
74
325
GD1DD
NOMESCO Finland
High resolution CT examination of lungs
2.3
10.2
79
357
EC1VA, ,
NOMESCO Finland
2.1
10.2
93
449
M16.1
ICD-10 Finland
Other primary coxarthrosis
1.9
10.2
136
751
SFA00
NOMESCO Finland
Small restoration
1.6
10.2
267
1773
ZXD10
NOMESCO Finland
Scheduled procedure
1.4
10.2
612
4785
J45.8
ICD-10 Finland
Mixed asthma
2.7
10.2
53
199
AA3AI
NOMESCO Finland
Cone beam CT of facial bones
3.9
10.1
29
75
J01EA01
ATC
trimethoprim; systemic
1.5
10.1
424
3108
J22
ICD-10 Finland
Unspecified acute lower respiratory infection
1.9
10.1
128
695
S89.9
ICD-10 Finland
Unspecified injury of lower leg
2.3
10.1
75
333
T81.0
ICD-10 Finland
Haemorrhage and haematoma complicating a procedure, not elsewhere classified
2.0
10.1
102
512
Z76.9
ICD-10 Finland
Person encountering health services in unspecified circumstances
1.7
10.1
181
1092
R05
ICD-10 Finland
Cough
1.5
10.0
382
2748
ZXE13
NOMESCO Finland
Procedure duration 90 to 119 minutes
2.3
10.0
75
334
Z03.3
ICD-10 Finland
Observation for suspected nervous system disorder
2.1
10.0
90
432
T84.5
ICD-10 Finland
Infection and inflammatory reaction due to internal joint prosthesis
4.8
10.0
22
46
NH3CG
NOMESCO Finland
Extensive MRI of foot
4.8
10.0
22
46
S97
ICPC
Chronic ulcer skin
2.2
10.0
81
373
TNC11
NOMESCO Finland
Injection of diagnostic or therapeutic substance in elbow joint
14.6
10.0
16
11
M94.0
ICD-10 Finland
Chondrocostal junction syndrome [Tietze]
2.8
10.0
49
178
SPAT1240
SPAT
Therapeutic discussion
1.6
10.0
214
1353
DM1AI
NOMESCO Finland
Cone beam CT of paranasal sinus
2.5
10.0
62
254
C08CA05
ATC
nifedipine; systemic
2.2
9.9
79
361
Z01.9
ICD-10 Finland
Special examination, unspecified
2.0
9.9
101
509
NG1BG
NOMESCO Finland
Knee and lower leg MRI examination with high intensity magnet
2.1
9.9
91
441
TNH10
NOMESCO Finland
Joint puncture, ankle joint or foot joint
16.8
9.9
15
9
M07.2*L40.5
ICD-10 Finland
Psoriatic spondylitis
16.8
9.9
15
9
A02BB01
ATC
misoprostol; oral
16.8
9.9
15
9
KC1EE
NOMESCO Finland
Ultrasound measurement of residual urine
1.8
9.8
138
774
M50.9
ICD-10 Finland
Cervical disc disorder, unspecified
12.2
9.8
17
14
L03.1
ICD-10 Finland
Cellulitis of other parts of limb
2.6
9.8
56
220
M07.5
ICD-10 Finland
Arthropathy in ulcerative colitis
26.1
9.8
13
5
B01AB04
ATC
dalteparin; parenteral
2.2
9.8
84
396
F51.0
ICD-10 Finland
Nonorganic insomnia
1.5
9.8
361
2580
ZXX03
NOMESCO Finland
Extent of procedure, 3 units
8.8
9.8
20
23
NK4AT
NOMESCO Finland
Puncture of joint with ultrasound guidance not elsewher classified
4.7
9.8
22
47
J01DA09
ATC
[U] cefadroxil
1.4
9.8
483
3647
326
Kela drug reimbursment
Adalimumab, golimumab, infliximab and ustekinumab (intestinal diseases)
3.5
9.8
33
96
VALMI, ,
NOMESCO Finland
1.4
9.7
482
3639
WVA20, ,
SPAT
2.4
9.7
63
263
-1, ,
ICPC
2.5
9.7
62
257
M16.0
ICD-10 Finland
Primary coxarthrosis, bilateral
2.2
9.7
83
391
WVA30, ,
SPAT
1.9
9.7
113
597
FB1BD
NOMESCO Finland
Extensive CT examination of arteria pulmonalis
1.9
9.7
112
590
RT272, ,
NOMESCO Finland
13.4
9.7
16
12
G99.2*M51.0
ICD-10 Finland
Lumbar and other intervertebral disc disorders with myelopathy
55.2
9.6
11
*
QXB99, ,
SPAT
2.7
9.6
51
193
WX723
NOMESCO Finland
CPAP therapy
2.1
9.6
87
419
M01AB16
ATC
aceclofenac; oral
2.7
9.6
49
182
K76.0
ICD-10 Finland
Fatty (change of) liver, not elsewhere classified
2.5
9.6
61
253
M01AC02
ATC
tenoxicam; systemic, rectal
2.5
9.6
61
253
M79.9
ICD-10 Finland
Soft tissue disorder, unspecified
4.5
9.6
23
52
DM1QA
NOMESCO Finland
Paranasal sinuses X-ray examination in one projection
2.2
9.5
80
374
S22.3
ICD-10 Finland
Fracture of rib
1.9
9.5
112
594
F32.1
ICD-10 Finland
Moderate depressive episode
1.8
9.5
140
798
R75
ICPC
Sinusitis acute/chronic
2.0
9.5
102
524
SPAT1225
SPAT
Implementation of podiatry rehabilitation plan
3.2
9.5
37
118
LC2BE
NOMESCO Finland
Transvaginal ultrasound examination of uterus, parametria and lower abdomen
1.4
9.5
588
4612
M05BA07
ATC
risedronic acid; oral
3.2
9.5
36
113
A02BC04
ATC
rabeprazole; oral
1.7
9.4
157
927
M96.1
ICD-10 Finland
Postlaminectomy syndrome, not elsewhere classified
100.5
9.4
10
*
M41.1
ICD-10 Finland
Juvenile idiopathic scoliosis
100.5
9.4
10
*
4AA12, ,
NOMESCO Finland
7.6
9.4
21
28
NA1CM
NOMESCO Finland
Cervical spine extensive MRI examination with 3 Tesla magnet
30.2
9.4
12
*
N05AH04
ATC
quetiapine; oral
1.5
9.4
316
2215
N06AX12
ATC
bupropion; oral
1.7
9.4
162
967
G55.1*M51.9
ICD-10 Finland
Nerve root and plexus compressions in intervertebral disc disorders (M50-M51+)
21.8
9.3
13
6
NB1BA
NOMESCO Finland
Shoulder extensive X-ray examination without contrast
2.7
9.3
48
179
ZX114
NOMESCO Finland
Intramuscular
3.4
9.3
32
94
L04
ICPC
Chest symptom/complaint
1.9
9.3
111
591
RS222, ,
NOMESCO Finland
4.5
9.3
22
49
M01AG02
ATC
tolfenamic acid; oral, rectal
1.5
9.3
287
1976
E27.3
ICD-10 Finland
Drug-induced adrenocortical insufficiency
10.7
9.3
17
16
SPAT1130
SPAT
Esophagoscopy, gastroscopy and duodenoscopy
2.7
9.2
48
180
N06AX03
ATC
mianserin; oral
2.3
9.2
70
314
S04
ICPC
Lump/swelling localized
1.6
9.2
205
1309
G62.9
ICD-10 Finland
Polyneuropathy, unspecified
2.9
9.2
42
147
SPAT1377
SPAT
Polysomnography
2.4
9.2
61
258
S80.0
ICD-10 Finland
Contusion of knee
1.8
9.2
147
859
K13.79
ICD-10 Finland
Change in the oral mucosa UNS
2.5
9.2
58
240
DMB20
NOMESCO Finland
Functional endoscopic opening of maxillary antrum
2.0
9.1
102
531
M53.8
ICD-10 Finland
Other specified dorsopathies
7.8
9.1
20
26
L04AC07
ATC
tocilizumab; parenteral
7.8
9.1
20
26
F43.21
ICD-10 Finland
Adaptation disorder with prolonged depression
4.3
9.1
23
54
SPAT1216
SPAT
Assessment of functional ability
1.7
9.1
173
1060
J01
ICD-10 Finland
Acute sinusitis
1.8
9.1
125
697
EBA00
NOMESCO Finland
Extraction of tooth
1.4
9.1
682
5503
WX200
NOMESCO Finland
Interscalenous plexus blockade
3.1
9.1
37
121
S92.3
ICD-10 Finland
Fracture of metatarsal bone
2.2
9.1
74
342
M32.9
ICD-10 Finland
Systemic lupus erythematosus, unspecified
4.4
9.1
22
50
S01XA18
ATC
ciclosporin; ophthalmic
4.4
9.1
22
50
G03DB01
ATC
dydrogesterone; oral
1.5
9.1
257
1736
E000001, ,
ATC
1.5
9.1
357
2581
R05FA02
ATC
opium derivatives and expectorants; systemic
1.4
9.1
682
5506
TCF00
NOMESCO Finland
Subconjunctival therapeutic injection
11.5
9.1
16
14
G50.1
ICD-10 Finland
Atypical facial pain
3.4
9.0
32
96
G55.1
ICD-10 Finland
Nerve root and plexus compressions in intervertebral disc disorders
15.6
9.0
14
9
7140B
ICD-9 Finland
Rheumatoid arthritis and other inflammatory polyarthropathies, Rheumatoid arthritis[ARTHRITIS RHEUMATOIDES SERONEGATIVA]
9.1
9.0
18
20
RK220, ,
NOMESCO Finland
9.1
9.0
18
20
3640A
ICD-9 Finland
Disorders of iris and ciliary body, Acute and subacute iridocyclitis
36.8
9.0
11
*
V49.9
ICD-10 Finland
Car occupant [any] injured in unspecified traffic accident
2.2
9.0
73
337
NHL68
NOMESCO Finland
Tenodesis, shortening or lengthening of tendon of foot
4.1
9.0
24
59
U05
ICPC
Urination problems other
2.3
9.0
68
305
SPAT1305
SPAT
Counselling and guidance related to physical exercise
1.8
9.0
129
730
E66.8
ICD-10 Finland
Other obesity
1.9
9.0
116
635
Y83.1
ICD-10 Finland
Surgical operation with implant of artificial internal device as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
3.6
9.0
29
82
XKC03
NOMESCO Finland
Water cystometry
2.8
8.9
43
155
Z2445
NOMESCO Finland
Psychologist
2.2
8.9
76
358
SHA04
NOMESCO Finland
Stomatognathic treatment, very demanding
3.4
8.9
31
92
M51.2
ICD-10 Finland
Other specified intervertebral disc displacement
24.1
8.9
12
5
N41.0
ICD-10 Finland
Acute prostatitis
3.3
8.9
33
102
M66.0
ICD-10 Finland
Rupture of popliteal cyst
3.7
8.9
27
73
Z71.3
ICD-10 Finland
Dietary counselling and surveillance
2.1
8.9
84
412
R01AD01
ATC
beclometasone; nasal
1.5
8.9
278
1919
SPAT1283
SPAT
Restricted health certificate
1.4
8.9
387
2852
N03AX09
ATC
lamotrigine; oral
2.0
8.8
97
502
R91
ICD-10 Finland
Abnormal findings on diagnostic imaging of lung
1.8
8.8
131
748
H26.4
ICD-10 Finland
After-cataract
1.9
8.8
106
566
EMB10
NOMESCO Finland
Tonsillectomy
1.8
8.8
129
734
R06AE09
ATC
levocetirizine; oral
1.5
8.8
288
2007
H81.0
ICD-10 Finland
Ménière disease
3.1
8.7
36
119
NA3CM
NOMESCO Finland
Lumbar spine extensive MRI examination with 3 Tesla magnet
50.2
8.7
10
*
WZA00
NOMESCO Finland
Concise certificate
1.8
8.7
127
723
M23.8
ICD-10 Finland
Other internal derangements of knee
2.2
8.7
74
349
N06AX26
ATC
vortioxetine; oral
1.7
8.6
156
943
L73.2
ICD-10 Finland
Hidradenitis suppurativa
3.2
8.6
33
104
Z03.5
ICD-10 Finland
Observation for other suspected cardiovascular diseases
1.8
8.6
123
694
R35
ICD-10 Finland
Polyuria
2.0
8.6
88
444
R01AD11
ATC
triamcinolone; nasal
1.7
8.6
156
944
K07.68
ICD-10 Finland
Other disorders of the jaw joint
4.8
8.6
19
40
Y88
ICD-10 Finland
Sequelae with surgical and medical care as external cause
4.8
8.6
19
40
NG1CG
NOMESCO Finland
Knee and lower leg extensive MRI examination with high intensity magnet
2.6
8.6
49
193
M77.4
ICD-10 Finland
Metatarsalgia
1.8
8.6
122
688
M53.9
ICD-10 Finland
Dorsopathy, unspecified
8.2
8.6
18
22
R22.9
ICD-10 Finland
Localized swelling, mass and lump, unspecified
1.7
8.6
175
1093
R99
ICPC
Respiratory disease other
3.1
8.6
35
115
E27.4
ICD-10 Finland
Other and unspecified adrenocortical insufficiency
16.3
8.5
13
8
N06AB10
ATC
escitalopram; oral
1.4
8.5
404
3019
ABD30
NOMESCO Finland
Implantation of spinal stimulation device
10.1
8.5
16
16
-50
ICPC
Medication/prescr/renewal
2.3
8.5
60
261
H92.0
ICD-10 Finland
Otalgia
1.8
8.5
127
727
R25.2
ICD-10 Finland
Cramp and spasm
2.9
8.5
39
137
K08.1
ICD-10 Finland
Loss of teeth due to accident, extraction or local periodontal disease
1.7
8.5
167
1033
M75.0
ICD-10 Finland
Adhesive capsulitis of shoulder
1.9
8.5
98
517
NA1DG
NOMESCO Finland
Cervical spine very extensive MRI examination with high intensity magnet
20.1
8.5
12
6
WX006
NOMESCO Finland
Intravenous sedation or analgesia without general anesthesia
1.9
8.5
109
596
R11
ICD-10 Finland
Nausea and vomiting
1.7
8.5
140
826
N05CD07
ATC
temazepam; oral
1.8
8.4
131
760
NB1CG
NOMESCO Finland
Shoulder and humerus extensive MRI examination with high intensity magnet
3.1
8.4
33
106
H02AB09
ATC
hydrocortisone; systemic
2.7
8.4
45
172
EGA00
NOMESCO Finland
Arthroscopy of mandibular joint
12.8
8.4
14
11
SPAT1370
SPAT
Other health check-up
2.2
8.4
65
295
A11
ICPC
Chest pain NOS
1.8
8.3
122
694
K51.2
ICD-10 Finland
Ulcerative (chronic) proctitis
2.8
8.3
40
144
D07BB04
ATC
hydrocortisone butyrate and antiseptics; topical
1.5
8.3
239
1618
K59.0
ICD-10 Finland
Constipation
2.1
8.3
79
388
NA6AG, ,
NOMESCO Finland
+∞
8.3
8
*
7231A
ICD-9 Finland
Other disorders of cervical region, Cervicalgia
+∞
8.3
8
*
4AB0X, ,
NOMESCO Finland
+∞
8.3
8
*
0381A
ICD-9 Finland
Septicaemia, Staphylococcal septicaemia[SEPTICHAEMIA STAPHYLOCOCCUS AUREUS]
+∞
8.3
8
*
K07.63
ICD-10 Finland
Pain in the jaw joint UNS
2.7
8.3
43
161
N39.4
ICD-10 Finland
Other specified urinary incontinence
1.8
8.3
121
687
R31
ICD-10 Finland
Unspecified haematuria
1.8
8.3
120
680
AA1BG
NOMESCO Finland
Standard MRI examination of brain with high intensity magnet
1.7
8.3
157
961
F43.1
ICD-10 Finland
Post-traumatic stress disorder
2.3
8.3
60
264
H15.0
ICD-10 Finland
Scleritis
8.6
8.3
17
20
Z76.8
ICD-10 Finland
Persons encountering health services in other specified circumstances
2.0
8.3
88
451
K05.10
ICD-10 Finland
Gingivitis (chronic) NOS
1.4
8.2
330
2391
J01DA06
ATC
[U] cefuroxime
1.5
8.2
249
1705
RD210, ,
NOMESCO Finland
3.2
8.2
32
102
WW200, ,
SPAT
1.4
8.2
508
3968
D48.0
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Bone and articular cartilage
3.4
8.2
29
87
G44.0
ICD-10 Finland
Cluster headache syndrome
3.4
8.2
29
87
K29.7
ICD-10 Finland
Gastritis, unspecified
2.4
8.2
55
234
FP4B5, ,
SPAT
4.2
8.2
21
50
M77.1
ICD-10 Finland
Lateral epicondylitis
1.7
8.2
155
949
SPAT1104
SPAT
Monitoring of emergency patient
2.0
8.2
91
474
R41.8
ICD-10 Finland
Other and unspecified symptoms and signs involving cognitive functions and awareness
1.8
8.2
118
669
N05BB01
ATC
hydroxyzine; systemic
1.8
8.2
115
647
A02BA03
ATC
famotidine; systemic
2.6
8.1
44
169
Z2221
NOMESCO Finland
Medical doctor
1.4
8.1
481
3731
EP1AE
NOMESCO Finland
Neck ultrasound examination
1.9
8.1
97
518
C03AA03
ATC
hydrochlorothiazide; oral
1.9
8.1
96
511
NA3CF
NOMESCO Finland
Lumbar spine extensive MRI examination with median intensity magnet
33.5
8.1
10
*
7290A
ICD-9 Finland
Other disorders of soft tissues, Rheumatism, unspecified and fibrositis
17.2
8.1
12
7
ZXM20
NOMESCO Finland
Intraoperative use of computerised tomography
11.7
8.1
14
12
S93.4
ICD-10 Finland
Sprain and strain of ankle
1.5
8.1
240
1638
R06.5
ICD-10 Finland
Mouth breathing
1.7
8.1
161
1000
R1410
NOMESCO Finland
Drawing up a rehabilitation plan
8.9
8.0
16
18
D11
ICPC
Diarrhoea
1.5
8.0
233
1583
SPAT1141
SPAT
Excision of skin or mucous membrane lesion
2.2
8.0
67
314
205
Kela drug reimbursment
Chronic hypertension
1.5
8.0
271
1901
M10.9
ICD-10 Finland
Gout, unspecified
2.0
8.0
78
388
A01AB04
ATC
amphotericin B; local oral
2.3
7.9
58
257
SPAT1262
SPAT
Handing over of treatment supplies
1.5
7.9
238
1630
N39.0
ICD-10 Finland
Urinary tract infection, site not specified
1.5
7.9
231
1572
K03.64
ICD-10 Finland
Dental calculus supragingival
1.3
7.9
688
5654
R03AK08
ATC
formoterol and beclometasone; inhalant
2.0
7.9
80
404
CJE20
NOMESCO Finland
Phakoemulsification with implantation of artificial lens in posterior chamber
1.5
7.8
299
2146
FM1DE
NOMESCO Finland
Doppler ultrasound examination of heart
1.8
7.8
120
694
I84.2
ICD-10 Finland
Internal hemorrhoids without complication
1.9
7.8
100
547
SPAT1210
SPAT
Application of cast or individual aid
2.2
7.8
66
311
WX704
NOMESCO Finland
Intubation
1.7
7.8
130
770
WZB00, ,
SPAT
1.6
7.8
181
1169
AN1
HP
Coronary angiography
1.9
7.7
97
526
A02BA04
ATC
nizatidine; systemic
2.0
7.7
87
455
T78.4
ICD-10 Finland
Allergy, unspecified
2.0
7.7
85
441
Z96.1
ICD-10 Finland
Presence of intraocular lens
1.7
7.7
145
886
N02CC04
ATC
rizatriptan; oral
1.8
7.7
122
711
78551
ICD-8 Finland
Symptoms referable to abdomen and lower gastro-intestinal tract, Symptomata abdominalis acuta NUD
2.4
7.7
51
216
L02.4
ICD-10 Finland
Cutaneous abscess, furuncle and carbuncle of limb
2.1
7.7
69
332
H10.3
ICD-10 Finland
Acute conjunctivitis, unspecified
1.7
7.7
137
826
B01AB10
ATC
tinzaparin; parenteral
1.6
7.7
170
1084
R21
ICD-10 Finland
Rash and other nonspecific skin eruption
1.9
7.6
86
450
EBA05
NOMESCO Finland
Complicated extraction of tooth
1.4
7.6
422
3233
J02.9
ICD-10 Finland
Acute pharyngitis, unspecified
1.7
7.6
130
774
AA1CG
NOMESCO Finland
Extensive MRI examination of brain with high intensity magnet
1.7
7.6
141
859
RT271, ,
NOMESCO Finland
18.4
7.6
11
6
S01EC04
ATC
brinzolamide; ophthalmic
2.5
7.6
47
193
L30.3
ICD-10 Finland
Infective dermatitis
2.1
7.6
66
314
M17.3
ICD-10 Finland
Other post-traumatic gonarthrosis
2.6
7.5
41
158
R06AX13
ATC
loratadine; oral
1.4
7.5
297
2144
D07AA02
ATC
hydrocortisone; topical
1.5
7.5
255
1787
ZYY98
NOMESCO Finland
Missed treatment contact, no notification given by patient
8.9
7.5
15
17
NXL00
NOMESCO Finland
Biopsy of muscle
8.9
7.5
15
17
TPH40
NOMESCO Finland
Insertion of a long peripheral venous catheter
4.1
7.5
20
49
L04AC05
ATC
ustekinumab; parenteral
6.2
7.5
19
31
N41.9
ICD-10 Finland
Inflammatory disease of prostate, unspecified
3.8
7.5
22
58
I20.99
ICD-10 Finland
Angina pectoris, unspecified
2.2
7.5
60
276
Y83.9
ICD-10 Finland
Surgical procedure, unspecified as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
2.3
7.5
52
225
C10AA04
ATC
fluvastatin; oral
2.0
7.5
82
425
J01MA06
ATC
norfloxacin; oral
1.5
7.5
202
1349
OAB72, ,
SPAT
2.8
7.5
36
130
C01DA02
ATC
glyceryl trinitrate; oral, oral aerosol, sublingual, transdermal
1.7
7.5
149
925
A06AD11
ATC
lactulose; oral
1.6
7.5
165
1052
E87.6
ICD-10 Finland
Hypokalaemia
2.3
7.5
53
232
R51.81
ICD-10 Finland
Facial pain NOS
2.4
7.4
47
195
G72.9
ICD-10 Finland
Myopathy, unspecified
6.5
7.4
18
28
TNX50
NOMESCO Finland
Removal of cutom molded cast and internal stretch
1.9
7.4
83
434
M20.1
ICD-10 Finland
Hallux valgus (acquired)
1.7
7.4
124
735
B80
ICPC
Iron deficiency anaemia
2.4
7.4
50
214
H93.1
ICD-10 Finland
Tinnitus
1.8
7.4
116
675
ND1AA
NOMESCO Finland
Wrist X-ray examination
1.8
7.4
115
668
KH1AE
NOMESCO Finland
Urinary tract ultrasound examination
2.0
7.4
80
414
R2110
NOMESCO Finland
Giving the first information
1.7
7.3
135
821
R06AX22
ATC
ebastine; oral
1.4
7.3
327
2415
M02AA15
ATC
diclofenac; topical
1.8
7.3
105
595
C10AX09
ATC
ezetimibe; oral
1.5
7.3
219
1497
CK2X4
NOMESCO Finland
Optical coherence tomography (OCT) of ocular fundus
1.7
7.3
129
776
7249X
ICD-9 Finland
Other and unspecified disorders of back, Other unspecified back disorders
+∞
7.3
7
*
NAG65
NOMESCO Finland
Anterior and posterior fusion of lumbar spine
+∞
7.3
7
*
72899
ICD-8 Finland
Vertebrogenic pain syndrome, Other and unspecified
+∞
7.3
7
*
NHF15
NOMESCO Finland
Synovectomy of ankle, arthroscopic
10.9
7.3
13
12
C05AA08
ATC
fluocortolone; rectal, topical
1.5
7.3
199
1333
RK210, ,
NOMESCO Finland
9.4
7.3
14
15
O47.0
ICD-10 Finland
False labour before 37 completed weeks of gestation
1.6
7.3
174
1131
JF1CG
NOMESCO Finland
Extensive MRI of small bowel
3.8
7.3
21
55
J01XC01
ATC
fusidic acid; systemic
3.2
7.3
27
84
E66.9
ICD-10 Finland
Obesity, unspecified
2.1
7.2
68
334
M89.0
ICD-10 Finland
Algoneurodystrophy
5.8
7.2
19
33
R10.2
ICD-10 Finland
Pelvic and perineal pain
2.4
7.2
47
198
X14
ICPC
Vaginal discharge
2.3
7.2
54
242
H43.8
ICD-10 Finland
Other disorders of vitreous body
1.7
7.2
139
857
J01.9
ICD-10 Finland
Acute sinusitis, unspecified
1.9
7.2
90
489
A04.7
ICD-10 Finland
Enterocolitis due to Clostridium difficile
2.7
7.2
37
139
L03.9
ICD-10 Finland
Cellulitis, unspecified
2.7
7.2
37
139
1222
FHL
Arthroscopy and synovial surgery
3.9
7.2
20
51
NAG41
NOMESCO Finland
Anterior fusion of cervical spine with fixation
30.1
7.1
9
*
SPAT1033
SPAT
Irrigation or wax removal of outer auditory canal
1.5
7.1
212
1446
ZXE11
NOMESCO Finland
Procedure duration 60 to 89 minutes
1.8
7.1
104
592
B35.3
ICD-10 Finland
Tinea pedis
1.9
7.1
86
461
N30.0
ICD-10 Finland
Acute cystitis
1.4
7.1
283
2045
M13
ICD-10 Finland
Other arthritis
20.1
7.1
10
5
Z56.5
ICD-10 Finland
Uncongenial work
20.1
7.1
10
5
R01BA51
ATC
phenylpropanolamine, combinations; oral
1.5
7.1
232
1613
Z03.80
ICD-10 Finland
Observation for other suspected diseases and conditions
2.1
7.1
67
329
L05
ICPC
Flank/axilla symptom/complaint
1.8
7.1
100
563
ZZH40
NOMESCO Finland
Substitute of bone
6.6
7.1
17
26
W00
ICD-10 Finland
Fall on same level involving ice and snow
1.6
7.1
184
1218
NHG22
NOMESCO Finland
Fusion of subtalar joint
7.9
7.1
15
19
E000007, ,
ATC
1.8
7.1
100
564
QX2XE
NOMESCO Finland
Ultrsound examination of soft tissue not elsewhere classified
2.4
7.1
48
206
J01.1
ICD-10 Finland
Acute frontal sinusitis
2.7
7.1
37
140
WX720
NOMESCO Finland
Own respiration
1.9
7.1
80
420
NBF25
NOMESCO Finland
Operation for humeroscapular osteochondritis, arthroscopic
2.9
7.1
32
112
XF402
NOMESCO Finland
ECG with work load test
1.7
7.1
121
722
F45.8
ICD-10 Finland
Other somatoform disorders
1.6
7.1
145
908
D82
ICPC
Teeth/gum disease
1.3
7.0
771
6507
NJ3CG
NOMESCO Finland
Extensive MRI examination of extremities with median high magnet
10.1
7.0
13
13
OAA81, ,
SPAT
1.9
7.0
89
485
P03
ICPC
Feeling depressed
1.5
7.0
199
1344
SPAT1083
SPAT
Initiation and monitoring of IV fluid therapy
2.1
7.0
60
284
E000003, ,
ATC
2.0
7.0
78
407
SPAT1251
SPAT
Organisation of medication
2.3
7.0
48
207
R55
ICD-10 Finland
Syncope and collapse
1.7
7.0
139
863
SGC00
NOMESCO Finland
Medication, disinfection of root canals
1.5
7.0
210
1436
M77.8
ICD-10 Finland
Other enthesopathies, not elsewhere classified
3.9
7.0
20
52
S60.2
ICD-10 Finland
Contusion of other parts of wrist and hand
1.8
7.0
98
552
JN4KR
NOMESCO Finland
Whole body very extensive metabolic PET with CT
4.4
7.0
17
39
J01CE02
ATC
phenoxymethylpenicillin; oral
1.3
7.0
1370
12430
Z71.2
ICD-10 Finland
Person consulting for explanation of investigation findings
1.3
6.9
540
4351
M71.2
ICD-10 Finland
Synovial cyst of popliteal space [Baker]
2.2
6.9
58
272
M75.5
ICD-10 Finland
Bursitis of shoulder
2.5
6.9
40
159
SPAT1101
SPAT
Orthostatic test
2.5
6.9
42
171
Z03.9
ICD-10 Finland
Observation for suspected disease or condition, unspecified
1.4
6.9
277
2004
M03BX01
ATC
baclofen; systemic
2.9
6.9
31
108
H30.2
ICD-10 Finland
Posterior cyclitis
7.5
6.9
15
20
A04.9
ICD-10 Finland
Bacterial intestinal infection, unspecified
4.0
6.9
19
48
NHL30
NOMESCO Finland
Suture or reinsertion of tendon of foot
4.0
6.9
19
48
Q79.6
ICD-10 Finland
Ehlers-Danlos syndrome
13.8
6.9
11
8
M16.6
ICD-10 Finland
Other secondary coxarthrosis, bilateral
13.8
6.9
11
8
R01AC02
ATC
levocabastine; nasal
2.2
6.9
58
273
L01BB02
ATC
mercaptopurine; oral
2.8
6.9
32
114
OAB74, ,
SPAT
3.5
6.8
23
67
M77.0
ICD-10 Finland
Medial epicondylitis
2.3
6.8
50
222
K02
ICD-10 Finland
Dental caries
1.7
6.8
132
814
XQ848
NOMESCO Finland
Dermatological photography
2.3
6.8
49
216
SXC05
NOMESCO Finland
Other oral or dental procedure
1.7
6.8
115
684
NGC20
NOMESCO Finland
Secondary implantation of prosthesis in knee joint, normal prosthesis
11.0
6.8
12
11
D05BB02
ATC
acitretin; oral
2.6
6.8
38
149
SPAT1220
SPAT
Assessment of need for rehabilitation and/or rehabilitation plan
2.0
6.8
73
377
M41.9
ICD-10 Finland
Scoliosis, unspecified
6.1
6.8
17
28
JF1DG
NOMESCO Finland
Small bowel very extensive MRI with with high intensity magnet
6.1
6.8
17
28
H22.1
ICD-10 Finland
Iridocyclitis in other diseases classified elsewhere
40.2
6.8
8
*
W64
ICD-10 Finland
Exposure to other and unspecified animate mechanical forces
4.3
6.7
17
40
T81.9
ICD-10 Finland
Unspecified complication of procedure
2.8
6.7
33
121
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
1.5
6.7
208
1432
I49.3
ICD-10 Finland
Ventricular premature depolarization
1.7
6.7
111
657
N76.0
ICD-10 Finland
Acute vaginitis
1.6
6.7
145
921
Z00.4
ICD-10 Finland
General psychiatric examination, not elsewhere classified
1.6
6.7
173
1146
R5110, ,
SPAT
1.8
6.7
102
590
N71.0
ICD-10 Finland
Acute inflammatory disease of uterus
2.1
6.7
61
297
TEA00
NOMESCO Finland
Biopsy of lip
3.7
6.6
20
54
I49.1
ICD-10 Finland
Atrial premature depolarization
2.2
6.6
56
264
NHG20
NOMESCO Finland
Fusion of talocrural joint
6.4
6.6
16
25
K50
ICD-10 Finland
Crohn disease [regional enteritis]
6.4
6.6
16
25
WX723, ,
SPAT
4.0
6.6
18
45
WYA30
NOMESCO Finland
Treatment of a patient needing special arrangements
1.6
6.6
137
860
K92.1
ICD-10 Finland
Melaena
2.0
6.6
64
318
NA6BG, ,
SPAT
7.8
6.6
14
18
P76
ICPC
Depressive disorder
1.7
6.6
130
806
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
1.8
6.6
96
547
M16.9
ICD-10 Finland
Coxarthrosis, unspecified
2.0
6.6
68
346
XF404
NOMESCO Finland
Ambulatory ECG
1.7
6.6
106
622
120
Kela drug reimbursment
Hypogammaglobulinaemia
12.3
6.6
11
9
TNH31
NOMESCO Finland
Prefabricated orthosis, ankle or foot
3.5
6.6
22
64
R52.0
ICD-10 Finland
Acute pain
2.1
6.5
61
299
K29.1
ICD-10 Finland
Other acute gastritis
3.8
6.5
19
50
SPAT1211
SPAT
Application of soft bandage
1.7
6.5
118
715
S83.2
ICD-10 Finland
Tear of meniscus, current
1.7
6.5
117
708
S90.3
ICD-10 Finland
Contusion of other and unspecified parts of foot
2.1
6.5
55
260
N30.1
ICD-10 Finland
Interstitial cystitis (chronic)
3.7
6.5
20
55
F43.22
ICD-10 Finland
Adaptation disorder with mixed anxiety and depression
1.8
6.5
100
580
D07CC01
ATC
betamethasone and antibiotics; topical
1.5
6.5
209
1451
QDB05
NOMESCO Finland
Revision of wound of skin of lower limb
2.6
6.5
36
141
H26.3
ICD-10 Finland
Drug-induced cataract
5.7
6.4
17
30
N41.1
ICD-10 Finland
Chronic prostatitis
2.7
6.4
32
118
C10AA05
ATC
atorvastatin; oral
1.3
6.4
545
4438
ABC50
NOMESCO Finland
Decopression of cervical spinal canal and nerve roots
70.1
6.4
7
*
H40.0
ICD-10 Finland
Glaucoma suspect
1.7
6.4
113
680
C08CA02
ATC
felodipine; oral
1.8
6.4
99
574
SPAT1043
SPAT
Audiometry
1.7
6.4
111
665
G04CA02
ATC
tamsulosin; oral
1.5
6.4
200
1379
O20.0
ICD-10 Finland
Threatened abortion
2.2
6.4
51
235
IHZ05, ,
SPAT
1.8
6.4
91
515
J06BA01
ATC
immunoglobulins, normal human, for extravascular adm.; systemic
14.3
6.4
10
7
L87
ICPC
Bursitis/tendinitis/synovitis NOS
3.0
6.4
27
91
S01BA07
ATC
fluorometholone; ophthalmic
2.8
6.4
31
113
R41.3
ICD-10 Finland
Other amnesia
2.6
6.4
35
136
E000002, ,
ATC
1.5
6.3
195
1340
L98.4
ICD-10 Finland
Chronic ulcer of skin, not elsewhere classified
3.0
6.3
26
86
NC1AA
NOMESCO Finland
Elbow X-ray examination without contrast
2.1
6.3
56
269
D12.0
ICD-10 Finland
Benign neoplasm: Caecum
2.7
6.3
33
125
F33.10
ICD-10 Finland
Recurrent depression, moderate episode without somatic syndrome
1.7
6.3
110
660
X17
ICPC
Pelvis symptom/complaint female
2.9
6.3
28
97
7151F
ICD-9 Finland
Osteo-arthrosis and allied disorders, Osteo-arthrosis, localised, primary[OSTEOARTHROSIS PRIMARIA, POLVI]
3.6
6.3
20
56
S91
ICPC
Psoriasis
3.6
6.3
20
56
L90
ICPC
Osteoarthrosis of knee
1.9
6.3
81
444
SPAT1144
SPAT
Treatment of reopened or infected surgical wound
1.8
6.3
90
510
SPAT1285
SPAT
Provision of consultation response
1.9
6.3
72
380
L04AA24
ATC
abatacept; parenteral
5.5
6.3
17
31
TEW99
NOMESCO Finland
Other minor procedure in surgery of teeth, jaws, mouth and pharynx
1.9
6.3
79
430
TNB10
NOMESCO Finland
Joint puncture, shoulder joint
11.0
6.3
11
10
SPAT1059
SPAT
Spirometry at the office
1.9
6.3
70
366
A08AA62
ATC
bupropion and naltrexone; systemic
3.5
6.3
21
61
ZYC04, ,
SPAT
3.5
6.3
21
61
NH3AE
NOMESCO Finland
Feet ultrasound examination
9.3
6.3
12
13
71490
ICD-8 Finland
Other specified forms of arthritis, Arthritis postinfectiosa NUD
9.3
6.3
12
13
Z01.7
ICD-10 Finland
Laboratory examination
1.4
6.3
298
2222
R03AK10
ATC
vilanterol and fluticasone furoate; inhalant
1.9
6.3
81
445
SGA01
NOMESCO Finland
Emergency treatment
1.4
6.3
333
2530
XX9TE
NOMESCO Finland
Compementary ultrasound examination
3.9
6.3
18
47
D07BA04
ATC
hydrocortisone and antiseptics; topical
1.5
6.3
184
1253
7242A
ICD-9 Finland
Other and unspecified disorders of back, Lumbago
+∞
6.3
6
*
ABC66
NOMESCO Finland
Decompression of lumbal spinal channel
+∞
6.3
6
*
NAG66
NOMESCO Finland
Posterior interbody fusion of lumbar spine, 2 vertebrae
+∞
6.3
6
*
ABC10
NOMESCO Finland
Microsurgical excision of cervical intervertebral disc displacement
+∞
6.3
6
*
R01AD05
ATC
budesonide; nasal
1.6
6.2
127
794
TNF10
NOMESCO Finland
Puncture of hip joint
26.7
6.2
8
*
K43.9
ICD-10 Finland
Other and unspecified ventral hernia without obstruction or gangrene
2.0
6.2
60
298
R5120
NOMESCO Finland
Preparation of an aid
2.4
6.2
40
168
G97.0
ICD-10 Finland
Cerebrospinal fluid leak from spinal puncture
2.9
6.2
28
98
R96
ICPC
Asthma
1.6
6.2
142
914
WYA10
NOMESCO Finland
Emergency care or similar visit
1.6
6.2
130
819
B02AA02
ATC
tranexamic acid; systemic
1.4
6.2
283
2096
NBG00
NOMESCO Finland
Plastic operation on acromioclavicular joint
3.1
6.2
24
77
K03.80
ICD-10 Finland
Irradiated enamel
1.7
6.2
109
657
3055, ,
Kela drug reimbursment
3.5
6.2
20
57
C09CA06
ATC
candesartan; oral
1.3
6.2
392
3063
DJD20
NOMESCO Finland
Plastic repair of septum of nose
2.0
6.1
60
300
X57
ICD-10 Finland
Unspecified privation
2.4
6.1
38
157
NF1AT
NOMESCO Finland
Puncture of hip joint with ultrasound guidance
7.7
6.1
13
17
A58
ICPC
General and Unspecified, Therapeutic counselling/listening
7.7
6.1
13
17
XLD00
NOMESCO Finland
Sytologyspecimen from mouth of uterus
1.4
6.1
232
1662
WX400
NOMESCO Finland
Inhalation anesthesy
1.9
6.1
72
384
A03CA02
ATC
clidinium and psycholeptics; oral
2.0
6.1
65
335
XX1VW
NOMESCO Finland
Written report from radiologist
3.8
6.1
18
48
ZX198
NOMESCO Finland
Other local administration
3.8
6.1
18
48
TCA20
NOMESCO Finland
Peribulbar therapeutic injection into orbit
12.6
6.1
10
8
Z30.2
ICD-10 Finland
Sterilization
1.5
6.1
206
1445
N06AG02
ATC
moclobemide; oral
2.0
6.1
63
322
L04AA44
ATC
[U] upadacitinib
8.6
6.1
12
14
SAA04
NOMESCO Finland
Special examination of mouth
1.8
6.0
83
465
K04.0
ICD-10 Finland
Pulpitis
1.5
6.0
190
1312
L21.8
ICD-10 Finland
Other seborrhoeic dermatitis
3.1
6.0
24
78
SPAT1149
SPAT
Suture or treatment of traumatic wound
1.6
6.0
156
1033
WGA11
NOMESCO Finland
Planning of pain management
6.7
6.0
14
21
ND1AE
NOMESCO Finland
Wrist ultrasound examination
10.0
6.0
11
11

TimeCodeWAS

↥

TODO / Current known limitations:

  • Only showing the top 300 codes, because showing all (sometimes 20k) makes the page too slow.
  • Legend / how to read the glyphs.
  • Show details (e.g. Fisher or Chi-square test, LR+, etc.) when clicking on a row.
  • Explanation on the underlying data / how the TimeCodeWAS is done (e.g. matched cases / controls, eligibility).
  • Download CSV.
  • No filters and sorters.
  • Limited amount of endpoints (~400) having TimeCodeWAS data.
  • Cross-links to Risteys lab test pages for lab test codes.
OMOP concept
ln(OR)
%cases with code / %controls with code
2×2 table
sulfasalazine; oral, rectal
A07EC01 [21600663]
3.7e+00
4.2e+00
4.6e+00
—
5.2e+00
4.8e+00
4.2e+00
cases:20.26%
controls:0.61%
cases:24.89%
controls:0.50%
cases:9.07%
controls:0.10%
—
—
cases:19.04%
controls:0.13%
cases:39.06%
controls:0.51%
cases:35.69%
controls:0.79%
429
129
1688
21026
527
105
1590
21050
192
21
1925
21134
—
403
28
1714
21111
819
106
1278
20835
712
156
1283
19597
Rheumatology
66 [38004491]
3.0e+00
3.8e+00
3.6e+00
—
4.8e+00
5.1e+00
4.4e+00
cases:24.52%
controls:1.58%
cases:32.50%
controls:1.06%
cases:8.12%
controls:0.24%
—
—
cases:19.23%
controls:0.19%
cases:64.00%
controls:1.07%
cases:63.21%
controls:2.09%
519
334
1598
20821
688
224
1429
20931
172
50
1945
21105
—
407
41
1710
21098
1342
224
755
20717
1261
412
734
19341
etanercept; parenteral
L04AB01 [21603908]
3.1e+00
3.4e+00
3.5e+00
1.0e+50
3.0e+00
4.2e+00
4.3e+00
cases:2.22%
controls:0.10%
cases:2.17%
controls:0.07%
cases:0.90%
controls:0.03%
cases:0.38%
controls:0.00%
cases:0.76%
controls:0.04%
cases:4.15%
controls:0.06%
cases:8.67%
controls:0.13%
47
21
2070
21134
46
15
2071
21140
19
6
2098
21149
8
0
2109
21155
16
8
2101
21131
87
13
2010
20928
173
26
1822
19727
adalimumab; parenteral
L04AB04 [21603911]
3.3e+00
3.2e+00
3.2e+00
—
3.3e+00
4.1e+00
4.2e+00
cases:2.65%
controls:0.10%
cases:2.27%
controls:0.10%
cases:1.23%
controls:0.05%
—
—
cases:1.56%
controls:0.06%
cases:6.10%
controls:0.11%
cases:11.68%
controls:0.19%
56
21
2061
21134
48
21
2069
21134
26
11
2091
21144
—
33
12
2084
21127
128
23
1969
20918
233
38
1762
19715
methotrexate; oral, parenteral
L04AX03 [21603929]
2.8e+00
3.0e+00
2.8e+00
—
3.6e+00
3.8e+00
3.5e+00
cases:13.56%
controls:0.97%
cases:14.69%
controls:0.88%
cases:4.82%
controls:0.29%
—
—
cases:9.40%
controls:0.29%
cases:27.90%
controls:0.88%
cases:32.43%
controls:1.41%
287
205
1830
20950
311
186
1806
20969
102
62
2015
21093
—
199
61
1918
21078
585
185
1512
20756
647
278
1348
19475
methotrexate
L01BA01 [21601423]
2.8e+00
3.0e+00
2.8e+00
—
3.6e+00
3.8e+00
3.5e+00
cases:13.56%
controls:0.97%
cases:14.69%
controls:0.88%
cases:4.82%
controls:0.29%
—
—
cases:9.40%
controls:0.29%
cases:27.90%
controls:0.88%
cases:32.43%
controls:1.41%
287
205
1830
20950
311
186
1806
20969
102
62
2015
21093
—
199
61
1918
21078
585
185
1512
20756
647
278
1348
19475
Acute and subacute iridocyclitis
H20.0 [45542994]
3.4e+00
4.1e+00
3.9e+00
1.0e+50
—
4.1e+00
3.4e+00
cases:8.31%
controls:0.30%
cases:5.86%
controls:0.10%
cases:1.61%
controls:0.03%
cases:1.18%
controls:0.00%
—
—
cases:5.05%
controls:0.09%
cases:8.07%
controls:0.30%
176
63
1941
21092
124
22
1993
21133
34
7
2083
21148
25
0
2092
21155
—
106
19
1991
20922
161
60
1834
19693
Arthritis, unspecified
M13.9 [45567463]
3.0e+00
4.1e+00
4.3e+00
1.0e+50
—
4.0e+00
2.8e+00
cases:7.61%
controls:0.40%
cases:9.02%
controls:0.17%
cases:2.79%
controls:0.04%
cases:1.94%
controls:0.00%
—
—
cases:7.77%
controls:0.15%
cases:9.62%
controls:0.62%
161
84
1956
21071
191
36
1926
21119
59
8
2058
21147
41
0
2076
21155
—
163
32
1934
20909
192
123
1803
19630
Lumbar and other intervertebral disc disorders with radiculopathy
M51.1 [45562747]
4.8e+00
4.2e+00
—
1.0e+50
—
4.7e+00
4.0e+00
cases:3.50%
controls:0.03%
cases:2.88%
controls:0.04%
—
—
cases:0.57%
controls:0.00%
—
—
cases:2.53%
controls:0.02%
cases:5.16%
controls:0.10%
74
6
2043
21149
61
9
2056
21146
—
12
0
2105
21155
—
53
5
2044
20936
103
20
1892
19733
Joint ultrasound examination not elsewhere classified
NK4XE [2001308469]
2.2e+00
3.0e+00
2.1e+00
1.0e+50
2.8e+00
3.7e+00
3.4e+00
cases:3.64%
controls:0.42%
cases:4.20%
controls:0.23%
cases:0.33%
controls:0.04%
cases:5.67%
controls:0.00%
cases:0.47%
controls:0.03%
cases:6.68%
controls:0.17%
cases:12.78%
controls:0.48%
77
89
2040
21066
89
48
2028
21107
7
9
2110
21146
120
0
1997
21155
10
6
2107
21133
140
36
1957
20905
255
95
1740
19658
golimumab; parenteral
L04AB06 [21603913]
2.5e+00
3.4e+00
—
1.0e+50
3.7e+00
3.6e+00
3.8e+00
cases:0.76%
controls:0.06%
cases:1.09%
controls:0.04%
—
—
cases:0.38%
controls:0.00%
cases:0.94%
controls:0.02%
cases:1.96%
controls:0.05%
cases:4.26%
controls:0.10%
16
13
2101
21142
23
8
2094
21147
—
8
0
2109
21155
20
5
2097
21134
41
11
2056
20930
85
19
1910
19734
Rheumatoid/seropositive arthritis
L88 [2002000707]
3.1e+00
3.1e+00
2.8e+00
—
—
4.3e+00
3.8e+00
cases:3.50%
controls:0.17%
cases:2.46%
controls:0.11%
cases:0.52%
controls:0.03%
—
—
—
—
cases:5.82%
controls:0.09%
cases:9.62%
controls:0.25%
74
35
2043
21120
52
24
2065
21131
11
7
2106
21148
—
—
122
18
1975
20923
192
49
1803
19704
Physical Medicine And Rehabilitation
25 [38004468]
2.1e+00
2.8e+00
2.8e+00
1.0e+50
3.9e+00
3.0e+00
2.1e+00
cases:16.15%
controls:2.24%
cases:12.75%
controls:0.87%
cases:2.36%
controls:0.14%
cases:2.22%
controls:0.00%
cases:5.34%
controls:0.11%
cases:15.26%
controls:0.87%
cases:21.15%
controls:3.03%
342
474
1775
20681
270
183
1847
20972
50
30
2067
21125
47
0
2070
21155
113
23
2004
21116
320
182
1777
20759
422
599
1573
19154
infliximab; parenteral
L04AB02 [21603909]
2.2e+00
2.8e+00
1.9e+00
—
2.7e+00
3.4e+00
3.8e+00
cases:1.32%
controls:0.15%
cases:1.28%
controls:0.08%
cases:0.33%
controls:0.05%
—
—
cases:0.57%
controls:0.04%
cases:2.67%
controls:0.10%
cases:4.66%
controls:0.11%
28
31
2089
21124
27
17
2090
21138
7
10
2110
21145
—
12
8
2105
21131
56
20
2041
20921
93
22
1902
19731
etoricoxib; oral
M01AH05 [21603996]
1.4e+00
2.0e+00
2.6e+00
4.7e+00
2.9e+00
1.9e+00
1.3e+00
cases:26.78%
controls:8.40%
cases:20.64%
controls:3.38%
cases:4.72%
controls:0.37%
cases:2.60%
controls:0.02%
cases:7.18%
controls:0.43%
cases:19.36%
controls:3.56%
cases:35.29%
controls:13.09%
567
1778
1550
19377
437
714
1680
20441
100
78
2017
21077
55
5
2062
21150
152
90
1965
21049
406
746
1691
20195
704
2586
1291
17167
Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab, tocilizumab and ustekinumab (rheumatoid diseases)
313 [2001600274]
3.1e+00
3.8e+00
—
1.0e+50
—
5.5e+00
4.2e+00
cases:3.92%
controls:0.18%
cases:2.79%
controls:0.06%
—
—
cases:0.47%
controls:0.00%
—
—
cases:7.34%
controls:0.03%
cases:14.24%
controls:0.24%
83
39
2034
21116
59
13
2058
21142
—
10
0
2107
21155
—
154
7
1943
20934
284
48
1711
19705
Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab and tocilizumab
281 [2001600213]
3.1e+00
3.8e+00
—
—
1.0e+50
5.3e+00
4.1e+00
cases:3.54%
controls:0.17%
cases:2.69%
controls:0.06%
—
—
—
—
cases:1.79%
controls:0.00%
cases:6.96%
controls:0.04%
cases:12.98%
controls:0.25%
75
36
2042
21119
57
13
2060
21142
—
—
38
0
2079
21139
146
8
1951
20933
259
50
1736
19703
celecoxib; oral
M01AH01 [21603992]
1.8e+00
2.8e+00
3.3e+00
—
3.4e+00
2.8e+00
2.0e+00
cases:6.52%
controls:1.10%
cases:4.87%
controls:0.31%
cases:0.99%
controls:0.04%
—
—
cases:1.42%
controls:0.05%
cases:4.96%
controls:0.33%
cases:7.57%
controls:1.07%
138
232
1979
20923
103
66
2014
21089
21
8
2096
21147
—
30
10
2087
21129
104
69
1993
20872
151
212
1844
19541
celecoxib
L01XX33 [21603805]
1.8e+00
2.8e+00
3.3e+00
—
3.4e+00
2.8e+00
2.0e+00
cases:6.52%
controls:1.10%
cases:4.87%
controls:0.31%
cases:0.99%
controls:0.04%
—
—
cases:1.42%
controls:0.05%
cases:4.96%
controls:0.33%
cases:7.57%
controls:1.07%
138
232
1979
20923
103
66
2014
21089
21
8
2096
21147
—
30
10
2087
21129
104
69
1993
20872
151
212
1844
19541
Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
88518-6 [36304997]
2.2e+00
2.9e+00
3.7e+00
1.0e+50
—
3.8e+00
3.0e+00
cases:1.84%
controls:0.22%
cases:1.70%
controls:0.09%
cases:1.13%
controls:0.03%
cases:0.33%
controls:0.00%
—
—
cases:4.34%
controls:0.11%
cases:6.37%
controls:0.34%
39
46
2078
21109
36
20
2081
21135
24
6
2093
21149
7
0
2110
21155
—
91
22
2006
20919
127
68
1868
19685
Connective tissue diseases, rheumatoid arthritis and comparable disease
202 [2001600200]
3.5e+00
4.0e+00
—
—
—
4.8e+00
3.1e+00
cases:12.47%
controls:0.43%
cases:9.21%
controls:0.18%
—
—
—
—
—
—
cases:12.59%
controls:0.12%
cases:9.07%
controls:0.46%
264
90
1853
21065
195
39
1922
21116
—
—
—
264
25
1833
20916
181
90
1814
19663
Differential panel, method unspecified - Blood
69738-3 [42870588]
1.2e+00
1.9e+00
3.4e+00
2.7e+00
2.2e+00
2.1e+00
1.8e+00
cases:8.55%
controls:2.74%
cases:10.20%
controls:1.74%
cases:11.71%
controls:0.42%
cases:0.47%
controls:0.03%
cases:3.78%
controls:0.43%
cases:15.45%
controls:2.15%
cases:25.51%
controls:5.32%
181
579
1936
20576
216
368
1901
20787
248
89
1869
21066
10
7
2107
21148
80
90
2037
21049
324
450
1773
20491
509
1050
1486
18703
Outpatient Visit
OP [9202]
1.0e+00
1.4e+00
1.2e+00
6.3e+00
1.6e+00
2.1e+00
1.5e+00
cases:79.88%
controls:59.45%
cases:69.72%
controls:37.05%
cases:23.90%
controls:8.45%
cases:68.92%
controls:0.41%
cases:31.27%
controls:8.37%
cases:82.98%
controls:37.30%
cases:90.48%
controls:68.90%
1691
12576
426
8579
1476
7837
641
13318
506
1787
1611
19368
1459
86
658
21069
662
1770
1455
19369
1740
7810
357
13131
1805
13610
190
6143
Monocytes [#/volume] in Blood
26484-6 [3001604]
1.1e+00
1.7e+00
3.4e+00
2.7e+00
2.1e+00
2.1e+00
1.8e+00
cases:12.56%
controls:4.75%
cases:14.79%
controls:3.00%
cases:16.15%
controls:0.67%
cases:0.61%
controls:0.04%
cases:5.48%
controls:0.73%
cases:22.32%
controls:3.40%
cases:38.95%
controls:9.65%
266
1004
1851
20151
313
635
1804
20520
342
141
1775
21014
13
9
2104
21146
116
154
2001
20985
468
711
1629
20230
777
1907
1218
17846
Basophils [#/volume] in Blood
26444-0 [3006315]
1.1e+00
1.7e+00
3.4e+00
2.7e+00
2.1e+00
2.1e+00
1.8e+00
cases:12.52%
controls:4.75%
cases:14.79%
controls:3.01%
cases:16.15%
controls:0.67%
cases:0.61%
controls:0.04%
cases:5.43%
controls:0.72%
cases:22.37%
controls:3.41%
cases:39.00%
controls:9.70%
265
1004
1852
20151
313
636
1804
20519
342
141
1775
21014
13
9
2104
21146
115
153
2002
20986
469
715
1628
20226
778
1916
1217
17837
Nuclear Ab [Titer] in Serum
29953-7 [3037522]
1.6e+00
2.3e+00
3.6e+00
1.0e+50
3.2e+00
2.1e+00
1.7e+00
cases:4.63%
controls:0.99%
cases:4.82%
controls:0.50%
cases:2.08%
controls:0.06%
cases:0.28%
controls:0.00%
cases:0.94%
controls:0.04%
cases:3.67%
controls:0.45%
cases:9.87%
controls:2.00%
98
210
2019
20945
102
105
2015
21050
44
12
2073
21143
6
0
2111
21155
20
8
2097
21131
77
94
2020
20847
197
396
1798
19357
Seronegative rheumatoid arthritis
M06.0 [45577103]
2.9e+00
2.9e+00
—
1.0e+50
3.0e+00
3.0e+00
2.8e+00
cases:2.60%
controls:0.15%
cases:2.27%
controls:0.13%
—
—
cases:0.61%
controls:0.00%
cases:0.76%
controls:0.04%
cases:2.43%
controls:0.12%
cases:3.76%
controls:0.23%
55
32
2062
21123
48
28
2069
21127
—
13
0
2104
21155
16
8
2101
21131
51
26
2046
20915
75
46
1920
19707
prednisolone
S01BA04 [21603621]
2.3e+00
2.6e+00
2.5e+00
—
3.0e+00
2.3e+00
1.9e+00
cases:5.90%
controls:0.64%
cases:4.06%
controls:0.31%
cases:0.94%
controls:0.08%
—
—
cases:0.85%
controls:0.04%
cases:3.15%
controls:0.34%
cases:7.42%
controls:1.23%
125
136
1992
21019
86
65
2031
21090
20
17
2097
21138
—
18
9
2099
21130
66
71
2031
20870
148
243
1847
19510
prednisolone
S03BA02 [21605202]
2.3e+00
2.6e+00
2.5e+00
—
3.0e+00
2.3e+00
1.9e+00
cases:5.90%
controls:0.64%
cases:4.06%
controls:0.31%
cases:0.94%
controls:0.08%
—
—
cases:0.85%
controls:0.04%
cases:3.15%
controls:0.34%
cases:7.42%
controls:1.23%
125
136
1992
21019
86
65
2031
21090
20
17
2097
21138
—
18
9
2099
21130
66
71
2031
20870
148
243
1847
19510
Eosinophils/Leukocytes in Blood
26450-7 [3006504]
9.9e-01
1.7e+00
3.3e+00
2.7e+00
2.1e+00
2.0e+00
1.6e+00
cases:11.48%
controls:4.61%
cases:13.98%
controls:2.92%
cases:14.97%
controls:0.64%
cases:0.57%
controls:0.04%
cases:5.34%
controls:0.70%
cases:20.46%
controls:3.22%
cases:33.63%
controls:9.01%
243
976
1874
20179
296
617
1821
20538
317
136
1800
21019
12
8
2105
21147
113
147
2004
20992
429
674
1668
20267
671
1780
1324
17973
Eosinophils [#/volume] in Blood
26449-9 [3013115]
9.9e-01
1.7e+00
3.3e+00
2.6e+00
2.0e+00
2.1e+00
1.8e+00
cases:12.71%
controls:5.12%
cases:15.07%
controls:3.17%
cases:16.49%
controls:0.73%
cases:0.61%
controls:0.05%
cases:5.86%
controls:0.79%
cases:23.13%
controls:3.58%
cases:40.10%
controls:10.21%
269
1083
1848
20072
319
670
1798
20485
349
155
1768
21000
13
10
2104
21145
124
168
1993
20971
485
750
1612
20191
800
2017
1195
17736
Monocytes/Leukocytes in Blood
26485-3 [3019069]
9.8e-01
1.7e+00
3.3e+00
2.7e+00
2.1e+00
2.1e+00
1.6e+00
cases:11.38%
controls:4.60%
cases:14.03%
controls:2.93%
cases:14.97%
controls:0.65%
cases:0.57%
controls:0.04%
cases:5.34%
controls:0.71%
cases:20.55%
controls:3.21%
cases:33.63%
controls:9.02%
241
973
1876
20182
297
620
1820
20535
317
137
1800
21018
12
8
2105
21147
113
150
2004
20989
431
673
1666
20268
671
1781
1324
17972
Lymphocytes [#/volume] in Blood
26474-7 [3019198]
9.8e-01
1.7e+00
3.3e+00
2.7e+00
2.0e+00
2.0e+00
1.7e+00
cases:12.66%
controls:5.18%
cases:14.97%
controls:3.17%
cases:16.11%
controls:0.72%
cases:0.61%
controls:0.04%
cases:5.57%
controls:0.77%
cases:22.37%
controls:3.61%
cases:39.30%
controls:10.22%
268
1095
1849
20060
317
671
1800
20484
341
153
1776
21002
13
9
2104
21146
118
163
1999
20976
469
757
1628
20184
784
2019
1211
17734
Basophils/Leukocytes in Blood
30180-4 [3022096]
9.9e-01
1.7e+00
3.3e+00
2.6e+00
2.1e+00
2.0e+00
1.6e+00
cases:11.48%
controls:4.60%
cases:13.89%
controls:2.89%
cases:14.97%
controls:0.64%
cases:0.57%
controls:0.04%
cases:5.38%
controls:0.69%
cases:20.31%
controls:3.22%
cases:33.78%
controls:9.01%
243
973
1874
20182
294
612
1823
20543
317
136
1800
21019
12
9
2105
21146
114
146
2003
20993
426
675
1671
20266
674
1780
1321
17973
Internal Medicine
11 [38004456]
9.2e-01
1.3e+00
1.5e+00
6.1e+00
1.8e+00
1.5e+00
1.2e+00
cases:31.51%
controls:15.45%
cases:18.75%
controls:6.16%
cases:4.87%
controls:1.10%
cases:16.63%
controls:0.04%
cases:6.28%
controls:1.13%
cases:22.37%
controls:5.87%
cases:33.78%
controls:13.48%
667
3268
1450
17887
397
1304
1720
19851
103
232
2014
20923
352
9
1765
21146
133
239
1984
20900
469
1230
1628
19711
674
2663
1321
17090
buprenorphine; parenteral, sublingual, transdermal
N02AE01 [21604287]
2.3e+00
2.6e+00
2.7e+00
—
2.2e+00
2.2e+00
2.2e+00
cases:1.94%
controls:0.19%
cases:1.75%
controls:0.14%
cases:0.61%
controls:0.04%
—
—
cases:0.52%
controls:0.06%
cases:1.96%
controls:0.21%
cases:4.06%
controls:0.46%
41
41
2076
21114
37
29
2080
21126
13
9
2104
21146
—
11
12
2106
21127
41
44
2056
20897
81
91
1914
19662
hydroxychloroquine; oral
P01BA02 [21604889]
2.2e+00
2.3e+00
2.3e+00
—
2.6e+00
2.4e+00
2.3e+00
cases:7.51%
controls:0.85%
cases:6.90%
controls:0.74%
cases:1.37%
controls:0.14%
—
—
cases:1.89%
controls:0.15%
cases:8.20%
controls:0.78%
cases:10.23%
controls:1.09%
159
180
1958
20975
146
157
1971
20998
29
29
2088
21126
—
40
31
2077
21108
172
163
1925
20778
204
215
1791
19538
Low back pain
M54.5 [45553207]
1.9e+00
2.7e+00
3.4e+00
—
2.7e+00
1.9e+00
1.4e+00
cases:11.38%
controls:1.94%
cases:10.25%
controls:0.78%
cases:1.98%
controls:0.07%
—
—
cases:1.13%
controls:0.08%
cases:5.15%
controls:0.77%
cases:13.23%
controls:3.63%
241
410
1876
20745
217
165
1900
20990
42
15
2075
21140
—
24
17
2093
21122
108
162
1989
20779
264
718
1731
19035
Lymphocytes/Leukocytes in Blood
26478-8 [3002030]
9.4e-01
1.6e+00
3.2e+00
2.6e+00
2.0e+00
1.9e+00
1.5e+00
cases:11.57%
controls:4.88%
cases:13.98%
controls:3.04%
cases:14.69%
controls:0.67%
cases:0.57%
controls:0.04%
cases:5.15%
controls:0.74%
cases:19.93%
controls:3.43%
cases:33.18%
controls:9.59%
245
1032
1872
20123
296
644
1821
20511
311
142
1806
21013
12
9
2105
21146
109
156
2008
20983
418
719
1679
20222
662
1894
1333
17859
Neutrophils/Leukocytes in Blood
26511-6 [3018010]
8.7e-01
1.6e+00
3.2e+00
2.6e+00
2.0e+00
2.0e+00
1.5e+00
cases:10.77%
controls:4.84%
cases:13.37%
controls:2.97%
cases:14.08%
controls:0.66%
cases:0.52%
controls:0.04%
cases:4.91%
controls:0.70%
cases:19.79%
controls:3.36%
cases:32.58%
controls:9.40%
228
1023
1889
20132
283
628
1834
20527
298
140
1819
21015
11
8
2106
21147
104
147
2013
20992
415
703
1682
20238
650
1856
1345
17897
tramadol; oral, parenteral, rectal
N02AX02 [21604298]
1.7e+00
2.2e+00
2.8e+00
—
2.9e+00
2.2e+00
1.7e+00
cases:15.21%
controls:3.26%
cases:9.73%
controls:1.17%
cases:3.16%
controls:0.20%
—
—
cases:2.69%
controls:0.16%
cases:8.73%
controls:1.01%
cases:17.19%
controls:3.59%
322
689
1795
20466
206
247
1911
20908
67
42
2050
21113
—
57
33
2060
21106
183
212
1914
20729
343
709
1652
19044
Arthrocentesis, unspecified region, unspecified region
TNX10 [2001308560]
2.4e+00
3.3e+00
—
1.0e+50
—
4.3e+00
3.4e+00
cases:4.02%
controls:0.40%
cases:4.11%
controls:0.15%
—
—
cases:4.11%
controls:0.00%
—
—
cases:7.01%
controls:0.10%
cases:11.73%
controls:0.42%
85
84
2032
21071
87
32
2030
21123
—
87
0
2030
21155
—
147
21
1950
20920
234
83
1761
19670
HLA-B27 [Presence]
4821-5 [3008898]
2.9e+00
4.4e+00
—
—
2.9e+00
2.0e+00
1.2e+00
cases:5.05%
controls:0.30%
cases:6.28%
controls:0.08%
—
—
—
—
cases:0.52%
controls:0.03%
cases:0.52%
controls:0.07%
cases:1.70%
controls:0.51%
107
63
2010
21092
133
17
1984
21138
—
—
11
6
2106
21133
11
15
2086
20926
34
101
1961
19652
Rheumatoid arthritis, unspecified
M06.9 [45533705]
3.0e+00
4.2e+00
—
1.0e+50
—
3.2e+00
3.0e+00
cases:1.79%
controls:0.09%
cases:1.61%
controls:0.02%
—
—
cases:0.24%
controls:0.00%
—
—
cases:1.24%
controls:0.05%
cases:3.01%
controls:0.15%
38
20
2079
21135
34
5
2083
21150
—
5
0
2112
21155
—
26
11
2071
20930
60
30
1935
19723
tropicamide
S01FA06 [21605065]
3.1e+00
3.8e+00
—
—
—
3.4e+00
3.0e+00
cases:2.41%
controls:0.11%
cases:1.75%
controls:0.04%
—
—
—
—
—
—
cases:1.34%
controls:0.04%
cases:4.01%
controls:0.22%
51
23
2066
21132
37
8
2080
21147
—
—
—
28
9
2069
20932
80
43
1915
19710
Rheumatism, unspecified
M79.0 [45567658]
2.5e+00
4.0e+00
—
1.0e+50
1.0e+50
3.8e+00
3.1e+00
cases:1.75%
controls:0.14%
cases:1.51%
controls:0.03%
—
—
cases:0.85%
controls:0.00%
cases:0.33%
controls:0.00%
cases:1.81%
controls:0.04%
cases:2.76%
controls:0.13%
37
30
2080
21125
32
6
2085
21149
—
18
0
2099
21155
7
0
2110
21139
38
9
2059
20932
55
26
1940
19727
Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
6768-6 [3035995]
7.9e-01
1.2e+00
3.1e+00
3.4e+00
1.6e+00
1.7e+00
1.4e+00
cases:15.40%
controls:7.62%
cases:15.59%
controls:5.12%
cases:17.24%
controls:0.96%
cases:0.94%
controls:0.03%
cases:4.68%
controls:0.98%
cases:23.89%
controls:5.67%
cases:44.31%
controls:16.12%
326
1613
1791
19542
330
1084
1787
20071
365
203
1752
20952
20
7
2097
21148
99
207
2018
20932
501
1188
1596
19753
884
3185
1111
16568
prednisolone; oral, parenteral
H02AB06 [21602734]
1.6e+00
2.2e+00
2.2e+00
—
3.0e+00
2.2e+00
1.8e+00
cases:25.22%
controls:6.22%
cases:19.13%
controls:2.48%
cases:3.54%
controls:0.41%
—
—
cases:6.66%
controls:0.34%
cases:20.17%
controls:2.65%
cases:33.28%
controls:7.65%
534
1315
1583
19840
405
525
1712
20630
75
87
2042
21068
—
141
72
1976
21067
423
554
1674
20387
664
1512
1331
18241
prednisolone
A07EA01 [21600653]
1.6e+00
2.2e+00
2.2e+00
—
3.0e+00
2.2e+00
1.8e+00
cases:25.27%
controls:6.24%
cases:19.18%
controls:2.49%
cases:3.54%
controls:0.41%
—
—
cases:6.66%
controls:0.34%
cases:20.17%
controls:2.66%
cases:33.33%
controls:7.69%
535
1321
1582
19834
406
527
1711
20628
75
87
2042
21068
—
141
72
1976
21067
423
556
1674
20385
665
1519
1330
18234
prednisone; oral
H02AB07 [21602735]
1.6e+00
2.4e+00
2.4e+00
—
2.7e+00
2.2e+00
1.6e+00
cases:4.87%
controls:0.99%
cases:3.02%
controls:0.27%
cases:0.43%
controls:0.04%
—
—
cases:0.66%
controls:0.04%
cases:2.53%
controls:0.29%
cases:4.51%
controls:0.92%
103
209
2014
20946
64
57
2053
21098
9
8
2108
21147
—
14
9
2103
21130
53
60
2044
20881
90
181
1905
19572
prednisone
A07EA03 [21600655]
1.6e+00
2.4e+00
2.4e+00
—
2.7e+00
2.2e+00
1.6e+00
cases:4.87%
controls:0.99%
cases:3.02%
controls:0.27%
cases:0.43%
controls:0.04%
—
—
cases:0.66%
controls:0.04%
cases:2.53%
controls:0.29%
cases:4.51%
controls:0.92%
103
209
2014
20946
64
57
2053
21098
9
8
2108
21147
—
14
9
2103
21130
53
60
2044
20881
90
181
1905
19572
Lumbar spine X-ray examination without contrast
NA3AA [2001307026]
2.5e+00
3.3e+00
—
1.0e+50
—
3.9e+00
3.3e+00
cases:1.56%
controls:0.13%
cases:1.23%
controls:0.05%
—
—
cases:1.23%
controls:0.00%
—
—
cases:1.19%
controls:0.02%
cases:3.81%
controls:0.15%
33
27
2084
21128
26
10
2091
21145
—
26
0
2091
21155
—
25
5
2072
20936
76
29
1919
19724
Neutrophils [#/volume] in Blood by Automated count
751-8 [3013650]
9.0e-01
1.5e+00
2.9e+00
2.1e+00
1.8e+00
2.0e+00
1.7e+00
cases:13.42%
controls:5.95%
cases:15.68%
controls:3.92%
cases:16.96%
controls:1.14%
cases:0.57%
controls:0.07%
cases:6.75%
controls:1.17%
cases:23.99%
controls:4.29%
cases:40.85%
controls:11.26%
284
1259
1833
19896
332
829
1785
20326
359
241
1758
20914
12
15
2105
21140
143
247
1974
20892
503
898
1594
20043
815
2224
1180
17529
Chronic iridocyclitis
H20.1 [45562191]
2.6e+00
3.2e+00
—
1.0e+50
—
3.4e+00
3.6e+00
cases:1.56%
controls:0.12%
cases:1.23%
controls:0.05%
—
—
cases:0.47%
controls:0.00%
—
—
cases:1.43%
controls:0.05%
cases:2.31%
controls:0.07%
33
25
2084
21130
26
11
2091
21144
—
10
0
2107
21155
—
30
10
2067
20931
46
13
1949
19740
Metamyelocytes/Leukocytes in Blood
28541-1 [3002179]
1.1e+00
1.7e+00
3.5e+00
—
2.5e+00
2.0e+00
1.9e+00
cases:0.66%
controls:0.22%
cases:1.28%
controls:0.23%
cases:0.94%
controls:0.03%
—
—
cases:0.52%
controls:0.04%
cases:2.15%
controls:0.31%
cases:6.37%
controls:1.01%
14
47
2103
21108
27
48
2090
21107
20
6
2097
21149
—
11
9
2106
21130
45
65
2052
20876
127
199
1868
19554
Cells panel - Urine sediment
58434-2 [40761535]
9.7e-01
1.6e+00
3.9e+00
1.0e+50
2.1e+00
2.2e+00
1.9e+00
cases:1.61%
controls:0.61%
cases:1.23%
controls:0.26%
cases:1.61%
controls:0.03%
cases:0.24%
controls:0.00%
cases:0.38%
controls:0.05%
cases:2.67%
controls:0.32%
cases:7.67%
controls:1.19%
34
130
2083
21025
26
54
2091
21101
34
7
2083
21148
5
0
2112
21155
8
10
2109
21129
56
66
2041
20875
153
235
1842
19518
Promyelocytes/Leukocytes in Blood
26524-9 [3021440]
1.1e+00
1.8e+00
3.5e+00
—
2.2e+00
2.0e+00
1.9e+00
cases:0.76%
controls:0.26%
cases:1.46%
controls:0.24%
cases:1.23%
controls:0.04%
—
—
cases:0.57%
controls:0.06%
cases:2.43%
controls:0.32%
cases:6.57%
controls:1.07%
16
54
2101
21101
31
50
2086
21105
26
8
2091
21147
—
12
13
2105
21126
51
68
2046
20873
131
211
1864
19542
meloxicam; oral, parenteral, rectal
M01AC06 [21603965]
1.4e+00
2.2e+00
2.4e+00
1.0e+50
3.1e+00
2.0e+00
1.4e+00
cases:14.88%
controls:4.07%
cases:9.54%
controls:1.13%
cases:1.23%
controls:0.12%
cases:1.37%
controls:0.00%
cases:2.55%
controls:0.11%
cases:7.63%
controls:1.14%
cases:14.59%
controls:3.87%
315
860
1802
20295
202
238
1915
20917
26
25
2091
21130
29
0
2088
21155
54
24
2063
21115
160
239
1937
20702
291
765
1704
18988
Neurosurgery
14 [38004459]
1.3e+00
1.9e+00
2.6e+00
1.0e+50
2.8e+00
2.1e+00
1.8e+00
cases:2.93%
controls:0.80%
cases:2.36%
controls:0.36%
cases:0.61%
controls:0.05%
cases:0.61%
controls:0.00%
cases:0.80%
controls:0.05%
cases:2.29%
controls:0.30%
cases:4.61%
controls:0.81%
62
170
2055
20985
50
77
2067
21078
13
10
2104
21145
13
0
2104
21155
17
10
2100
21129
48
62
2049
20879
92
160
1903
19593
Myelocytes/Leukocytes in Blood
26498-6 [3017181]
1.0e+00
1.7e+00
3.5e+00
—
2.2e+00
2.0e+00
1.9e+00
cases:0.76%
controls:0.27%
cases:1.46%
controls:0.26%
cases:1.23%
controls:0.04%
—
—
cases:0.57%
controls:0.06%
cases:2.48%
controls:0.33%
cases:6.82%
controls:1.13%
16
57
2101
21098
31
55
2086
21100
26
8
2091
21147
—
12
13
2105
21126
52
70
2045
20871
136
224
1859
19529
Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood
64084-7 [40766800]
1.9e+00
3.3e+00
—
—
1.0e+50
3.8e+00
3.3e+00
cases:0.43%
controls:0.06%
cases:0.66%
controls:0.02%
—
—
—
—
cases:0.47%
controls:0.00%
cases:1.62%
controls:0.04%
cases:1.80%
controls:0.07%
9
13
2108
21142
14
5
2103
21150
—
—
10
0
2107
21139
34
8
2063
20933
36
14
1959
19739
Blasts/Leukocytes in Blood
26446-5 [3025159]
1.0e+00
1.7e+00
3.5e+00
—
2.1e+00
2.0e+00
1.9e+00
cases:0.66%
controls:0.24%
cases:1.32%
controls:0.25%
cases:1.23%
controls:0.04%
—
—
cases:0.52%
controls:0.06%
cases:2.43%
controls:0.32%
cases:6.67%
controls:1.07%
14
50
2103
21105
28
53
2089
21102
26
8
2091
21147
—
11
13
2106
21126
51
67
2046
20874
133
212
1862
19541
Pharmacy visit
OMOP4822462 [581458]
8.9e-01
1.8e+00
1.1e+00
2.7e+00
1.5e+00
2.1e+00
2.0e+00
cases:95.56%
controls:89.86%
cases:94.95%
controls:75.20%
cases:59.14%
controls:32.27%
cases:19.70%
controls:1.61%
cases:68.26%
controls:32.19%
cases:96.57%
controls:76.79%
cases:99.10%
controls:93.92%
2023
19009
94
2146
2010
15908
107
5247
1252
6827
865
14328
417
341
1700
20814
1445
6804
672
14335
2025
16080
72
4861
1977
18553
18
1200
Erythrocyte sedimentation rate [Velocity] in Red Blood Cells by Westergren method
4537-7 [3013707]
9.1e-01
1.8e+00
3.7e+00
—
2.2e+00
2.0e+00
1.5e+00
cases:17.34%
controls:7.81%
cases:22.25%
controls:4.36%
cases:19.18%
controls:0.60%
—
—
cases:4.87%
controls:0.55%
cases:26.13%
controls:4.54%
cases:46.17%
controls:16.28%
367
1653
1750
19502
471
922
1646
20233
406
127
1711
21028
—
103
116
2014
21023
548
951
1549
19990
921
3216
1074
16537
Pain in joint
M25.5 [45586941]
1.6e+00
2.6e+00
2.7e+00
—
2.3e+00
1.8e+00
1.1e+00
cases:10.25%
controls:2.19%
cases:9.21%
controls:0.77%
cases:2.13%
controls:0.14%
—
—
cases:1.04%
controls:0.10%
cases:5.29%
controls:0.96%
cases:11.43%
controls:4.04%
217
463
1900
20692
195
162
1922
20993
45
30
2072
21125
—
22
22
2095
21117
111
200
1986
20741
228
799
1767
18954
Urinalysis macro (dipstick) panel - Urine
24357-6 [3037467]
6.6e-01
1.2e+00
3.1e+00
3.2e+00
1.3e+00
1.5e+00
1.1e+00
cases:13.98%
controls:7.77%
cases:12.94%
controls:4.21%
cases:12.56%
controls:0.63%
cases:0.66%
controls:0.03%
cases:2.22%
controls:0.62%
cases:16.40%
controls:4.28%
cases:35.39%
controls:14.94%
296
1643
1821
19512
274
891
1843
20264
266
133
1851
21022
14
6
2103
21149
47
132
2070
21007
344
896
1753
20045
706
2952
1289
16801
leflunomide; oral
L04AK01 [955035]
2.6e+00
2.9e+00
—
—
—
3.2e+00
3.3e+00
cases:1.61%
controls:0.12%
cases:1.32%
controls:0.08%
—
—
—
—
—
—
cases:2.19%
controls:0.09%
cases:4.31%
controls:0.16%
34
25
2083
21130
28
16
2089
21139
—
—
—
46
19
2051
20922
86
32
1909
19721
Inpatient Hospital
21 [8717]
6.0e-01
8.8e-01
1.3e+00
5.8e+00
1.5e+00
1.0e+00
8.8e-01
cases:39.58%
controls:26.51%
cases:17.81%
controls:8.28%
cases:3.83%
controls:1.05%
cases:9.64%
controls:0.03%
cases:4.39%
controls:0.97%
cases:18.17%
controls:7.52%
cases:38.65%
controls:20.63%
838
5609
1279
15546
377
1751
1740
19404
81
222
2036
20933
204
7
1913
21148
93
205
2024
20934
381
1574
1716
19367
771
4076
1224
15677
gabapentin; oral
N02BF01 [955005]
1.9e+00
2.0e+00
2.1e+00
—
2.0e+00
2.1e+00
1.8e+00
cases:3.68%
controls:0.54%
cases:2.55%
controls:0.35%
cases:0.80%
controls:0.10%
—
—
cases:0.71%
controls:0.09%
cases:3.10%
controls:0.38%
cases:7.37%
controls:1.26%
78
115
2039
21040
54
74
2063
21081
17
22
2100
21133
—
15
20
2102
21119
65
80
2032
20861
147
249
1848
19504
Cyclic citrullinated peptide Ab [Units/volume] in Serum
53027-9 [3041942]
1.5e+00
2.8e+00
3.9e+00
—
2.1e+00
8.6e-01
8.5e-01
cases:4.96%
controls:1.18%
cases:6.94%
controls:0.46%
cases:2.08%
controls:0.04%
—
—
cases:0.38%
controls:0.05%
cases:1.14%
controls:0.49%
cases:6.02%
controls:2.67%
105
250
2012
20905
147
97
1970
21058
44
9
2073
21146
—
8
10
2109
21129
24
102
2073
20839
120
527
1875
19226
oxycodone; oral, parenteral
N02AA05 [21604260]
1.5e+00
2.3e+00
2.4e+00
—
1.9e+00
2.0e+00
1.5e+00
cases:1.32%
controls:0.30%
cases:1.65%
controls:0.16%
cases:0.76%
controls:0.07%
—
—
cases:0.47%
controls:0.07%
cases:1.86%
controls:0.26%
cases:3.51%
controls:0.77%
28
64
2089
21091
35
34
2082
21121
16
14
2101
21141
—
10
15
2107
21124
39
54
2058
20887
70
152
1925
19601
Dorsalgia, unspecified
M54.9 [45538791]
2.5e+00
4.1e+00
1.0e+50
1.0e+50
1.0e+50
3.1e+00
1.9e+00
cases:4.02%
controls:0.35%
cases:4.39%
controls:0.08%
cases:0.85%
controls:0.00%
cases:0.33%
controls:0.00%
cases:0.57%
controls:0.00%
cases:2.34%
controls:0.11%
cases:3.91%
controls:0.60%
85
73
2032
21082
93
16
2024
21139
18
0
2099
21155
7
0
2110
21155
12
0
2105
21139
49
23
2048
20918
78
119
1917
19634
rofecoxib; oral
M01AH02 [21603993]
1.6e+00
2.5e+00
—
—
2.8e+00
2.9e+00
1.7e+00
cases:2.65%
controls:0.57%
cases:1.61%
controls:0.13%
—
—
—
—
cases:0.38%
controls:0.02%
cases:1.86%
controls:0.10%
cases:2.31%
controls:0.41%
56
121
2061
21034
34
28
2083
21127
—
—
8
5
2109
21134
39
21
2058
20920
46
81
1949
19672
C reactive protein [Mass/volume] in Serum or Plasma
1988-5 [3020460]
5.0e-01
1.1e+00
2.8e+00
3.3e+00
1.5e+00
1.3e+00
8.8e-01
cases:22.39%
controls:14.92%
cases:25.37%
controls:9.87%
cases:21.82%
controls:1.63%
cases:2.55%
controls:0.10%
cases:7.09%
controls:1.70%
cases:29.80%
controls:10.44%
cases:51.58%
controls:30.57%
474
3156
1643
17999
537
2089
1580
19066
462
344
1655
20811
54
21
2063
21134
150
359
1967
20780
625
2187
1472
18754
1029
6038
966
13715
Infectious Disease
44 [38004484]
9.1e-01
1.7e+00
2.0e+00
—
3.4e+00
2.1e+00
1.2e+00
cases:2.31%
controls:0.94%
cases:2.50%
controls:0.45%
cases:0.71%
controls:0.09%
—
—
cases:1.84%
controls:0.06%
cases:3.53%
controls:0.46%
cases:4.31%
controls:1.29%
49
199
2068
20956
53
96
2064
21059
15
20
2102
21135
—
39
13
2078
21126
74
97
2023
20844
86
254
1909
19499
pantoprazole; oral, parenteral
A02BC02 [21600097]
9.0e-01
1.3e+00
1.6e+00
3.6e+00
1.4e+00
1.4e+00
1.1e+00
cases:20.45%
controls:9.45%
cases:16.49%
controls:5.01%
cases:3.40%
controls:0.73%
cases:1.46%
controls:0.04%
cases:3.92%
controls:0.97%
cases:17.26%
controls:4.92%
cases:31.98%
controls:13.02%
433
1999
1684
19156
349
1060
1768
20095
72
154
2045
21001
31
9
2086
21146
83
204
2034
20935
362
1030
1735
19911
638
2572
1357
17181
Low back symptom/complaint
L03 [2002000628]
1.5e+00
2.0e+00
2.2e+00
—
2.5e+00
1.8e+00
1.2e+00
cases:6.33%
controls:1.45%
cases:4.06%
controls:0.55%
cases:0.66%
controls:0.07%
—
—
cases:0.80%
controls:0.07%
cases:3.77%
controls:0.64%
cases:8.27%
controls:2.66%
134
306
1983
20849
86
117
2031
21038
14
15
2103
21140
—
17
14
2100
21125
79
135
2018
20806
165
526
1830
19227
Other Crohn disease
K50.8 [45533599]
1.7e+00
1.6e+00
2.2e+00
—
2.0e+00
1.8e+00
2.0e+00
cases:0.94%
controls:0.17%
cases:0.76%
controls:0.15%
cases:0.28%
controls:0.03%
—
—
cases:0.38%
controls:0.05%
cases:0.81%
controls:0.13%
cases:1.30%
controls:0.18%
20
37
2097
21118
16
32
2101
21123
6
7
2111
21148
—
8
11
2109
21128
17
27
2080
20914
26
36
1969
19717
CBC W Ordered Manual Differential panel - Blood
57782-5 [40760892]
1.1e+00
1.7e+00
3.1e+00
—
2.0e+00
1.8e+00
1.6e+00
cases:5.24%
controls:1.82%
cases:5.57%
controls:1.11%
cases:4.25%
controls:0.21%
—
—
cases:1.46%
controls:0.20%
cases:7.58%
controls:1.29%
cases:19.00%
controls:4.57%
111
386
2006
20769
118
234
1999
20921
90
44
2027
21111
—
31
42
2086
21097
159
270
1938
20671
379
903
1616
18850
pregabalin; oral
N02BF02 [955152]
1.7e+00
1.9e+00
1.8e+00
—
1.9e+00
2.0e+00
1.8e+00
cases:7.04%
controls:1.35%
cases:4.44%
controls:0.68%
cases:1.37%
controls:0.23%
—
—
cases:1.61%
controls:0.24%
cases:4.72%
controls:0.67%
cases:9.67%
controls:1.68%
149
285
1968
20870
94
143
2023
21012
29
49
2088
21106
—
34
50
2083
21089
99
140
1998
20801
193
331
1802
19422
Hip joint ultrasound examination
NF1AE [2001307895]
1.9e+00
2.6e+00
—
1.0e+50
—
3.1e+00
3.5e+00
cases:0.85%
controls:0.12%
cases:0.76%
controls:0.06%
—
—
cases:1.42%
controls:0.00%
—
—
cases:1.72%
controls:0.08%
cases:3.56%
controls:0.11%
18
26
2099
21129
16
12
2101
21143
—
30
0
2087
21155
—
36
16
2061
20925
71
22
1924
19731
Emergency Room Visit
ER [9203]
8.7e-01
1.3e+00
1.6e+00
4.3e+00
1.3e+00
9.4e-01
8.5e-01
cases:48.09%
controls:27.91%
cases:26.41%
controls:9.19%
cases:5.34%
controls:1.16%
cases:3.35%
controls:0.05%
cases:3.59%
controls:0.96%
cases:19.79%
controls:8.78%
cases:43.71%
controls:24.83%
1018
5904
1099
15251
559
1945
1558
19210
113
246
2004
20909
71
10
2046
21145
76
203
2041
20936
415
1838
1682
19103
872
4905
1123
14848
Telephone, letter or other consultation without direct patient contact
ZY020 [2001311600]
1.2e+00
2.2e+00
—
—
2.9e+00
2.6e+00
2.0e+00
cases:1.79%
controls:0.57%
cases:1.70%
controls:0.19%
—
—
—
—
cases:0.80%
controls:0.04%
cases:2.19%
controls:0.17%
cases:3.11%
controls:0.42%
38
121
2079
21034
36
40
2081
21115
—
—
17
9
2100
21130
46
36
2051
20905
62
83
1933
19670
Intravenous
ZX120 [2001311495]
1.0e+00
1.7e+00
1.8e+00
1.0e+50
2.1e+00
2.3e+00
1.9e+00
cases:1.84%
controls:0.66%
cases:1.61%
controls:0.28%
cases:0.33%
controls:0.06%
cases:0.47%
controls:0.00%
cases:0.52%
controls:0.07%
cases:2.77%
controls:0.28%
cases:4.31%
controls:0.67%
39
140
2078
21015
34
60
2083
21095
7
12
2110
21143
10
0
2107
21155
11
14
2106
21125
58
59
2039
20882
86
132
1909
19621
Psoriasis vulgaris
L40.0 [45543370]
1.1e+00
1.2e+00
2.2e+00
—
2.9e+00
2.0e+00
1.5e+00
cases:1.04%
controls:0.36%
cases:0.66%
controls:0.20%
cases:0.28%
controls:0.03%
—
—
cases:0.43%
controls:0.02%
cases:1.24%
controls:0.17%
cases:2.16%
controls:0.47%
22
77
2095
21078
14
43
2103
21112
6
7
2111
21148
—
9
5
2108
21134
26
36
2071
20905
43
92
1952
19661
codeine and paracetamol
N02AJ06 [1123647]
9.5e-01
1.5e+00
1.9e+00
2.4e+00
1.7e+00
1.3e+00
1.0e+00
cases:20.45%
controls:9.02%
cases:13.04%
controls:3.21%
cases:2.88%
controls:0.43%
cases:0.38%
controls:0.03%
cases:2.41%
controls:0.44%
cases:10.68%
controls:3.22%
cases:24.91%
controls:10.92%
433
1908
1684
19247
276
679
1841
20476
61
92
2056
21063
8
7
2109
21148
51
94
2066
21045
224
674
1873
20267
497
2158
1498
17595
Normoblasts [#/volume] in Blood
715-3 [3021589]
5.2e-01
1.0e+00
2.5e+00
2.4e+00
1.6e+00
1.4e+00
1.2e+00
cases:6.42%
controls:3.93%
cases:8.17%
controls:3.04%
cases:9.21%
controls:0.81%
cases:0.57%
controls:0.05%
cases:3.68%
controls:0.74%
cases:12.68%
controls:3.34%
cases:23.01%
controls:8.58%
136
831
1981
20324
173
643
1944
20512
195
172
1922
20983
12
11
2105
21144
78
156
2039
20983
266
699
1831
20242
459
1694
1536
18059
dexamethasone
S01BA01 [21603618]
1.4e+00
1.9e+00
2.0e+00
—
2.5e+00
1.4e+00
1.3e+00
cases:4.96%
controls:1.23%
cases:2.69%
controls:0.42%
cases:0.47%
controls:0.06%
—
—
cases:0.66%
controls:0.05%
cases:2.43%
controls:0.60%
cases:6.72%
controls:1.92%
105
261
2012
20894
57
88
2060
21067
10
13
2107
21142
—
14
11
2103
21128
51
125
2046
20816
134
379
1861
19374
dexamethasone
S03BA01 [21605201]
1.4e+00
1.9e+00
2.0e+00
—
2.5e+00
1.4e+00
1.3e+00
cases:4.91%
controls:1.23%
cases:2.69%
controls:0.42%
cases:0.47%
controls:0.06%
—
—
cases:0.66%
controls:0.05%
cases:2.38%
controls:0.60%
cases:6.72%
controls:1.92%
104
261
2013
20894
57
88
2060
21067
10
13
2107
21142
—
14
11
2103
21128
50
125
2047
20816
134
379
1861
19374
Rehabilitation Hospital
283X00000X [38004285]
2.0e+00
2.7e+00
—
—
—
3.3e+00
2.4e+00
cases:1.42%
controls:0.19%
cases:1.18%
controls:0.08%
—
—
—
—
—
—
cases:1.72%
controls:0.06%
cases:2.31%
controls:0.21%
30
40
2087
21115
25
17
2092
21138
—
—
—
36
13
2061
20928
46
42
1949
19711
Hepatitis B virus core Ab [Presence] in Serum
16933-4 [3021879]
5.9e-01
1.2e+00
2.5e+00
—
3.0e+00
1.8e+00
1.5e+00
cases:1.89%
controls:1.05%
cases:1.56%
controls:0.50%
cases:0.76%
controls:0.06%
—
—
cases:0.90%
controls:0.05%
cases:2.43%
controls:0.43%
cases:5.76%
controls:1.37%
40
223
2077
20932
33
105
2084
21050
16
13
2101
21142
—
19
10
2098
21129
51
90
2046
20851
115
271
1880
19482
Crystals [Presence] in Synovial fluid by Light microscopy
38458-6 [3050238]
1.7e+00
3.2e+00
—
—
—
3.2e+00
2.4e+00
cases:0.61%
controls:0.12%
cases:1.04%
controls:0.04%
—
—
—
—
—
—
cases:0.81%
controls:0.03%
cases:2.16%
controls:0.20%
13
25
2104
21130
22
9
2095
21146
—
—
—
17
7
2080
20934
43
40
1952
19713
folic acid; oral, parenteral
B03BB01 [21601129]
1.3e+00
1.8e+00
1.3e+00
1.0e+50
3.2e+00
2.2e+00
1.9e+00
cases:1.70%
controls:0.48%
cases:1.98%
controls:0.33%
cases:0.24%
controls:0.07%
cases:0.43%
controls:0.00%
cases:1.04%
controls:0.04%
cases:3.58%
controls:0.42%
cases:7.77%
controls:1.25%
36
101
2081
21054
42
70
2075
21085
5
14
2112
21141
9
0
2108
21155
22
9
2095
21130
75
88
2022
20853
155
246
1840
19507
folic acid
V04CX02 [715877]
1.3e+00
1.8e+00
1.3e+00
1.0e+50
3.2e+00
2.2e+00
1.9e+00
cases:1.70%
controls:0.48%
cases:1.98%
controls:0.33%
cases:0.24%
controls:0.07%
cases:0.43%
controls:0.00%
cases:1.04%
controls:0.04%
cases:3.58%
controls:0.42%
cases:7.77%
controls:1.25%
36
101
2081
21054
42
70
2075
21085
5
14
2112
21141
9
0
2108
21155
22
9
2095
21130
75
88
2022
20853
155
246
1840
19507
Other psoriatic arthropathies
M07.3*L40.5 [2000503010]
1.9e+00
2.5e+00
—
1.0e+50
—
3.0e+00
2.9e+00
cases:0.85%
controls:0.13%
cases:0.90%
controls:0.07%
—
—
cases:0.38%
controls:0.00%
—
—
cases:1.72%
controls:0.09%
cases:3.41%
controls:0.19%
18
28
2099
21127
19
15
2098
21140
—
8
0
2109
21155
—
36
19
2061
20922
68
37
1927
19716
nimesulide; oral
M01AX17 [21604007]
1.3e+00
1.7e+00
2.5e+00
—
2.5e+00
1.3e+00
1.1e+00
cases:4.72%
controls:1.38%
cases:1.70%
controls:0.33%
cases:0.33%
controls:0.03%
—
—
cases:0.33%
controls:0.03%
cases:1.10%
controls:0.29%
cases:1.20%
controls:0.41%
100
291
2017
20864
36
69
2081
21086
7
6
2110
21149
—
7
6
2110
21133
23
61
2074
20880
24
80
1971
19673
Hemoglobin [Presence] in Urine by Test strip
5794-3 [3011397]
8.6e-01
1.2e+00
3.4e+00
1.0e+50
1.9e+00
1.7e+00
1.2e+00
cases:3.97%
controls:1.73%
cases:3.31%
controls:0.99%
cases:4.16%
controls:0.15%
cases:0.57%
controls:0.00%
cases:0.85%
controls:0.13%
cases:5.82%
controls:1.15%
cases:14.59%
controls:4.86%
84
365
2033
20790
70
209
2047
20946
88
32
2029
21123
12
0
2105
21155
18
27
2099
21112
122
241
1975
20700
291
960
1704
18793
Sciatica
M54.3 [45586994]
2.8e+00
2.9e+00
—
—
—
2.3e+00
2.1e+00
cases:1.18%
controls:0.07%
cases:0.66%
controls:0.04%
—
—
—
—
—
—
cases:0.33%
controls:0.03%
cases:1.15%
controls:0.14%
25
15
2092
21140
14
8
2103
21147
—
—
—
7
7
2090
20934
23
28
1972
19725
Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
1742-6 [3006923]
4.0e-01
8.3e-01
2.5e+00
2.7e+00
1.9e+00
1.1e+00
6.7e-01
cases:21.78%
controls:15.68%
cases:23.38%
controls:11.78%
cases:20.97%
controls:2.08%
cases:1.23%
controls:0.09%
cases:11.48%
controls:1.96%
cases:31.57%
controls:13.11%
cases:52.23%
controls:35.92%
461
3318
1656
17837
495
2492
1622
18663
444
441
1673
20714
26
18
2091
21137
243
414
1874
20725
662
2746
1435
18195
1042
7095
953
12658
Granulocytes [#/volume] in Blood
30394-1 [3035715]
1.7e+00
2.4e+00
1.0e+50
—
—
3.4e+00
2.6e+00
cases:1.09%
controls:0.20%
cases:0.66%
controls:0.06%
cases:0.80%
controls:0.00%
—
—
—
—
cases:1.10%
controls:0.04%
cases:2.21%
controls:0.17%
23
42
2094
21113
14
13
2103
21142
17
0
2100
21155
—
—
23
8
2074
20933
44
34
1951
19719
Physiotherapy
R4110 [2001310233]
1.1e+00
1.4e+00
1.4e+00
1.0e+50
2.4e+00
2.3e+00
1.4e+00
cases:6.00%
controls:2.16%
cases:2.98%
controls:0.78%
cases:0.66%
controls:0.17%
cases:1.18%
controls:0.00%
cases:1.37%
controls:0.13%
cases:6.58%
controls:0.69%
cases:9.02%
controls:2.28%
127
456
1990
20699
63
165
2054
20990
14
35
2103
21120
25
0
2092
21155
29
27
2088
21112
138
144
1959
20797
180
451
1815
19302
Reactive arthropathy, unspecified
M02.9 [45591683]
3.0e+00
4.0e+00
—
—
—
—
3.0e+00
cases:1.70%
controls:0.09%
cases:1.46%
controls:0.03%
—
—
—
—
—
—
—
—
cases:1.15%
controls:0.06%
36
18
2081
21137
31
6
2086
21149
—
—
—
—
23
12
1972
19741
Lumbago with sciatica
M54.4 [45553205]
2.5e+00
3.0e+00
—
1.0e+50
—
2.5e+00
1.9e+00
cases:3.68%
controls:0.32%
cases:3.26%
controls:0.17%
—
—
cases:0.47%
controls:0.00%
—
—
cases:2.00%
controls:0.16%
cases:5.56%
controls:0.90%
78
67
2039
21088
69
37
2048
21118
—
10
0
2107
21155
—
42
34
2055
20907
111
178
1884
19575
amitriptyline; oral, parenteral
N06AA09 [21604696]
1.4e+00
1.6e+00
1.6e+00
—
1.8e+00
1.8e+00
1.6e+00
cases:7.42%
controls:1.89%
cases:5.48%
controls:1.13%
cases:1.09%
controls:0.23%
—
—
cases:1.28%
controls:0.21%
cases:5.77%
controls:1.05%
cases:11.78%
controls:2.74%
157
400
1960
20755
116
238
2001
20917
23
48
2094
21107
—
27
44
2090
21095
121
219
1976
20722
235
542
1760
19211
Hepatitis B virus core and surface Ab and surface Ag panel - Serum
77190-7 [46237023]
4.3e-01
1.0e+00
2.9e+00
—
2.8e+00
1.6e+00
1.5e+00
cases:0.76%
controls:0.49%
cases:0.71%
controls:0.26%
cases:0.43%
controls:0.02%
—
—
cases:0.52%
controls:0.03%
cases:0.95%
controls:0.20%
cases:2.46%
controls:0.56%
16
104
2101
21051
15
55
2102
21100
9
5
2108
21150
—
11
7
2106
21132
20
41
2077
20900
49
111
1946
19642
levofloxacin; inhalant, oral, parenteral
J01MA12 [21603019]
6.7e-01
1.2e+00
2.5e+00
—
3.3e+00
1.5e+00
6.6e-01
cases:2.22%
controls:1.15%
cases:1.23%
controls:0.38%
cases:0.33%
controls:0.03%
—
—
cases:0.61%
controls:0.02%
cases:1.53%
controls:0.34%
cases:2.91%
controls:1.52%
47
244
2070
20911
26
80
2091
21075
7
6
2110
21149
—
13
5
2104
21134
32
72
2065
20869
58
301
1937
19452
Arthropathic psoriasis
L40.5 [45557703]
1.9e+00
2.0e+00
—
1.0e+50
1.0e+50
2.9e+00
2.9e+00
cases:0.66%
controls:0.10%
cases:0.47%
controls:0.07%
—
—
cases:0.28%
controls:0.00%
cases:0.43%
controls:0.00%
cases:1.38%
controls:0.08%
cases:2.71%
controls:0.15%
14
21
2103
21134
10
14
2107
21141
—
6
0
2111
21155
9
0
2108
21139
29
16
2068
20925
54
29
1941
19724
Other rheumatoid arthritis
M06 [45596441]
3.1e+00
3.8e+00
—
—
—
—
2.7e+00
cases:1.37%
controls:0.06%
cases:1.04%
controls:0.02%
—
—
—
—
—
—
—
—
cases:1.55%
controls:0.10%
29
13
2088
21142
22
5
2095
21150
—
—
—
—
31
20
1964
19733
paracetamol; oral, parenteral, rectal
N02BE01 [21604344]
8.1e-01
1.2e+00
1.2e+00
3.0e+00
1.4e+00
1.1e+00
9.2e-01
cases:37.46%
controls:21.05%
cases:26.55%
controls:9.71%
cases:4.06%
controls:1.29%
cases:0.76%
controls:0.04%
cases:4.82%
controls:1.24%
cases:25.56%
controls:10.31%
cases:51.63%
controls:29.79%
793
4453
1324
16702
562
2055
1555
19100
86
272
2031
20883
16
8
2101
21147
102
262
2015
20877
536
2160
1561
18781
1030
5884
965
13869
Crohn disease of small intestine
K50.0 [45596324]
2.1e+00
2.3e+00
—
—
—
2.6e+00
2.6e+00
cases:0.80%
controls:0.10%
cases:0.52%
controls:0.05%
—
—
—
—
—
—
cases:0.81%
controls:0.06%
cases:1.15%
controls:0.09%
17
21
2100
21134
11
11
2106
21144
—
—
—
17
13
2080
20928
23
17
1972
19736
Albumin [Presence] in Urine by Test strip
50949-7 [3029937]
7.3e-01
1.2e+00
3.1e+00
—
1.7e+00
1.5e+00
1.3e+00
cases:5.48%
controls:2.72%
cases:4.72%
controls:1.44%
cases:4.49%
controls:0.22%
—
—
cases:1.09%
controls:0.21%
cases:6.63%
controls:1.51%
cases:19.00%
controls:5.80%
116
575
2001
20580
100
305
2017
20850
95
46
2022
21109
—
23
44
2094
21095
139
316
1958
20625
379
1146
1616
18607
Physiotherapist
Z3226 [2001311560]
7.8e-01
1.3e+00
1.6e+00
—
2.2e+00
2.2e+00
1.5e+00
cases:3.68%
controls:1.73%
cases:1.51%
controls:0.43%
cases:0.43%
controls:0.09%
—
—
cases:0.61%
controls:0.07%
cases:3.39%
controls:0.40%
cases:5.06%
controls:1.21%
78
365
2039
20790
32
91
2085
21064
9
18
2108
21137
—
13
14
2104
21125
71
83
2026
20858
101
239
1894
19514
duloxetine; oral
N06AX21 [21604749]
1.3e+00
1.6e+00
1.6e+00
—
1.5e+00
1.9e+00
1.6e+00
cases:2.83%
controls:0.78%
cases:2.22%
controls:0.46%
cases:0.80%
controls:0.16%
—
—
cases:0.66%
controls:0.15%
cases:2.81%
controls:0.45%
cases:5.56%
controls:1.17%
60
165
2057
20990
47
97
2070
21058
17
34
2100
21121
—
14
32
2103
21107
59
94
2038
20847
111
231
1884
19522
Ulcerative colitis, unspecified
K51.9 [45605941]
1.3e+00
2.1e+00
—
1.0e+50
2.3e+00
2.1e+00
1.7e+00
cases:1.13%
controls:0.33%
cases:0.71%
controls:0.09%
—
—
cases:0.43%
controls:0.00%
cases:0.28%
controls:0.03%
cases:1.10%
controls:0.14%
cases:1.90%
controls:0.34%
24
69
2093
21086
15
19
2102
21136
—
9
0
2108
21155
6
6
2111
21133
23
29
2074
20912
38
67
1957
19686
Limited function/disability (L)
L28 [2002000647]
1.2e+00
1.2e+00
2.6e+00
—
2.1e+00
1.2e+00
1.0e+00
cases:1.79%
controls:0.53%
cases:0.76%
controls:0.23%
cases:0.43%
controls:0.03%
—
—
cases:0.28%
controls:0.03%
cases:1.19%
controls:0.35%
cases:2.91%
controls:1.06%
38
113
2079
21042
16
48
2101
21107
9
7
2108
21148
—
6
7
2111
21132
25
73
2072
20868
58
210
1937
19543
IgG [Mass/volume] in Serum or Plasma
2465-3 [3005719]
9.3e-01
1.0e+00
1.9e+00
—
2.6e+00
1.3e+00
1.7e+00
cases:1.42%
controls:0.56%
cases:0.94%
controls:0.34%
cases:0.38%
controls:0.06%
—
—
cases:0.43%
controls:0.03%
cases:1.10%
controls:0.31%
cases:4.66%
controls:0.93%
30
119
2087
21036
20
71
2097
21084
8
12
2109
21143
—
9
7
2108
21132
23
64
2074
20877
93
183
1902
19570
Creatinine [Moles/volume] in Serum or Plasma
14682-9 [3020564]
3.1e-01
6.8e-01
2.4e+00
3.2e+00
1.2e+00
9.4e-01
6.0e-01
cases:21.16%
controls:16.47%
cases:22.67%
controls:12.96%
cases:21.02%
controls:2.31%
cases:2.22%
controls:0.09%
cases:7.13%
controls:2.26%
cases:29.71%
controls:14.12%
cases:51.53%
controls:36.92%
448
3484
1669
17671
480
2741
1637
18414
445
488
1672
20667
47
20
2070
21135
151
478
1966
20661
623
2956
1474
17985
1028
7293
967
12460
Back syndrome without radiat pain
L84 [2002000703]
1.8e+00
3.0e+00
—
—
—
3.1e+00
1.4e+00
cases:1.09%
controls:0.17%
cases:0.99%
controls:0.05%
—
—
—
—
—
—
cases:0.62%
controls:0.03%
cases:1.10%
controls:0.26%
23
37
2094
21118
21
11
2096
21144
—
—
—
13
6
2084
20935
22
52
1973
19701
Puncture and needle biopsy of soft tissue, unspecified region
TNX00 [2001308558]
2.7e+00
3.2e+00
—
1.0e+50
—
—
3.4e+00
cases:0.57%
controls:0.04%
cases:0.57%
controls:0.02%
—
—
cases:0.57%
controls:0.00%
—
—
—
—
cases:1.80%
controls:0.06%
12
8
2105
21147
12
5
2105
21150
—
12
0
2105
21155
—
—
36
12
1959
19741
Thorax X-ray examination
GD1AA [2001303617]
7.4e-01
1.4e+00
2.0e+00
—
2.0e+00
1.8e+00
1.4e+00
cases:6.80%
controls:3.37%
cases:4.77%
controls:1.26%
cases:1.13%
controls:0.16%
—
—
cases:0.99%
controls:0.14%
cases:6.68%
controls:1.13%
cases:15.74%
controls:4.23%
144
712
1973
20443
101
267
2016
20888
24
34
2093
21121
—
21
30
2096
21109
140
236
1957
20705
314
835
1681
18918
Office Visit
OMOP4822458 [581477]
7.4e-01
1.3e+00
1.6e+00
—
2.6e+00
1.8e+00
1.2e+00
cases:13.23%
controls:6.78%
cases:7.04%
controls:2.01%
cases:1.13%
controls:0.23%
—
—
cases:3.26%
controls:0.26%
cases:10.01%
controls:1.77%
cases:15.79%
controls:5.33%
280
1434
1837
19721
149
425
1968
20730
24
48
2093
21107
—
69
54
2048
21085
210
371
1887
20570
315
1052
1680
18701
Fibromyalgia
M79.7 [45553272]
1.7e+00
1.9e+00
—
1.0e+50
—
2.9e+00
2.7e+00
cases:0.66%
controls:0.12%
cases:0.47%
controls:0.07%
—
—
cases:0.43%
controls:0.00%
—
—
cases:1.24%
controls:0.07%
cases:2.61%
controls:0.18%
14
26
2103
21129
10
15
2107
21140
—
9
0
2108
21155
—
26
15
2071
20926
52
35
1943
19718
Polyarthritis, unspecified
M13.0 [45538675]
2.8e+00
—
1.0e+50
—
—
2.9e+00
3.4e+00
cases:0.76%
controls:0.05%
—
—
cases:0.24%
controls:0.00%
—
—
—
—
cases:0.52%
controls:0.03%
cases:0.90%
controls:0.03%
16
10
2101
21145
—
5
0
2112
21155
—
—
11
6
2086
20935
18
6
1977
19747
Aid fitting and borrowing and monitoring of use
SPAT1230 [2001700331]
1.0e+00
1.4e+00
2.1e+00
—
2.0e+00
1.3e+00
1.2e+00
cases:2.22%
controls:0.81%
cases:1.42%
controls:0.36%
cases:0.47%
controls:0.06%
—
—
cases:0.28%
controls:0.04%
cases:1.34%
controls:0.36%
cases:4.11%
controls:1.23%
47
172
2070
20983
30
77
2087
21078
10
12
2107
21143
—
6
8
2111
21131
28
76
2069
20865
82
242
1913
19511
ENMG
XA402 [2001300405]
2.0e+00
2.6e+00
—
—
—
2.5e+00
2.0e+00
cases:0.61%
controls:0.09%
cases:0.33%
controls:0.02%
—
—
—
—
—
—
cases:0.29%
controls:0.02%
cases:0.75%
controls:0.11%
13
18
2104
21137
7
5
2110
21150
—
—
—
6
5
2091
20936
15
21
1980
19732
Granulocytes/Leukocytes in Blood
30395-8 [3035933]
1.5e+00
2.3e+00
1.0e+50
—
—
2.9e+00
2.3e+00
cases:1.13%
controls:0.25%
cases:0.71%
controls:0.07%
cases:0.80%
controls:0.00%
—
—
—
—
cases:1.14%
controls:0.06%
cases:2.46%
controls:0.25%
24
52
2093
21103
15
15
2102
21140
17
0
2100
21155
—
—
24
13
2073
20928
49
50
1946
19703
ibuprofen
R02AX02 [1588667]
8.2e-01
1.1e+00
1.1e+00
3.0e+00
1.3e+00
9.6e-01
6.6e-01
cases:53.00%
controls:33.12%
cases:34.62%
controls:14.37%
cases:5.01%
controls:1.71%
cases:1.32%
controls:0.07%
cases:6.42%
controls:1.79%
cases:31.28%
controls:14.89%
cases:54.39%
controls:38.08%
1122
7006
995
14149
733
3041
1384
18114
106
362
2011
20793
28
14
2089
21141
136
378
1981
20761
656
3119
1441
17822
1085
7521
910
12232
ibuprofen; oral, parenteral, rectal
M01AE01 [21603967]
8.2e-01
1.1e+00
1.1e+00
3.0e+00
1.3e+00
9.6e-01
6.6e-01
cases:53.00%
controls:33.12%
cases:34.62%
controls:14.37%
cases:5.01%
controls:1.71%
cases:1.32%
controls:0.07%
cases:6.42%
controls:1.79%
cases:31.28%
controls:14.89%
cases:54.39%
controls:38.08%
1122
7006
995
14149
733
3041
1384
18114
106
362
2011
20793
28
14
2089
21141
136
378
1981
20761
656
3119
1441
17822
1085
7521
910
12232
Specific gravity of Urine by Refractometry
5810-7 [3019150]
7.3e-01
1.1e+00
2.9e+00
1.0e+50
1.8e+00
1.3e+00
1.1e+00
cases:4.72%
controls:2.34%
cases:3.64%
controls:1.19%
cases:3.50%
controls:0.20%
cases:0.43%
controls:0.00%
cases:1.04%
controls:0.17%
cases:5.01%
controls:1.36%
cases:14.69%
controls:5.58%
100
494
2017
20661
77
251
2040
20904
74
42
2043
21113
9
0
2108
21155
22
35
2095
21104
105
285
1992
20656
293
1103
1702
18650
Gastroenterology
10 [38004455]
1.2e+00
1.4e+00
1.5e+00
—
1.7e+00
1.8e+00
1.5e+00
cases:8.12%
controls:2.69%
cases:5.29%
controls:1.40%
cases:1.42%
controls:0.31%
—
—
cases:1.70%
controls:0.31%
cases:7.39%
controls:1.37%
cases:14.94%
controls:3.85%
172
570
1945
20585
112
296
2005
20859
30
66
2087
21089
—
36
66
2081
21073
155
286
1942
20655
298
761
1697
18992
Pain in thoracic spine
M54.6 [45606247]
2.3e+00
2.8e+00
—
—
—
2.4e+00
1.5e+00
cases:2.22%
controls:0.22%
cases:1.61%
controls:0.10%
—
—
—
—
—
—
cases:0.62%
controls:0.06%
cases:2.36%
controls:0.56%
47
47
2070
21108
34
21
2083
21134
—
—
—
13
12
2084
20929
47
111
1948
19642
Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)/1.73 sq M
62238-1 [40764999]
3.1e-01
6.0e-01
2.3e+00
3.2e+00
1.1e+00
8.7e-01
4.8e-01
cases:13.42%
controls:10.19%
cases:13.98%
controls:8.17%
cases:13.70%
controls:1.53%
cases:1.42%
controls:0.06%
cases:4.44%
controls:1.54%
cases:19.22%
controls:9.10%
cases:34.89%
controls:24.86%
284
2156
1833
18999
296
1729
1821
19426
290
323
1827
20832
30
12
2087
21143
94
325
2023
20814
403
1905
1694
19036
696
4911
1299
14842
naproxen and esomeprazole; oral
M01AE52 [40254096]
1.3e+00
2.0e+00
2.3e+00
—
—
1.9e+00
1.3e+00
cases:3.35%
controls:0.90%
cases:2.41%
controls:0.32%
cases:0.38%
controls:0.04%
—
—
—
—
cases:2.05%
controls:0.32%
cases:4.86%
controls:1.40%
71
191
2046
20964
51
68
2066
21087
8
8
2109
21147
—
—
43
67
2054
20874
97
277
1898
19476
Hepatitis C virus Ab [Presence] in Serum
16128-1 [3017143]
4.2e-01
8.8e-01
2.5e+00
—
2.6e+00
1.6e+00
1.3e+00
cases:2.65%
controls:1.75%
cases:1.98%
controls:0.84%
cases:0.90%
controls:0.08%
—
—
cases:1.09%
controls:0.09%
cases:3.29%
controls:0.70%
cases:8.17%
controls:2.28%
56
370
2061
20785
42
177
2075
20978
19
16
2098
21139
—
23
18
2094
21121
69
146
2028
20795
163
451
1832
19302
Crohn disease, unspecified
K50.9 [45562490]
1.8e+00
2.2e+00
—
1.0e+50
—
2.5e+00
2.3e+00
cases:0.61%
controls:0.10%
cases:0.43%
controls:0.05%
—
—
cases:0.24%
controls:0.00%
—
—
cases:0.48%
controls:0.04%
cases:1.10%
controls:0.12%
13
21
2104
21134
9
10
2108
21145
—
5
0
2112
21155
—
10
8
2087
20933
22
23
1973
19730
Nitrite [Presence] in Urine by Test strip
5802-4 [3021601]
6.8e-01
1.1e+00
3.1e+00
—
1.4e+00
1.4e+00
1.2e+00
cases:8.17%
controls:4.32%
cases:7.23%
controls:2.50%
cases:7.27%
controls:0.36%
—
—
cases:1.56%
controls:0.40%
cases:10.63%
controls:2.75%
cases:28.42%
controls:11.16%
173
914
1944
20241
153
529
1964
20626
154
77
1963
21078
—
33
85
2084
21054
223
576
1874
20365
567
2205
1428
17548
Back syndrome with radiating pain
L86 [2002000705]
1.8e+00
2.5e+00
—
—
—
2.6e+00
1.8e+00
cases:1.04%
controls:0.17%
cases:0.66%
controls:0.05%
—
—
—
—
—
—
cases:0.52%
controls:0.04%
cases:1.05%
controls:0.18%
22
35
2095
21120
14
11
2103
21144
—
—
—
11
8
2086
20933
21
36
1974
19717
Erythrocyte [DistWidth] in Red Blood Cells
30385-9 [3002385]
3.2e-01
6.8e-01
2.2e+00
2.7e+00
1.4e+00
9.2e-01
6.1e-01
cases:16.25%
controls:12.34%
cases:17.76%
controls:9.90%
cases:15.92%
controls:2.14%
cases:1.56%
controls:0.10%
cases:7.75%
controls:2.11%
cases:23.08%
controls:10.68%
cases:40.80%
controls:27.29%
344
2610
1773
18545
376
2095
1741
19060
337
452
1780
20703
33
22
2084
21133
164
447
1953
20692
484
2237
1613
18704
814
5391
1181
14362
Essential (primary) hypertension
I10 [45591453]
4.5e-01
6.5e-01
7.8e-01
4.6e+00
1.0e+00
7.7e-01
4.4e-01
cases:9.31%
controls:6.12%
cases:5.53%
controls:2.95%
cases:1.09%
controls:0.50%
cases:2.74%
controls:0.03%
cases:1.32%
controls:0.47%
cases:6.87%
controls:3.29%
cases:15.49%
controls:10.52%
197
1295
1920
19860
117
624
2000
20531
23
106
2094
21049
58
6
2059
21149
28
100
2089
21039
144
689
1953
20252
309
2078
1686
17675
nabumetone; oral
M01AX01 [21603999]
2.4e+00
—
—
—
—
3.7e+00
2.6e+00
cases:1.51%
controls:0.14%
—
—
—
—
—
—
—
—
cases:1.00%
controls:0.02%
cases:0.95%
controls:0.07%
32
30
2085
21125
—
—
—
—
21
5
2076
20936
19
14
1976
19739
Polymyalgia rheumatica
M35.3 [45533830]
2.0e+00
2.7e+00
—
1.0e+50
—
2.4e+00
1.6e+00
cases:0.80%
controls:0.11%
cases:0.99%
controls:0.07%
—
—
cases:0.28%
controls:0.00%
—
—
cases:0.52%
controls:0.05%
cases:0.80%
controls:0.16%
17
24
2100
21131
21
14
2096
21141
—
6
0
2111
21155
—
11
10
2086
20931
16
31
1979
19722
DNA double strand Ab [Units/volume] in Serum
5130-0 [3023420]
2.0e+00
2.2e+00
—
—
—
2.4e+00
2.1e+00
cases:2.13%
controls:0.29%
cases:1.37%
controls:0.16%
—
—
—
—
—
—
cases:1.86%
controls:0.17%
cases:3.96%
controls:0.52%
45
61
2072
21094
29
33
2088
21122
—
—
—
39
35
2058
20906
79
102
1916
19651
Glucose [Presence] in Urine by Test strip
25428-4 [3009261]
6.6e-01
1.1e+00
3.0e+00
—
1.4e+00
1.4e+00
1.1e+00
cases:8.31%
controls:4.48%
cases:7.23%
controls:2.60%
cases:7.32%
controls:0.38%
—
—
cases:1.56%
controls:0.41%
cases:10.68%
controls:2.82%
cases:28.72%
controls:11.47%
176
948
1941
20207
153
550
1964
20605
155
81
1962
21074
—
33
86
2084
21053
224
590
1873
20351
573
2266
1422
17487
Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
2742-5 [3034780]
1.3e+00
2.1e+00
1.7e+00
—
2.5e+00
1.6e+00
1.0e+00
cases:0.94%
controls:0.25%
cases:1.32%
controls:0.16%
cases:0.24%
controls:0.04%
—
—
cases:0.28%
controls:0.02%
cases:0.67%
controls:0.13%
cases:1.45%
controls:0.53%
20
53
2097
21102
28
33
2089
21122
5
9
2112
21146
—
6
5
2111
21134
14
27
2083
20914
29
104
1966
19649
Ketones [Presence] in Urine by Test strip
2514-8 [3035350]
6.5e-01
1.1e+00
3.0e+00
—
1.3e+00
1.4e+00
1.1e+00
cases:8.12%
controls:4.41%
cases:7.18%
controls:2.58%
cases:7.27%
controls:0.38%
—
—
cases:1.51%
controls:0.41%
cases:10.63%
controls:2.82%
cases:28.52%
controls:11.39%
172
932
1945
20223
152
546
1965
20609
154
80
1963
21075
—
32
86
2085
21053
223
590
1874
20351
569
2250
1426
17503
clindamycin; oral, parenteral
J01FF01 [21602985]
6.3e-01
1.3e+00
1.5e+00
—
2.6e+00
1.6e+00
9.3e-01
cases:5.62%
controls:3.06%
cases:2.93%
controls:0.82%
cases:0.47%
controls:0.10%
—
—
cases:1.04%
controls:0.08%
cases:3.39%
controls:0.73%
cases:6.67%
controls:2.73%
119
648
1998
20507
62
174
2055
20981
10
22
2107
21133
—
22
16
2095
21123
71
152
2026
20789
133
539
1862
19214
Dorsalgia
M54 [45553203]
1.4e+00
2.3e+00
2.3e+00
—
—
1.5e+00
9.8e-01
cases:2.69%
controls:0.65%
cases:2.50%
controls:0.25%
cases:0.38%
controls:0.04%
—
—
—
—
cases:1.00%
controls:0.22%
cases:2.91%
controls:1.11%
57
138
2060
21017
53
53
2064
21102
8
8
2109
21147
—
—
21
46
2076
20895
58
220
1937
19533
pH of Urine
2756-5 [3015736]
6.2e-01
1.0e+00
3.0e+00
—
1.5e+00
1.3e+00
1.1e+00
cases:6.75%
controls:3.74%
cases:5.34%
controls:1.99%
cases:5.24%
controls:0.29%
—
—
cases:1.42%
controls:0.31%
cases:7.92%
controls:2.21%
cases:22.66%
controls:9.03%
143
791
1974
20364
113
422
2004
20733
111
61
2006
21094
—
30
66
2087
21073
166
462
1931
20479
452
1783
1543
17970
Thoracal spine X-ray examination without contrast
NA2AA [2001307007]
2.2e+00
3.0e+00
—
1.0e+50
—
—
3.4e+00
cases:0.33%
controls:0.04%
cases:0.47%
controls:0.02%
—
—
cases:0.43%
controls:0.00%
—
—
—
—
cases:1.00%
controls:0.04%
7
8
2110
21147
10
5
2107
21150
—
9
0
2108
21155
—
—
20
7
1975
19746
Implementation of physical therapy rehabilitation plan
SPAT1223 [2001700324]
9.3e-01
1.6e+00
1.9e+00
—
1.5e+00
1.5e+00
1.0e+00
cases:4.30%
controls:1.74%
cases:3.45%
controls:0.71%
cases:0.80%
controls:0.12%
—
—
cases:0.61%
controls:0.14%
cases:3.15%
controls:0.74%
cases:7.07%
controls:2.66%
91
369
2026
20786
73
151
2044
21004
17
25
2100
21130
—
13
29
2104
21110
66
154
2031
20787
141
526
1854
19227
Rheumatoid factor [Units/volume] in Serum or Plasma
11572-5 [3021614]
1.4e+00
2.6e+00
3.6e+00
—
1.2e+00
4.8e-01
7.5e-01
cases:5.34%
controls:1.32%
cases:7.09%
controls:0.54%
cases:2.27%
controls:0.06%
—
—
cases:0.24%
controls:0.07%
cases:0.95%
controls:0.59%
cases:5.91%
controls:2.90%
113
279
2004
20876
150
115
1967
21040
48
13
2069
21142
—
5
15
2112
21124
20
124
2077
20817
118
572
1877
19181
lansoprazole; oral
A02BC03 [21600098]
1.2e+00
1.6e+00
1.3e+00
1.0e+50
1.6e+00
1.5e+00
1.1e+00
cases:9.64%
controls:3.19%
cases:6.38%
controls:1.30%
cases:1.04%
controls:0.28%
cases:0.28%
controls:0.00%
cases:1.42%
controls:0.28%
cases:6.01%
controls:1.38%
cases:9.17%
controls:3.10%
204
674
1913
20481
135
276
1982
20879
22
59
2095
21096
6
0
2111
21155
30
59
2087
21080
126
288
1971
20653
183
613
1812
19140
Platelets [#/volume] in Blood
26515-7 [3007461]
2.6e-01
6.7e-01
2.1e+00
2.7e+00
1.4e+00
8.2e-01
4.2e-01
cases:24.89%
controls:20.40%
cases:28.39%
controls:16.86%
cases:23.05%
controls:3.39%
cases:2.46%
controls:0.17%
cases:12.47%
controls:3.43%
cases:33.57%
controls:18.21%
cases:54.34%
controls:43.86%
527
4315
1590
16840
601
3566
1516
17589
488
718
1629
20437
52
35
2065
21120
264
726
1853
20413
704
3813
1393
17128
1084
8663
911
11090
Systemic lupus erythematosus, unspecified
M32.9 [45553167]
2.0e+00
2.3e+00
—
1.0e+50
—
2.1e+00
2.0e+00
cases:0.47%
controls:0.06%
cases:0.33%
controls:0.03%
—
—
cases:0.24%
controls:0.00%
—
—
cases:0.38%
controls:0.05%
cases:0.55%
controls:0.08%
10
13
2107
21142
7
7
2110
21148
—
5
0
2112
21155
—
8
10
2089
20931
11
15
1984
19738
Hematocrit [Volume Fraction] of Blood by calculation
20570-8 [3009542]
2.5e-01
6.7e-01
2.1e+00
2.7e+00
1.4e+00
8.2e-01
4.1e-01
cases:24.89%
controls:20.47%
cases:28.48%
controls:16.95%
cases:23.05%
controls:3.40%
cases:2.50%
controls:0.17%
cases:12.47%
controls:3.45%
cases:33.62%
controls:18.29%
cases:54.34%
controls:44.05%
527
4330
1590
16825
603
3586
1514
17569
488
720
1629
20435
53
35
2064
21120
264
729
1853
20410
705
3831
1392
17110
1084
8702
911
11051
ketoprofen; oral, parenteral, rectal
M01AE03 [21603969]
9.6e-01
1.5e+00
1.9e+00
—
2.0e+00
1.2e+00
8.6e-01
cases:10.44%
controls:4.27%
cases:4.72%
controls:1.11%
cases:0.71%
controls:0.11%
—
—
cases:1.18%
controls:0.16%
cases:3.10%
controls:0.96%
cases:6.87%
controls:3.04%
221
904
1896
20251
100
235
2017
20920
15
23
2102
21132
—
25
33
2092
21106
65
200
2032
20741
137
600
1858
19153
Leukocytes [#/volume] in Blood
26464-8 [3010813]
2.6e-01
6.7e-01
2.1e+00
2.7e+00
1.4e+00
8.1e-01
4.1e-01
cases:25.04%
controls:20.48%
cases:28.53%
controls:16.97%
cases:23.05%
controls:3.40%
cases:2.46%
controls:0.17%
cases:12.52%
controls:3.44%
cases:33.62%
controls:18.32%
cases:54.39%
controls:44.12%
530
4332
1587
16823
604
3591
1513
17564
488
719
1629
20436
52
35
2065
21120
265
728
1852
20411
705
3837
1392
17104
1085
8716
910
11037
carisoprodol; oral
M03BA02 [21604094]
2.2e+00
2.4e+00
—
—
—
2.1e+00
1.7e+00
cases:1.09%
controls:0.12%
cases:0.66%
controls:0.06%
—
—
—
—
—
—
cases:0.48%
controls:0.06%
cases:0.75%
controls:0.14%
23
25
2094
21130
14
13
2103
21142
—
—
—
10
12
2087
20929
15
28
1980
19725
MCH [Entitic mass]
28539-5 [3035941]
2.5e-01
6.7e-01
2.1e+00
2.7e+00
1.4e+00
8.2e-01
4.1e-01
cases:24.89%
controls:20.45%
cases:28.48%
controls:16.91%
cases:23.05%
controls:3.40%
cases:2.46%
controls:0.17%
cases:12.47%
controls:3.44%
cases:33.62%
controls:18.27%
cases:54.34%
controls:44.00%
527
4327
1590
16828
603
3578
1514
17577
488
720
1629
20435
52
35
2065
21120
264
728
1853
20411
705
3826
1392
17115
1084
8692
911
11061
Crohn disease of large intestine
K50.1 [45601173]
1.7e+00
2.2e+00
—
—
—
2.2e+00
2.4e+00
cases:0.61%
controls:0.12%
cases:0.43%
controls:0.05%
—
—
—
—
—
—
cases:0.38%
controls:0.04%
cases:0.90%
controls:0.09%
13
25
2104
21130
9
10
2108
21145
—
—
—
8
9
2089
20932
18
17
1977
19736
MCV [Entitic mean volume] in Red Blood Cells
30428-7 [3024731]
2.5e-01
6.7e-01
2.1e+00
2.7e+00
1.4e+00
8.2e-01
4.1e-01
cases:24.89%
controls:20.46%
cases:28.48%
controls:16.94%
cases:23.05%
controls:3.41%
cases:2.46%
controls:0.17%
cases:12.47%
controls:3.44%
cases:33.62%
controls:18.28%
cases:54.34%
controls:44.06%
527
4329
1590
16826
603
3583
1514
17572
488
721
1629
20434
52
35
2065
21120
264
728
1853
20411
705
3829
1392
17112
1084
8703
911
11050
Erythrocytes [#/volume] in Blood
26453-1 [3026361]
2.5e-01
6.7e-01
2.1e+00
2.7e+00
1.4e+00
8.2e-01
4.1e-01
cases:24.89%
controls:20.48%
cases:28.48%
controls:16.95%
cases:23.05%
controls:3.41%
cases:2.46%
controls:0.17%
cases:12.47%
controls:3.45%
cases:33.62%
controls:18.29%
cases:54.34%
controls:44.06%
527
4332
1590
16823
603
3586
1514
17569
488
721
1629
20434
52
35
2065
21120
264
729
1853
20410
705
3831
1392
17110
1084
8704
911
11049
Ocular pain
H57.1 [45596140]
1.7e+00
2.7e+00
—
—
—
2.3e+00
1.7e+00
cases:0.80%
controls:0.14%
cases:0.47%
controls:0.03%
—
—
—
—
—
—
cases:0.33%
controls:0.03%
cases:1.45%
controls:0.27%
17
30
2100
21125
10
7
2107
21148
—
—
—
7
7
2090
20934
29
54
1966
19699
orphenadrine (chloride); oral, parenteral
N04AB02 [21604458]
1.1e+00
1.6e+00
2.1e+00
—
1.5e+00
1.1e+00
8.5e-01
cases:14.55%
controls:5.28%
cases:7.27%
controls:1.58%
cases:1.23%
controls:0.15%
—
—
cases:0.71%
controls:0.15%
cases:5.20%
controls:1.71%
cases:12.93%
controls:5.99%
308
1117
1809
20038
154
335
1963
20820
26
31
2091
21124
—
15
32
2102
21107
109
359
1988
20582
258
1183
1737
18570
orphenadrine (citrate); oral, parenteral
M03BC01 [21604112]
1.1e+00
1.6e+00
2.1e+00
—
1.5e+00
1.1e+00
8.5e-01
cases:14.55%
controls:5.28%
cases:7.27%
controls:1.58%
cases:1.23%
controls:0.15%
—
—
cases:0.71%
controls:0.15%
cases:5.20%
controls:1.71%
cases:12.93%
controls:5.99%
308
1117
1809
20038
154
335
1963
20820
26
31
2091
21124
—
15
32
2102
21107
109
359
1988
20582
258
1183
1737
18570
Iridocyclitis, unspecified
H20.9 [45533269]
3.4e+00
—
—
—
—
2.5e+00
2.5e+00
cases:1.13%
controls:0.04%
—
—
—
—
—
—
—
—
cases:0.33%
controls:0.03%
cases:0.80%
controls:0.07%
24
8
2093
21147
—
—
—
—
7
6
2090
20935
16
13
1979
19740
Hemoglobin [Mass/volume] in Blood
718-7 [3000963]
2.5e-01
6.7e-01
2.1e+00
2.7e+00
1.4e+00
8.1e-01
4.1e-01
cases:24.94%
controls:20.52%
cases:28.48%
controls:16.99%
cases:23.10%
controls:3.42%
cases:2.46%
controls:0.17%
cases:12.47%
controls:3.47%
cases:33.62%
controls:18.35%
cases:54.39%
controls:44.18%
528
4342
1589
16813
603
3594
1514
17561
489
724
1628
20431
52
35
2065
21120
264
733
1853
20406
705
3842
1392
17099
1085
8727
910
11026
scopolamine
S01FA02 [21605061]
3.1e+00
—
—
—
—
2.5e+00
2.8e+00
cases:1.61%
controls:0.08%
—
—
—
—
—
—
—
—
cases:0.48%
controls:0.04%
cases:1.20%
controls:0.08%
34
16
2083
21139
—
—
—
—
10
8
2087
20933
24
15
1971
19738
Neurology
13 [38004458]
7.1e-01
7.9e-01
1.1e+00
2.6e+00
1.1e+00
1.1e+00
9.4e-01
cases:11.29%
controls:5.90%
cases:5.53%
controls:2.59%
cases:1.51%
controls:0.50%
cases:0.57%
controls:0.04%
cases:1.46%
controls:0.48%
cases:7.39%
controls:2.64%
cases:15.44%
controls:6.66%
239
1249
1878
19906
117
548
2000
20607
32
105
2085
21050
12
9
2105
21146
31
102
2086
21037
155
553
1942
20388
308
1316
1687
18437
Orthopedic Surgery
20 [38004465]
1.1e+00
1.4e+00
1.6e+00
—
1.5e+00
1.4e+00
1.3e+00
cases:18.61%
controls:7.26%
cases:10.53%
controls:2.73%
cases:2.55%
controls:0.51%
—
—
cases:1.89%
controls:0.43%
cases:10.87%
controls:2.79%
cases:27.47%
controls:9.73%
394
1535
1723
19620
223
578
1894
20577
54
108
2063
21047
—
40
90
2077
21049
228
585
1869
20356
548
1922
1447
17831
diclofenac; oral, parenteral, rectal
M01AB05 [21603945]
9.8e-01
1.6e+00
2.0e+00
—
1.9e+00
1.2e+00
6.8e-01
cases:28.81%
controls:13.21%
cases:16.20%
controls:3.89%
cases:3.16%
controls:0.43%
—
—
cases:2.74%
controls:0.44%
cases:11.68%
controls:3.76%
cases:22.96%
controls:13.11%
610
2794
1507
18361
343
822
1774
20333
67
90
2050
21065
—
58
92
2059
21047
245
788
1852
20153
458
2590
1537
17163
inFLIXimab Ab [Units/volume] in Serum by Immunoassay
90780-8 [1175556]
2.3e+00
—
—
—
—
2.6e+00
3.4e+00
cases:0.38%
controls:0.04%
—
—
—
—
—
—
—
—
cases:0.38%
controls:0.03%
cases:1.85%
controls:0.06%
8
8
2109
21147
—
—
—
—
8
6
2089
20935
37
12
1958
19741
Other specified intervertebral disc degeneration
M51.3 [45591865]
4.7e+00
—
1.0e+50
1.0e+50
—
—
3.6e+00
cases:2.55%
controls:0.02%
—
—
cases:0.52%
controls:0.00%
cases:0.99%
controls:0.00%
—
—
—
—
cases:4.11%
controls:0.12%
54
5
2063
21150
—
11
0
2106
21155
21
0
2096
21155
—
—
82
23
1913
19730
Calprotectin [Mass/mass] in Stool
38445-3 [3048689]
8.3e-01
1.1e+00
1.7e+00
—
2.0e+00
1.4e+00
1.3e+00
cases:2.93%
controls:1.30%
cases:2.13%
controls:0.73%
cases:0.66%
controls:0.12%
—
—
cases:0.57%
controls:0.08%
cases:2.81%
controls:0.70%
cases:8.22%
controls:2.46%
62
274
2055
20881
45
155
2072
21000
14
25
2103
21130
—
12
17
2105
21122
59
147
2038
20794
164
485
1831
19268
misoprostol; oral
A02BB01 [21600093]
2.0e+00
2.8e+00
—
—
—
1.6e+00
1.9e+00
cases:1.94%
controls:0.26%
cases:1.37%
controls:0.09%
—
—
—
—
—
—
cases:0.43%
controls:0.09%
cases:1.20%
controls:0.18%
41
55
2076
21100
29
18
2088
21137
—
—
—
9
19
2088
20922
24
36
1971
19717
misoprostol; oral, vaginal
G02AD06 [21602443]
2.0e+00
2.8e+00
—
—
—
1.6e+00
1.9e+00
cases:1.94%
controls:0.26%
cases:1.37%
controls:0.09%
—
—
—
—
—
—
cases:0.43%
controls:0.09%
cases:1.20%
controls:0.18%
41
55
2076
21100
29
18
2088
21137
—
—
—
9
19
2088
20922
24
36
1971
19717
mesalazine; oral, rectal
A07EC02 [21600664]
1.3e+00
1.4e+00
1.6e+00
—
1.2e+00
1.4e+00
1.3e+00
cases:3.50%
controls:0.97%
cases:2.88%
controls:0.70%
cases:1.13%
controls:0.22%
—
—
cases:0.71%
controls:0.21%
cases:2.81%
controls:0.73%
cases:3.56%
controls:1.04%
74
206
2043
20949
61
149
2056
21006
24
47
2093
21108
—
15
44
2102
21095
59
153
2038
20788
71
206
1924
19547
oxycodone and naloxone; oral
N02AA55 [21604265]
1.2e+00
1.6e+00
2.2e+00
—
—
2.0e+00
1.3e+00
cases:1.56%
controls:0.48%
cases:1.04%
controls:0.22%
cases:0.38%
controls:0.04%
—
—
—
—
cases:1.29%
controls:0.18%
cases:3.86%
controls:1.06%
33
101
2084
21054
22
47
2095
21108
8
9
2109
21146
—
—
27
38
2070
20903
77
209
1918
19544
Primary generalized (osteo)arthrosis
M15.0 [45543479]
2.2e+00
—
—
1.0e+50
—
3.1e+00
2.9e+00
cases:0.33%
controls:0.04%
—
—
—
—
cases:0.61%
controls:0.00%
—
—
cases:0.52%
controls:0.02%
cases:1.30%
controls:0.07%
7
8
2110
21147
—
—
13
0
2104
21155
—
11
5
2086
20936
26
14
1969
19739
calcium (different salts in combination); oral
A12AA20 [21600872]
1.1e+00
1.1e+00
1.2e+00
—
1.6e+00
1.6e+00
1.5e+00
cases:10.53%
controls:3.65%
cases:8.31%
controls:2.88%
cases:2.17%
controls:0.65%
—
—
cases:2.74%
controls:0.58%
cases:12.64%
controls:2.97%
cases:21.15%
controls:5.43%
223
772
1894
20383
176
609
1941
20546
46
137
2071
21018
—
58
122
2059
21017
265
621
1832
20320
422
1072
1573
18681
Anesthesiology Critical Care Medicine
OMOP4821991 [45756751]
1.6e+00
2.1e+00
—
—
—
2.4e+00
2.2e+00
cases:1.09%
controls:0.23%
cases:1.04%
controls:0.13%
—
—
—
—
—
—
cases:1.14%
controls:0.11%
cases:2.86%
controls:0.33%
23
49
2094
21106
22
28
2095
21127
—
—
—
24
23
2073
20918
57
66
1938
19687
Coloscopy
UJF32 [2001305029]
1.1e+00
1.4e+00
—
—
2.4e+00
1.8e+00
1.3e+00
cases:5.29%
controls:1.76%
cases:2.36%
controls:0.57%
—
—
—
—
cases:0.47%
controls:0.04%
cases:2.86%
controls:0.48%
cases:7.97%
controls:2.26%
112
373
2005
20782
50
120
2067
21035
—
—
10
9
2107
21130
60
101
2037
20840
159
446
1836
19307
Cervical spine MRI examination with high intensity magnet
NA1BG [2001306990]
2.2e+00
—
—
1.0e+50
—
3.2e+00
2.7e+00
cases:0.85%
controls:0.09%
—
—
—
—
cases:0.28%
controls:0.00%
—
—
cases:0.91%
controls:0.04%
cases:1.60%
controls:0.11%
18
20
2099
21135
—
—
6
0
2111
21155
—
19
8
2078
20933
32
21
1963
19732
Urinalysis microscopic panel [#/volume] - Urine by Automated count
50554-5 [3029287]
5.2e-01
1.2e+00
2.5e+00
—
1.6e+00
1.2e+00
1.1e+00
cases:4.58%
controls:2.77%
cases:4.06%
controls:1.28%
cases:2.60%
controls:0.22%
—
—
cases:1.04%
controls:0.22%
cases:4.48%
controls:1.37%
cases:13.63%
controls:4.79%
97
586
2020
20569
86
271
2031
20884
55
47
2062
21108
—
22
47
2095
21092
94
287
2003
20654
272
946
1723
18807
Joint symptom/complaint NOS
L20 [2002000644]
1.3e+00
2.6e+00
—
—
—
2.7e+00
1.5e+00
cases:0.61%
controls:0.17%
cases:0.85%
controls:0.07%
—
—
—
—
—
—
cases:0.67%
controls:0.04%
cases:1.10%
controls:0.25%
13
36
2104
21119
18
14
2099
21141
—
—
—
14
9
2083
20932
22
49
1973
19704
Cervicalgia
M54.2 [45591867]
1.8e+00
2.1e+00
—
—
—
2.3e+00
1.9e+00
cases:1.37%
controls:0.22%
cases:0.76%
controls:0.09%
—
—
—
—
—
—
cases:0.67%
controls:0.07%
cases:2.26%
controls:0.36%
29
47
2088
21108
16
20
2101
21135
—
—
—
14
14
2083
20927
45
71
1950
19682
Leukocyte esterase [Presence] in Urine by Automated test strip
60026-2 [40763086]
6.1e-01
1.0e+00
2.8e+00
—
1.3e+00
1.3e+00
1.1e+00
cases:6.99%
controls:3.94%
cases:5.57%
controls:2.07%
cases:4.82%
controls:0.31%
—
—
cases:1.23%
controls:0.34%
cases:7.58%
controls:2.25%
cases:22.36%
controls:9.05%
148
834
1969
20321
118
438
1999
20717
102
65
2015
21090
—
26
71
2091
21068
159
471
1938
20470
446
1788
1549
17965
Achilles tendinitis
M76.6 [45596682]
1.7e+00
2.8e+00
—
—
—
2.1e+00
1.5e+00
cases:0.66%
controls:0.13%
cases:0.76%
controls:0.05%
—
—
—
—
—
—
cases:0.38%
controls:0.05%
cases:1.15%
controls:0.25%
14
27
2103
21128
16
10
2101
21145
—
—
—
8
10
2089
20931
23
49
1972
19704
CBC panel - Blood by Automated count
58410-2 [40761511]
2.7e-01
6.1e-01
1.8e+00
2.9e+00
1.3e+00
6.9e-01
4.0e-01
cases:21.07%
controls:16.96%
cases:19.89%
controls:11.89%
cases:10.58%
controls:1.97%
cases:1.56%
controls:0.09%
cases:7.04%
controls:1.94%
cases:21.89%
controls:12.36%
cases:44.56%
controls:34.94%
446
3587
1671
17568
421
2516
1696
18639
224
417
1893
20738
33
18
2084
21137
149
410
1968
20729
459
2588
1638
18353
889
6902
1106
12851
Extractable nuclear Ab [Units/volume] in Serum
30342-0 [3015171]
2.0e+00
2.4e+00
—
—
—
1.9e+00
1.8e+00
cases:1.65%
controls:0.23%
cases:1.28%
controls:0.12%
—
—
—
—
—
—
cases:0.91%
controls:0.14%
cases:3.06%
controls:0.53%
35
49
2082
21106
27
26
2090
21129
—
—
—
19
29
2078
20912
61
104
1934
19649
inFLIXimab [Mass/volume] in Serum or Plasma
39803-2 [3042299]
2.3e+00
—
—
—
—
2.4e+00
3.3e+00
cases:0.47%
controls:0.05%
—
—
—
—
—
—
—
—
cases:0.43%
controls:0.04%
cases:1.95%
controls:0.08%
10
10
2107
21145
—
—
—
—
9
8
2088
20933
39
15
1956
19738
buprenorphine; implant, parenteral, sublingual
N07BC01 [21604826]
2.4e+00
2.6e+00
—
—
—
2.0e+00
3.0e+00
cases:0.38%
controls:0.03%
cases:0.38%
controls:0.03%
—
—
—
—
—
—
cases:0.24%
controls:0.03%
cases:1.15%
controls:0.06%
8
7
2109
21148
8
6
2109
21149
—
—
—
5
7
2092
20934
23
12
1972
19741
MCHC [Entitic Mass/volume] in Red Blood Cells
28540-3 [3003338]
3.0e-01
6.2e-01
2.0e+00
2.7e+00
1.4e+00
7.0e-01
2.9e-01
cases:20.12%
controls:15.77%
cases:20.64%
controls:12.33%
cases:15.12%
controls:2.37%
cases:1.65%
controls:0.11%
cases:8.55%
controls:2.36%
cases:23.27%
controls:13.15%
cases:40.80%
controls:33.93%
426
3337
1691
17818
437
2608
1680
18547
320
502
1797
20653
35
23
2082
21132
181
499
1936
20640
488
2753
1609
18188
814
6703
1181
13050
Borrelia burgdorferi IgM Ab [Units/volume] in Serum
7818-8 [3008230]
1.1e+00
1.9e+00
2.3e+00
—
—
1.7e+00
9.3e-01
cases:1.84%
controls:0.62%
cases:1.28%
controls:0.20%
cases:0.33%
controls:0.03%
—
—
—
—
cases:0.76%
controls:0.13%
cases:2.21%
controls:0.88%
39
132
2078
21023
27
42
2090
21113
7
7
2110
21148
—
—
16
28
2081
20913
44
174
1951
19579
piroxicam; oral, parenteral, rectal
M01AC01 [21603961]
9.5e-01
1.4e+00
1.8e+00
—
1.6e+00
1.1e+00
1.0e+00
cases:8.22%
controls:3.33%
cases:3.26%
controls:0.85%
cases:0.47%
controls:0.08%
—
—
cases:0.43%
controls:0.09%
cases:2.43%
controls:0.83%
cases:6.07%
controls:2.27%
174
705
1943
20450
69
179
2048
20976
10
16
2107
21139
—
9
18
2108
21121
51
174
2046
20767
121
449
1874
19304
Lumbar spine extensive MRI examination with high intensity magnet
NA3CG [2001307039]
3.6e+00
—
1.0e+50
1.0e+50
1.0e+50
1.0e+50
4.2e+00
cases:0.85%
controls:0.02%
—
—
cases:0.33%
controls:0.00%
cases:0.99%
controls:0.00%
cases:0.38%
controls:0.00%
cases:1.05%
controls:0.00%
cases:1.70%
controls:0.03%
18
5
2099
21150
—
7
0
2110
21155
21
0
2096
21155
8
0
2109
21139
22
0
2075
20941
34
5
1961
19748
Care involving use of other rehabilitation procedures
Z50.8 [45556842]
1.1e+00
1.7e+00
—
—
1.9e+00
1.8e+00
1.3e+00
cases:1.13%
controls:0.37%
cases:0.80%
controls:0.15%
—
—
—
—
cases:0.33%
controls:0.05%
cases:1.05%
controls:0.17%
cases:1.70%
controls:0.49%
24
79
2093
21076
17
32
2100
21123
—
—
7
10
2110
21129
22
36
2075
20905
34
97
1961
19656
Leukocytes [#/volume] in Urine
30405-5 [3018095]
5.3e-01
1.1e+00
2.7e+00
—
1.5e+00
1.1e+00
9.3e-01
cases:4.49%
controls:2.68%
cases:4.11%
controls:1.43%
cases:3.59%
controls:0.24%
—
—
cases:0.94%
controls:0.22%
cases:4.53%
controls:1.60%
cases:12.88%
controls:5.53%
95
568
2022
20587
87
302
2030
20853
76
51
2041
21104
—
20
47
2097
21092
95
335
2002
20606
257
1092
1738
18661
certolizumab pegol; parenteral
L04AB05 [21603912]
—
—
—
—
—
3.6e+00
4.1e+00
—
—
—
—
—
—
—
—
—
—
cases:0.91%
controls:0.02%
cases:2.81%
controls:0.05%
—
—
—
—
—
19
5
2078
20936
56
9
1939
19744
Short blood count panel - Blood
55429-5 [40758558]
6.3e-01
9.8e-01
2.2e+00
—
1.3e+00
1.4e+00
1.3e+00
cases:5.24%
controls:2.86%
cases:4.30%
controls:1.66%
cases:3.78%
controls:0.43%
—
—
cases:1.65%
controls:0.48%
cases:5.67%
controls:1.50%
cases:14.24%
controls:4.18%
111
605
2006
20550
91
352
2026
20803
80
92
2037
21063
—
35
101
2082
21038
119
315
1978
20626
284
825
1711
18928
Pulmonary Disease
29 [38004472]
6.6e-01
6.8e-01
9.2e-01
2.6e+00
8.6e-01
9.9e-01
9.4e-01
cases:7.84%
controls:4.22%
cases:4.20%
controls:2.16%
cases:0.94%
controls:0.38%
cases:0.33%
controls:0.02%
cases:0.99%
controls:0.42%
cases:5.58%
controls:2.15%
cases:12.68%
controls:5.38%
166
893
1951
20262
89
458
2028
20697
20
80
2097
21075
7
5
2110
21150
21
89
2096
21050
117
451
1980
20490
253
1062
1742
18691
Neutrophils [#/volume] in Blood
26499-4 [3017732]
1.0e+00
1.7e+00
2.5e+00
—
1.3e+00
1.4e+00
1.1e+00
cases:1.18%
controls:0.43%
cases:1.46%
controls:0.28%
cases:0.61%
controls:0.05%
—
—
cases:0.28%
controls:0.08%
cases:1.19%
controls:0.31%
cases:4.86%
controls:1.70%
25
90
2092
21065
31
60
2086
21095
13
11
2104
21144
—
6
16
2111
21123
25
65
2072
20876
97
336
1898
19417
Teaching
WZC30 [2001310891]
6.2e-01
1.1e+00
—
1.0e+50
2.9e+00
2.0e+00
1.5e+00
cases:1.37%
controls:0.74%
cases:1.13%
controls:0.37%
—
—
cases:1.13%
controls:0.00%
cases:0.52%
controls:0.03%
cases:3.20%
controls:0.43%
cases:6.27%
controls:1.49%
29
157
2088
20998
24
78
2093
21077
—
24
0
2093
21155
11
6
2106
21133
67
90
2030
20851
125
294
1870
19459
Erysipelas
A46 [45561706]
3.0e-01
1.5e+00
2.2e+00
—
2.1e+00
9.8e-01
7.9e-01
cases:0.94%
controls:0.70%
cases:0.99%
controls:0.23%
cases:0.33%
controls:0.04%
—
—
cases:0.28%
controls:0.03%
cases:0.86%
controls:0.32%
cases:2.51%
controls:1.15%
20
148
2097
21007
21
49
2096
21106
7
8
2110
21147
—
6
7
2111
21132
18
68
2079
20873
50
228
1945
19525
Bacterial infection, unspecified
A49.9 [45590816]
4.9e-01
1.8e+00
2.2e+00
—
2.5e+00
1.0e+00
1.1e+00
cases:0.66%
controls:0.41%
cases:1.18%
controls:0.19%
cases:0.28%
controls:0.03%
—
—
cases:0.33%
controls:0.03%
cases:0.52%
controls:0.19%
cases:1.60%
controls:0.56%
14
86
2103
21069
25
40
2092
21115
6
7
2111
21148
—
7
6
2110
21133
11
40
2086
20901
32
110
1963
19643
Cathetrisation of vein
TPH04 [2001309597]
7.9e-01
1.3e+00
1.5e+00
1.0e+50
2.7e+00
1.5e+00
1.3e+00
cases:2.93%
controls:1.36%
cases:1.51%
controls:0.43%
cases:0.24%
controls:0.05%
cases:0.33%
controls:0.00%
cases:0.66%
controls:0.04%
cases:2.19%
controls:0.52%
cases:6.32%
controls:1.87%
62
287
2055
20868
32
92
2085
21063
5
11
2112
21144
7
0
2110
21155
14
9
2103
21130
46
108
2051
20833
126
370
1869
19383
naproxen; oral, rectal
M01AE02 [21603968]
8.1e-01
1.3e+00
1.3e+00
—
2.0e+00
1.2e+00
8.2e-01
cases:18.94%
controls:9.44%
cases:10.25%
controls:3.09%
cases:1.51%
controls:0.41%
—
—
cases:2.27%
controls:0.30%
cases:10.01%
controls:3.10%
cases:18.05%
controls:8.81%
401
1998
1716
19157
217
654
1900
20501
32
86
2085
21069
—
48
64
2069
21075
210
650
1887
20291
360
1741
1635
18012
naproxcinod
M01AE18 [40254094]
8.1e-01
1.3e+00
1.3e+00
—
2.0e+00
1.2e+00
8.2e-01
cases:18.94%
controls:9.44%
cases:10.25%
controls:3.09%
cases:1.51%
controls:0.41%
—
—
cases:2.27%
controls:0.30%
cases:10.01%
controls:3.10%
cases:18.05%
controls:8.81%
401
1998
1716
19157
217
654
1900
20501
32
86
2085
21069
—
48
64
2069
21075
210
650
1887
20291
360
1741
1635
18012
Leukocytes [#/volume] in Synovial fluid
26469-7 [3000475]
1.7e+00
3.3e+00
—
1.0e+50
1.0e+50
—
2.4e+00
cases:0.66%
controls:0.12%
cases:1.18%
controls:0.04%
—
—
cases:0.38%
controls:0.00%
cases:0.33%
controls:0.00%
—
—
cases:2.11%
controls:0.19%
14
25
2103
21130
25
9
2092
21146
—
8
0
2109
21155
7
0
2110
21139
—
42
38
1953
19715
Radiculopathy
M54.1 [45577287]
2.8e+00
—
—
—
—
2.5e+00
2.2e+00
cases:0.61%
controls:0.04%
—
—
—
—
—
—
—
—
cases:0.29%
controls:0.02%
cases:0.65%
controls:0.08%
13
8
2104
21147
—
—
—
—
6
5
2091
20936
13
15
1982
19738
Injection of diagnostic or therapeutic substance in ankle joint or foot joint
TNH11 [2001308401]
2.5e+00
—
—
1.0e+50
—
2.0e+00
2.9e+00
cases:0.33%
controls:0.03%
—
—
—
—
cases:0.38%
controls:0.00%
—
—
cases:0.38%
controls:0.05%
cases:1.05%
controls:0.06%
7
6
2110
21149
—
—
8
0
2109
21155
—
8
11
2089
20930
21
11
1974
19742
Case Management Agency
251B00000X [38004193]
4.7e-01
6.0e-01
6.7e-01
3.4e+00
1.1e+00
6.7e-01
5.2e-01
cases:61.08%
controls:49.58%
cases:57.25%
controls:42.37%
cases:25.70%
controls:14.98%
cases:18.71%
controls:0.78%
cases:33.77%
controls:15.08%
cases:62.80%
controls:46.29%
cases:79.45%
controls:69.63%
1293
10489
824
10666
1212
8963
905
12192
544
3168
1573
17987
396
165
1721
20990
715
3188
1402
17951
1317
9694
780
11247
1585
13755
410
5998
alendronic acid; oral
M05BA04 [21604152]
1.1e+00
1.3e+00
1.8e+00
—
1.5e+00
1.7e+00
1.5e+00
cases:1.13%
controls:0.39%
cases:0.94%
controls:0.26%
cases:0.38%
controls:0.06%
—
—
cases:0.24%
controls:0.05%
cases:1.34%
controls:0.26%
cases:2.16%
controls:0.49%
24
83
2093
21072
20
54
2097
21101
8
13
2109
21142
—
5
11
2112
21128
28
54
2069
20887
43
96
1952
19657
Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
34487-9 [3044938]
1.3e-01
1.2e+00
2.0e+00
—
2.2e+00
1.1e+00
8.2e-01
cases:0.76%
controls:0.66%
cases:0.85%
controls:0.26%
cases:0.38%
controls:0.05%
—
—
cases:0.38%
controls:0.04%
cases:1.14%
controls:0.37%
cases:3.61%
controls:1.63%
16
140
2101
21015
18
55
2099
21100
8
11
2109
21144
—
8
9
2109
21130
24
77
2073
20864
72
321
1923
19432
methylprednisolone; oral, parenteral
H02AB04 [21602732]
1.3e+00
1.7e+00
1.8e+00
—
1.3e+00
1.4e+00
1.1e+00
cases:4.58%
controls:1.27%
cases:2.27%
controls:0.44%
cases:0.33%
controls:0.06%
—
—
cases:0.28%
controls:0.08%
cases:1.67%
controls:0.43%
cases:3.56%
controls:1.17%
97
268
2020
20887
48
93
2069
21062
7
12
2110
21143
—
6
16
2111
21123
35
90
2062
20851
71
232
1924
19521
Lumbar spine MRI examination with high intensity magnet
NA3BG [2001307034]
3.6e+00
—
1.0e+50
1.0e+50
—
—
3.6e+00
cases:2.03%
controls:0.06%
—
—
cases:0.28%
controls:0.00%
cases:1.32%
controls:0.00%
—
—
—
—
cases:4.31%
controls:0.12%
43
12
2074
21143
—
6
0
2111
21155
28
0
2089
21155
—
—
86
24
1909
19729
Sicca syndrome [Sjögren]
M35.0 [45562711]
1.4e+00
2.1e+00
—
1.0e+50
—
1.8e+00
1.8e+00
cases:0.66%
controls:0.16%
cases:0.61%
controls:0.08%
—
—
cases:0.57%
controls:0.00%
—
—
cases:0.67%
controls:0.11%
cases:1.05%
controls:0.17%
14
33
2103
21122
13
16
2104
21139
—
12
0
2105
21155
—
14
23
2083
20918
21
34
1974
19719
Cell count panel - Synovial fluid
34559-5 [3044941]
1.8e+00
3.1e+00
—
—
1.0e+50
—
2.3e+00
cases:0.47%
controls:0.08%
cases:0.71%
controls:0.03%
—
—
—
—
cases:0.28%
controls:0.00%
—
—
cases:1.40%
controls:0.15%
10
17
2107
21138
15
7
2102
21148
—
—
6
0
2111
21139
—
28
29
1967
19724
Epithelial cells [#/volume] in Urine
30383-4 [3000850]
3.7e-01
1.0e+00
2.5e+00
1.0e+50
1.8e+00
7.6e-01
1.1e+00
cases:2.55%
controls:1.77%
cases:1.98%
controls:0.70%
cases:1.18%
controls:0.10%
cases:0.28%
controls:0.00%
cases:0.52%
controls:0.09%
cases:1.43%
controls:0.67%
cases:6.57%
controls:2.39%
54
375
2063
20780
42
149
2075
21006
25
21
2092
21134
6
0
2111
21155
11
19
2106
21120
30
141
2067
20800
131
473
1864
19280
Differential panel - Synovial fluid
29582-4 [3021788]
1.8e+00
3.1e+00
—
—
—
—
2.2e+00
cases:0.47%
controls:0.08%
cases:0.80%
controls:0.04%
—
—
—
—
—
—
—
—
cases:1.30%
controls:0.14%
10
17
2107
21138
17
8
2100
21147
—
—
—
—
26
28
1969
19725
Thoracal spine MRI examination with high intensity magnet
NA2BG [2001307013]
2.8e+00
—
—
1.0e+50
—
—
4.2e+00
cases:0.47%
controls:0.03%
—
—
—
—
cases:0.90%
controls:0.00%
—
—
—
—
cases:1.60%
controls:0.03%
10
6
2107
21149
—
—
19
0
2098
21155
—
—
32
5
1963
19748
tizanidine; oral
M03BX02 [21604116]
1.1e+00
1.4e+00
1.4e+00
—
1.3e+00
1.0e+00
7.3e-01
cases:28.44%
controls:11.97%
cases:14.08%
controls:3.72%
cases:1.75%
controls:0.43%
—
—
cases:1.65%
controls:0.47%
cases:9.63%
controls:3.76%
cases:22.06%
controls:12.02%
602
2532
1515
18623
298
788
1819
20367
37
90
2080
21065
—
35
100
2082
21039
202
788
1895
20153
440
2375
1555
17378
Episcleritis
H15.1 [45591265]
2.0e+00
—
—
—
—
2.3e+00
2.7e+00
cases:0.71%
controls:0.10%
—
—
—
—
—
—
—
—
cases:0.33%
controls:0.03%
cases:1.00%
controls:0.07%
15
21
2102
21134
—
—
—
—
7
7
2090
20934
20
14
1975
19739
omeprazole; oral, parenteral
A02BC01 [21600096]
9.7e-01
1.4e+00
9.9e-01
—
1.6e+00
1.1e+00
9.0e-01
cases:7.42%
controls:2.96%
cases:4.53%
controls:1.21%
cases:0.71%
controls:0.26%
—
—
cases:1.13%
controls:0.22%
cases:3.67%
controls:1.31%
cases:7.32%
controls:3.12%
157
626
1960
20529
96
255
2021
20900
15
56
2102
21099
—
24
47
2093
21092
77
275
2020
20666
146
616
1849
19137
Foot and toes X-ray examination
NH3AA [2001308267]
1.2e+00
2.0e+00
—
1.0e+50
—
2.0e+00
1.6e+00
cases:1.51%
controls:0.45%
cases:0.99%
controls:0.14%
—
—
cases:0.80%
controls:0.00%
—
—
cases:1.00%
controls:0.14%
cases:3.11%
controls:0.61%
32
96
2085
21059
21
29
2096
21126
—
17
0
2100
21155
—
21
29
2076
20912
62
121
1933
19632
Urate [Moles/volume] in Serum or Plasma
14933-6 [3026493]
8.6e-01
1.5e+00
3.1e+00
—
1.1e+00
6.5e-01
7.2e-01
cases:3.97%
controls:1.73%
cases:3.83%
controls:0.88%
cases:1.56%
controls:0.07%
—
—
cases:0.38%
controls:0.13%
cases:1.76%
controls:0.93%
cases:7.52%
controls:3.80%
84
365
2033
20790
81
187
2036
20968
33
15
2084
21140
—
8
27
2109
21112
37
195
2060
20746
150
751
1845
19002
nortriptyline; oral, parenteral
N06AA10 [21604697]
1.5e+00
1.9e+00
2.1e+00
—
—
1.8e+00
1.6e+00
cases:1.46%
controls:0.33%
cases:1.09%
controls:0.17%
cases:0.24%
controls:0.03%
—
—
—
—
cases:0.86%
controls:0.14%
cases:2.91%
controls:0.59%
31
69
2086
21086
23
35
2094
21120
5
6
2112
21149
—
—
18
30
2079
20911
58
117
1937
19636
sodium aurothiomalate; parenteral
M01CB01 [21604025]
3.0e+00
—
—
—
—
—
3.8e+00
cases:0.85%
controls:0.04%
—
—
—
—
—
—
—
—
—
—
cases:1.10%
controls:0.03%
18
9
2099
21146
—
—
—
—
—
22
5
1973
19748
Cholangitis
K83.0 [45552955]
2.5e+00
2.1e+00
—
—
—
2.0e+00
2.3e+00
cases:0.33%
controls:0.03%
cases:0.24%
controls:0.03%
—
—
—
—
—
—
cases:0.29%
controls:0.04%
cases:0.45%
controls:0.05%
7
6
2110
21149
5
6
2112
21149
—
—
—
6
8
2091
20933
9
9
1986
19744
Fever, unspecified
R50.9 [45582716]
8.6e-01
1.4e+00
2.2e+00
1.0e+50
1.8e+00
1.3e+00
9.9e-01
cases:2.13%
controls:0.91%
cases:1.32%
controls:0.32%
cases:0.52%
controls:0.06%
cases:0.33%
controls:0.00%
cases:0.28%
controls:0.05%
cases:1.19%
controls:0.34%
cases:3.31%
controls:1.26%
45
193
2072
20962
28
68
2089
21087
11
12
2106
21143
7
0
2110
21155
6
10
2111
21129
25
71
2072
20870
66
248
1929
19505
Clinical & Laboratory Dermatological Immunology Physician
207NI0002X [38003841]
7.6e-01
9.4e-01
1.2e+00
—
1.6e+00
1.3e+00
9.6e-01
cases:11.43%
controls:5.68%
cases:5.38%
controls:2.17%
cases:1.32%
controls:0.40%
—
—
cases:1.51%
controls:0.31%
cases:7.20%
controls:2.11%
cases:14.49%
controls:6.10%
242
1201
1875
19954
114
460
2003
20695
28
85
2089
21070
—
32
66
2085
21073
151
441
1946
20500
289
1204
1706
18549
Sodium [Moles/volume] in Serum or Plasma
2951-2 [3019550]
2.4e-01
3.7e-01
1.1e+00
3.4e+00
9.3e-01
3.0e-01
3.5e-01
cases:16.91%
controls:13.75%
cases:14.36%
controls:10.34%
cases:4.77%
controls:1.67%
cases:1.75%
controls:0.06%
cases:4.11%
controls:1.66%
cases:14.45%
controls:11.08%
cases:39.25%
controls:31.25%
358
2909
1759
18246
304
2187
1813
18968
101
354
2016
20801
37
12
2080
21143
87
351
2030
20788
303
2321
1794
18620
783
6173
1212
13580
Pain general/multiple sites
A01 [2002000142]
1.3e+00
2.4e+00
—
—
—
1.6e+00
1.4e+00
cases:1.04%
controls:0.29%
cases:0.66%
controls:0.06%
—
—
—
—
—
—
cases:0.81%
controls:0.16%
cases:2.16%
controls:0.54%
22
62
2095
21093
14
13
2103
21142
—
—
—
17
33
2080
20908
43
106
1952
19647
Myalgia
M79.1 [45587062]
8.6e-01
1.4e+00
2.2e+00
—
—
1.3e+00
1.0e+00
cases:1.79%
controls:0.77%
cases:1.23%
controls:0.32%
cases:0.43%
controls:0.05%
—
—
—
—
cases:1.00%
controls:0.28%
cases:3.86%
controls:1.44%
38
163
2079
20992
26
67
2091
21088
9
10
2108
21145
—
—
21
59
2076
20882
77
285
1918
19468
Ophthalmology
18 [38004463]
8.6e-01
1.1e+00
1.5e+00
—
1.5e+00
9.2e-01
8.1e-01
cases:18.61%
controls:8.80%
cases:11.15%
controls:3.95%
cases:2.79%
controls:0.62%
—
—
cases:2.55%
controls:0.60%
cases:10.01%
controls:4.26%
cases:22.71%
controls:11.56%
394
1861
1723
19294
236
836
1881
20319
59
132
2058
21023
—
54
126
2063
21013
210
893
1887
20048
453
2283
1542
17470
Medical doctor
Z2221 [2001311556]
4.0e-01
1.0e+00
1.4e+00
—
1.5e+00
1.3e+00
1.1e+00
cases:6.85%
controls:4.70%
cases:3.73%
controls:1.38%
cases:0.85%
controls:0.21%
—
—
cases:0.80%
controls:0.19%
cases:4.34%
controls:1.22%
cases:8.37%
controls:2.96%
145
995
1972
20160
79
292
2038
20863
18
44
2099
21111
—
17
40
2100
21099
91
256
2006
20685
167
584
1828
19169
Potassium [Moles/volume] in Serum or Plasma
2823-3 [3023103]
2.5e-01
3.7e-01
1.0e+00
3.4e+00
9.3e-01
2.9e-01
3.5e-01
cases:17.15%
controls:13.89%
cases:14.41%
controls:10.43%
cases:4.72%
controls:1.72%
cases:1.70%
controls:0.06%
cases:4.16%
controls:1.69%
cases:14.54%
controls:11.26%
cases:39.35%
controls:31.47%
363
2939
1754
18216
305
2207
1812
18948
100
363
2017
20792
36
12
2081
21143
88
357
2029
20782
305
2357
1792
18584
785
6216
1210
13537
Back symptom/complaint
L02 [2002000627]
1.3e+00
2.0e+00
—
—
—
2.2e+00
1.1e+00
cases:1.70%
controls:0.48%
cases:1.09%
controls:0.15%
—
—
—
—
—
—
cases:1.48%
controls:0.17%
cases:2.56%
controls:0.83%
36
101
2081
21054
23
32
2094
21123
—
—
—
31
35
2066
20906
51
163
1944
19590
General Practice
1 [38004446]
7.2e-01
1.1e+00
1.4e+00
—
1.9e+00
8.0e-01
6.8e-01
cases:13.84%
controls:7.23%
cases:7.04%
controls:2.47%
cases:1.37%
controls:0.35%
—
—
cases:2.08%
controls:0.31%
cases:5.63%
controls:2.61%
cases:14.54%
controls:7.92%
293
1529
1824
19626
149
523
1968
20632
29
75
2088
21080
—
44
66
2073
21073
118
546
1979
20395
290
1565
1705
18188
Trochanteric bursitis
M70.6 [45606304]
1.4e+00
1.8e+00
—
—
—
1.8e+00
1.5e+00
cases:1.70%
controls:0.42%
cases:1.09%
controls:0.17%
—
—
—
—
—
—
cases:1.00%
controls:0.17%
cases:3.76%
controls:0.83%
36
89
2081
21066
23
37
2094
21118
—
—
—
21
36
2076
20905
75
164
1920
19589
Esophagoscopy, gastroscopy and duodenoscopy
UJD10 [2001304788]
9.7e-01
1.0e+00
2.3e+00
—
—
1.0e+00
1.2e+00
cases:5.34%
controls:2.08%
cases:1.65%
controls:0.59%
cases:0.47%
controls:0.05%
—
—
—
—
cases:1.76%
controls:0.64%
cases:7.47%
controls:2.37%
113
441
2004
20714
35
124
2082
21031
10
10
2107
21145
—
—
37
134
2060
20807
149
468
1846
19285
orphenadrine, combinations
M03BC51 [21604113]
9.7e-01
1.5e+00
2.4e+00
—
1.5e+00
1.0e+00
7.1e-01
cases:8.03%
controls:3.20%
cases:3.64%
controls:0.87%
cases:0.66%
controls:0.06%
—
—
cases:0.33%
controls:0.07%
cases:2.43%
controls:0.91%
cases:6.07%
controls:3.06%
170
676
1947
20479
77
183
2040
20972
14
13
2103
21142
—
7
15
2110
21124
51
190
2046
20751
121
605
1874
19148
diclofenac, combinations; oral
M01AB55 [21603959]
2.0e+00
2.7e+00
—
—
—
1.4e+00
1.8e+00
cases:1.79%
controls:0.25%
cases:1.18%
controls:0.08%
—
—
—
—
—
—
cases:0.33%
controls:0.09%
cases:1.05%
controls:0.17%
38
52
2079
21103
25
17
2092
21138
—
—
—
7
18
2090
20923
21
34
1974
19719
25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
68438-1 [40771025]
4.8e-01
7.4e-01
2.1e+00
—
1.4e+00
8.9e-01
8.6e-01
cases:4.72%
controls:2.98%
cases:3.97%
controls:1.93%
cases:1.84%
controls:0.23%
—
—
cases:1.04%
controls:0.25%
cases:5.10%
controls:2.16%
cases:17.34%
controls:8.12%
100
631
2017
20524
84
408
2033
20747
39
49
2078
21106
—
22
52
2095
21087
107
453
1990
20488
346
1604
1649
18149
Snapping jaw
K07.60 [2000502791]
1.4e+00
1.8e+00
—
—
—
1.8e+00
1.4e+00
cases:1.37%
controls:0.33%
cases:0.99%
controls:0.17%
—
—
—
—
—
—
cases:0.72%
controls:0.11%
cases:2.56%
controls:0.64%
29
69
2088
21086
21
35
2096
21120
—
—
—
15
24
2082
20917
51
126
1944
19627
Other specified special examinations
Z01.8 [45581003]
9.6e-01
1.2e+00
1.4e+00
—
1.8e+00
1.3e+00
1.2e+00
cases:4.20%
controls:1.65%
cases:1.65%
controls:0.51%
cases:0.33%
controls:0.08%
—
—
cases:0.38%
controls:0.06%
cases:1.96%
controls:0.52%
cases:6.37%
controls:2.07%
89
350
2028
20805
35
107
2082
21048
7
17
2110
21138
—
8
13
2109
21126
41
108
2056
20833
127
409
1868
19344
paracetamol, combinations excl. psycholeptics
N02BE51 [21604348]
9.8e-01
1.5e+00
2.3e+00
—
1.5e+00
9.9e-01
7.4e-01
cases:8.64%
controls:3.43%
cases:3.83%
controls:0.91%
cases:0.66%
controls:0.07%
—
—
cases:0.38%
controls:0.09%
cases:2.58%
controls:0.97%
cases:6.42%
controls:3.16%
183
726
1934
20429
81
193
2036
20962
14
14
2103
21141
—
8
18
2109
21121
54
203
2043
20738
128
625
1867
19128
Albumin [Mass/volume] in Serum or Plasma
1751-7 [3024561]
5.7e-01
8.7e-01
1.5e+00
—
1.5e+00
1.1e+00
9.6e-01
cases:5.38%
controls:3.13%
cases:4.06%
controls:1.74%
cases:1.56%
controls:0.36%
—
—
cases:1.32%
controls:0.30%
cases:5.48%
controls:1.91%
cases:14.64%
controls:6.17%
114
662
2003
20493
86
369
2031
20786
33
77
2084
21078
—
28
63
2089
21076
115
399
1982
20542
292
1219
1703
18534
ciprofloxacin; oral, parenteral
J01MA02 [21603009]
5.8e-01
1.4e+00
1.6e+00
—
1.4e+00
9.3e-01
6.3e-01
cases:7.75%
controls:4.49%
cases:3.78%
controls:1.00%
cases:0.52%
controls:0.11%
—
—
cases:0.57%
controls:0.15%
cases:2.81%
controls:1.13%
cases:7.07%
controls:3.88%
164
949
1953
20206
80
212
2037
20943
11
23
2106
21132
—
12
31
2105
21108
59
237
2038
20704
141
767
1854
18986
esomeprazole; oral, parenteral
A02BC05 [21600100]
8.4e-01
1.1e+00
1.1e+00
—
1.2e+00
1.1e+00
1.1e+00
cases:11.43%
controls:5.29%
cases:7.13%
controls:2.56%
cases:1.46%
controls:0.49%
—
—
cases:1.46%
controls:0.44%
cases:7.25%
controls:2.65%
cases:16.49%
controls:5.94%
242
1119
1875
20036
151
542
1966
20613
31
104
2086
21051
—
31
93
2086
21046
152
554
1945
20387
329
1173
1666
18580
Hand and fingers X-ray examination
ND2AA [2001307607]
8.1e-01
1.6e+00
—
—
—
2.1e+00
1.8e+00
cases:1.23%
controls:0.55%
cases:0.85%
controls:0.17%
—
—
—
—
—
—
cases:1.05%
controls:0.12%
cases:3.71%
controls:0.61%
26
116
2091
21039
18
36
2099
21119
—
—
—
22
26
2075
20915
74
120
1921
19633
pH of Serum or Plasma
2753-2 [3018418]
4.7e-01
9.4e-01
2.1e+00
—
1.6e+00
8.6e-01
8.6e-01
cases:2.83%
controls:1.79%
cases:2.83%
controls:1.13%
cases:1.42%
controls:0.17%
—
—
cases:1.09%
controls:0.21%
cases:2.77%
controls:1.19%
cases:8.57%
controls:3.80%
60
379
2057
20776
60
238
2057
20917
30
37
2087
21118
—
23
45
2094
21094
58
250
2039
20691
171
751
1824
19002
Hepatitis B virus surface Ag [Presence] in Serum
5195-3 [3019284]
2.7e-01
3.8e-01
2.0e+00
—
2.3e+00
1.1e+00
8.8e-01
cases:3.97%
controls:3.06%
cases:2.08%
controls:1.43%
cases:0.94%
controls:0.13%
—
—
cases:1.23%
controls:0.12%
cases:3.86%
controls:1.26%
cases:10.43%
controls:4.59%
84
648
2033
20507
44
303
2073
20852
20
27
2097
21128
—
26
26
2091
21113
81
264
2016
20677
208
907
1787
18846
Other specified arthritis
M13.8 [45577155]
3.5e+00
—
—
—
—
—
2.8e+00
cases:0.80%
controls:0.02%
—
—
—
—
—
—
—
—
—
—
cases:1.00%
controls:0.06%
17
5
2100
21150
—
—
—
—
—
20
12
1975
19741
Bacteria identified in Isolate by Culture
43409-2 [3042936]
2.8e-01
1.4e+00
1.6e+00
—
2.7e+00
1.2e+00
9.9e-01
cases:1.23%
controls:0.93%
cases:1.51%
controls:0.39%
cases:0.33%
controls:0.07%
—
—
cases:0.94%
controls:0.06%
cases:1.00%
controls:0.29%
cases:4.56%
controls:1.75%
26
197
2091
20958
32
82
2085
21073
7
14
2110
21141
—
20
13
2097
21126
21
61
2076
20880
91
345
1904
19408
Surgical procedure, unspecified as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
Y83.9 [45547252]
8.7e-01
2.1e+00
—
—
—
2.8e+00
1.5e+00
cases:0.24%
controls:0.10%
cases:0.33%
controls:0.04%
—
—
—
—
—
—
cases:0.38%
controls:0.02%
cases:0.50%
controls:0.11%
5
21
2112
21134
7
9
2110
21146
—
—
—
8
5
2089
20936
10
22
1985
19731
Injection of diagnostic or therapeutic substance in knee
TNG11 [2001308222]
2.8e+00
—
—
1.0e+50
—
—
3.6e+00
cases:0.38%
controls:0.02%
—
—
—
—
cases:0.24%
controls:0.00%
—
—
—
—
cases:1.05%
controls:0.03%
8
5
2109
21150
—
—
5
0
2112
21155
—
—
21
6
1974
19747
Protein [Presence] in Urine by Test strip
20454-5 [3014051]
6.1e-01
8.9e-01
2.9e+00
—
1.0e+00
1.2e+00
7.0e-01
cases:3.26%
controls:1.81%
cases:2.74%
controls:1.14%
cases:2.79%
controls:0.16%
—
—
cases:0.52%
controls:0.18%
cases:4.15%
controls:1.29%
cases:10.98%
controls:5.76%
69
382
2048
20773
58
241
2059
20914
59
33
2058
21122
—
11
39
2106
21100
87
270
2010
20671
219
1137
1776
18616
Protein electrophoresis panel - Serum or Plasma
24351-9 [3004588]
1.2e+00
2.1e+00
—
—
—
1.5e+00
1.4e+00
cases:0.71%
controls:0.21%
cases:0.85%
controls:0.10%
—
—
—
—
—
—
cases:0.52%
controls:0.11%
cases:1.70%
controls:0.41%
15
45
2102
21110
18
22
2099
21133
—
—
—
11
24
2086
20917
34
81
1961
19672
Extensive medical or dental certificate
WZA10 [2001310880]
2.1e+00
—
—
1.0e+50
—
1.0e+50
4.2e+00
cases:0.57%
controls:0.07%
—
—
—
—
cases:0.90%
controls:0.00%
—
—
cases:1.10%
controls:0.00%
cases:2.26%
controls:0.04%
12
15
2105
21140
—
—
19
0
2098
21155
—
23
0
2074
20941
45
7
1950
19746
Medical assessment of need and possibilities to rehabilitation
R1210 [2001310174]
1.7e+00
—
—
—
—
2.3e+00
2.2e+00
cases:0.47%
controls:0.09%
—
—
—
—
—
—
—
—
cases:0.29%
controls:0.03%
cases:0.60%
controls:0.07%
10
18
2107
21137
—
—
—
—
6
6
2091
20935
12
13
1983
19740
Brachial plexus disorders
G54.0 [45586302]
2.1e+00
2.3e+00
—
—
—
—
1.9e+00
cases:0.80%
controls:0.10%
cases:0.33%
controls:0.03%
—
—
—
—
—
—
—
—
cases:0.75%
controls:0.12%
17
22
2100
21133
7
7
2110
21148
—
—
—
—
15
23
1980
19730
Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
19072-8 [3016431]
5.8e-01
8.0e-01
1.8e+00
—
1.4e+00
8.6e-01
7.6e-01
cases:5.48%
controls:3.13%
cases:4.16%
controls:1.91%
cases:1.70%
controls:0.29%
—
—
cases:1.37%
controls:0.33%
cases:4.48%
controls:1.95%
cases:14.29%
controls:7.21%
116
663
2001
20492
88
405
2029
20750
36
62
2081
21093
—
29
69
2088
21070
94
408
2003
20533
285
1424
1710
18329
cyclopentolate
S01FA04 [21605063]
3.6e+00
—
—
—
—
—
2.6e+00
cases:1.18%
controls:0.03%
—
—
—
—
—
—
—
—
—
—
cases:0.60%
controls:0.05%
25
7
2092
21148
—
—
—
—
—
12
9
1983
19744
Neck symptom/complaint
L01 [2002000626]
8.0e-01
1.2e+00
2.2e+00
—
—
1.0e+00
9.6e-01
cases:2.13%
controls:0.97%
cases:1.09%
controls:0.35%
cases:0.33%
controls:0.04%
—
—
—
—
cases:0.91%
controls:0.32%
cases:3.96%
controls:1.56%
45
205
2072
20950
23
73
2094
21082
7
8
2110
21147
—
—
19
67
2078
20874
79
308
1916
19445
Erythrocytes [Presence] in Urine by Automated
53292-9 [3041096]
5.4e-01
9.2e-01
2.7e+00
—
1.0e+00
1.1e+00
8.9e-01
cases:4.49%
controls:2.67%
cases:3.59%
controls:1.46%
cases:2.88%
controls:0.21%
—
—
cases:0.66%
controls:0.24%
cases:4.53%
controls:1.53%
cases:13.73%
controls:6.16%
95
564
2022
20591
76
308
2041
20847
61
44
2056
21111
—
14
51
2103
21088
95
320
2002
20621
274
1216
1721
18537
Laboratory Visit
OMOP4822461 [32036]
1.2e-01
3.8e-01
1.5e+00
2.5e+00
1.1e+00
4.5e-01
2.1e-01
cases:27.59%
controls:25.18%
cases:31.70%
controls:24.10%
cases:25.41%
controls:6.81%
cases:4.63%
controls:0.40%
cases:16.91%
controls:6.56%
cases:36.05%
controls:26.49%
cases:56.64%
controls:51.53%
584
5327
1533
15828
671
5099
1446
16056
538
1441
1579
19714
98
85
2019
21070
358
1387
1759
19752
756
5547
1341
15394
1130
10179
865
9574
Casts [#/volume] in Urine by Automated count
51483-6 [3030467]
3.0e-01
9.4e-01
2.1e+00
—
1.5e+00
7.1e-01
8.6e-01
cases:2.74%
controls:2.05%
cases:2.46%
controls:0.98%
cases:1.37%
controls:0.17%
—
—
cases:0.66%
controls:0.14%
cases:2.05%
controls:1.02%
cases:7.52%
controls:3.34%
58
433
2059
20722
52
207
2065
20948
29
37
2088
21118
—
14
30
2103
21109
43
214
2054
20727
150
660
1845
19093
Functional diarrhoea
K59.1 [45543327]
1.2e+00
1.9e+00
—
—
—
1.7e+00
1.2e+00
cases:0.66%
controls:0.19%
cases:0.43%
controls:0.06%
—
—
—
—
—
—
cases:0.43%
controls:0.08%
cases:1.10%
controls:0.33%
14
41
2103
21114
9
13
2108
21142
—
—
—
9
16
2088
20925
22
66
1973
19687
Erythrocytes [#/volume] in Urine
30391-7 [3002582]
4.2e-01
1.1e+00
2.0e+00
—
1.5e+00
7.2e-01
7.9e-01
cases:3.54%
controls:2.36%
cases:3.21%
controls:1.13%
cases:1.42%
controls:0.19%
—
—
cases:0.76%
controls:0.17%
cases:2.58%
controls:1.27%
cases:8.87%
controls:4.21%
75
499
2042
20656
68
238
2049
20917
30
41
2087
21114
—
16
36
2101
21103
54
265
2043
20676
177
832
1818
18921
Hip X-ray examination
NF1AA [2001307894]
1.7e+00
1.2e+00
—
—
—
2.5e+00
1.9e+00
cases:0.90%
controls:0.17%
cases:0.24%
controls:0.07%
—
—
—
—
—
—
cases:0.57%
controls:0.05%
cases:2.11%
controls:0.31%
19
36
2098
21119
5
15
2112
21140
—
—
—
12
10
2085
20931
42
62
1953
19691
Calcium.ionized [Moles/volume] in Serum or Plasma
1995-0 [3021347]
4.2e-01
7.8e-01
1.8e+00
—
1.4e+00
8.2e-01
8.2e-01
cases:4.20%
controls:2.80%
cases:3.68%
controls:1.72%
cases:1.56%
controls:0.26%
—
—
cases:1.23%
controls:0.30%
cases:3.86%
controls:1.74%
cases:12.63%
controls:5.97%
89
592
2028
20563
78
364
2039
20791
33
55
2084
21100
—
26
64
2091
21075
81
365
2016
20576
252
1179
1743
18574
Other specified rheumatoid arthritis
M06.8 [45543441]
2.6e+00
—
—
—
—
—
3.5e+00
cases:0.38%
controls:0.03%
—
—
—
—
—
—
—
—
—
—
cases:0.95%
controls:0.03%
8
6
2109
21149
—
—
—
—
—
19
6
1976
19747
INR in Blood by Coagulation assay
34714-6 [3032080]
3.8e-01
7.4e-01
7.5e-01
2.6e+00
1.2e+00
9.0e-01
6.3e-01
cases:4.11%
controls:2.84%
cases:3.12%
controls:1.51%
cases:0.94%
controls:0.45%
cases:0.38%
controls:0.03%
cases:1.32%
controls:0.42%
cases:3.72%
controls:1.55%
cases:10.68%
controls:5.97%
87
600
2030
20555
66
320
2051
20835
20
95
2097
21060
8
6
2109
21149
28
89
2089
21050
78
325
2019
20616
213
1180
1782
18573
piroxicam; ointment
M02AA07 [21604043]
9.0e-01
1.3e+00
1.7e+00
—
1.3e+00
1.0e+00
1.0e+00
cases:6.80%
controls:2.88%
cases:2.79%
controls:0.75%
cases:0.38%
controls:0.07%
—
—
cases:0.28%
controls:0.08%
cases:2.15%
controls:0.77%
cases:5.56%
controls:2.13%
144
610
1973
20545
59
159
2058
20996
8
14
2109
21141
—
6
17
2111
21122
45
162
2052
20779
111
420
1884
19333
Musculoskeletal disease other
L99 [2002000718]
1.8e+00
—
—
—
—
2.1e+00
2.2e+00
cases:0.33%
controls:0.06%
—
—
—
—
—
—
—
—
cases:0.33%
controls:0.04%
cases:0.95%
controls:0.11%
7
12
2110
21143
—
—
—
—
7
9
2090
20932
19
22
1976
19731
Emergency Medicine
93 [38004510]
5.6e-01
1.0e+00
1.4e+00
—
1.4e+00
9.0e-01
6.1e-01
cases:9.97%
controls:5.92%
cases:8.55%
controls:3.24%
cases:1.89%
controls:0.47%
—
—
cases:1.75%
controls:0.42%
cases:8.15%
controls:3.50%
cases:23.36%
controls:14.25%
211
1253
1906
19902
181
685
1936
20470
40
99
2077
21056
—
37
88
2080
21051
171
733
1926
20208
466
2815
1529
16938
Bacteria identified in Blood by Culture
600-7 [3023368]
3.6e-01
1.1e+00
1.7e+00
—
2.5e+00
5.8e-01
6.2e-01
cases:2.08%
controls:1.46%
cases:2.17%
controls:0.74%
cases:0.66%
controls:0.12%
—
—
cases:1.23%
controls:0.10%
cases:1.29%
controls:0.73%
cases:5.61%
controls:3.10%
44
309
2073
20846
46
156
2071
20999
14
26
2103
21129
—
26
21
2091
21118
27
152
2070
20789
112
612
1883
19141
etodolac; oral
M01AB08 [21603948]
1.4e+00
1.8e+00
—
—
—
1.6e+00
1.1e+00
cases:2.03%
controls:0.53%
cases:0.80%
controls:0.13%
—
—
—
—
—
—
cases:0.67%
controls:0.13%
cases:1.50%
controls:0.51%
43
113
2074
21042
17
27
2100
21128
—
—
—
14
28
2083
20913
30
100
1965
19653
indometacin; oral, parenteral, rectal
M01AB01 [21603941]
1.5e+00
1.8e+00
—
—
—
1.4e+00
1.2e+00
cases:1.37%
controls:0.32%
cases:0.85%
controls:0.14%
—
—
—
—
—
—
cases:0.62%
controls:0.15%
cases:1.25%
controls:0.39%
29
68
2088
21087
18
29
2099
21126
—
—
—
13
31
2084
20910
25
77
1970
19676
General Surgery
2 [38004447]
7.1e-01
9.5e-01
1.4e+00
—
1.2e+00
8.9e-01
7.1e-01
cases:23.57%
controls:13.16%
cases:9.54%
controls:3.93%
cases:2.17%
controls:0.53%
—
—
cases:1.61%
controls:0.48%
cases:8.54%
controls:3.69%
cases:19.30%
controls:10.56%
499
2785
1618
18370
202
832
1915
20323
46
113
2071
21042
—
34
102
2083
21037
179
772
1918
20169
385
2086
1610
17667
Other ultrasound examination
XX9XE [2001311056]
2.9e+00
—
—
1.0e+50
—
—
3.0e+00
cases:0.43%
controls:0.02%
—
—
—
—
cases:0.24%
controls:0.00%
—
—
—
—
cases:0.80%
controls:0.04%
9
5
2108
21150
—
—
5
0
2112
21155
—
—
16
8
1979
19745
Foot and toes extensive X-ray examination
NH3BA [2001308270]
8.4e-01
2.3e+00
—
—
—
2.1e+00
1.5e+00
cases:0.28%
controls:0.12%
cases:0.28%
controls:0.03%
—
—
—
—
—
—
cases:0.33%
controls:0.04%
cases:0.85%
controls:0.19%
6
26
2111
21129
6
6
2111
21149
—
—
—
7
9
2090
20932
17
37
1978
19716
Cervical spine X-ray examination without contrast
NA1AA [2001306981]
2.5e+00
—
—
1.0e+50
—
—
3.4e+00
cases:0.57%
controls:0.05%
—
—
—
—
cases:0.28%
controls:0.00%
—
—
—
—
cases:1.00%
controls:0.04%
12
10
2105
21145
—
—
6
0
2111
21155
—
—
20
7
1975
19746
Bacteria [Presence] in Urine
87829-8 [36304419]
3.7e-01
9.2e-01
1.9e+00
—
1.5e+00
6.0e-01
8.7e-01
cases:2.88%
controls:2.01%
cases:2.31%
controls:0.93%
cases:1.18%
controls:0.17%
—
—
cases:0.66%
controls:0.15%
cases:1.81%
controls:1.00%
cases:7.27%
controls:3.17%
61
425
2056
20730
49
197
2068
20958
25
36
2092
21119
—
14
32
2103
21107
38
209
2059
20732
145
626
1850
19127
Asthma, unspecified
J45.9 [45562456]
8.5e-01
1.0e+00
1.3e+00
1.0e+50
1.7e+00
1.3e+00
9.9e-01
cases:3.45%
controls:1.50%
cases:1.65%
controls:0.60%
cases:0.43%
controls:0.11%
cases:0.66%
controls:0.00%
cases:0.43%
controls:0.08%
cases:2.24%
controls:0.64%
cases:5.71%
controls:2.20%
73
317
2044
20838
35
126
2082
21029
9
24
2108
21131
14
0
2103
21155
9
17
2108
21122
47
135
2050
20806
114
434
1881
19319
Complement C3 [Mass/volume] in Serum or Plasma
4485-9 [3000620]
1.1e+00
1.7e+00
—
—
—
1.6e+00
1.3e+00
cases:0.76%
controls:0.26%
cases:0.57%
controls:0.10%
—
—
—
—
—
—
cases:0.48%
controls:0.10%
cases:1.70%
controls:0.46%
16
55
2101
21100
12
21
2105
21134
—
—
—
10
20
2087
20921
34
90
1961
19663
Band form neutrophils/Leukocytes in Blood
26508-2 [3004809]
2.6e+00
1.7e+00
—
—
—
—
1.5e+00
cases:0.43%
controls:0.03%
cases:0.38%
controls:0.07%
—
—
—
—
—
—
—
—
cases:0.75%
controls:0.18%
9
7
2108
21148
8
14
2109
21141
—
—
—
—
15
35
1980
19718
indometacin
C01EB03 [21600365]
1.4e+00
1.7e+00
—
—
—
1.5e+00
1.1e+00
cases:1.32%
controls:0.32%
cases:0.76%
controls:0.14%
—
—
—
—
—
—
cases:0.62%
controls:0.14%
cases:1.20%
controls:0.39%
28
68
2089
21087
16
29
2101
21126
—
—
—
13
30
2084
20911
24
77
1971
19676
Pain in limb
M79.6 [45587063]
9.7e-01
1.2e+00
1.8e+00
—
9.5e-01
1.0e+00
7.1e-01
cases:6.33%
controls:2.50%
cases:3.21%
controls:0.95%
cases:0.76%
controls:0.13%
—
—
cases:0.33%
controls:0.13%
cases:3.05%
controls:1.10%
cases:10.93%
controls:5.67%
134
529
1983
20626
68
202
2049
20953
16
27
2101
21128
—
7
27
2110
21112
64
231
2033
20710
218
1120
1777
18633
Monoarthritis, not elsewhere classified
M13.1 [45591736]
3.3e+00
—
—
—
—
—
2.4e+00
cases:0.66%
controls:0.02%
—
—
—
—
—
—
—
—
—
—
cases:0.50%
controls:0.05%
14
5
2103
21150
—
—
—
—
—
10
9
1985
19744
Microorganisms panel - Urine sediment
58435-9 [40761536]
5.9e-01
1.1e+00
2.4e+00
—
1.4e+00
1.1e+00
1.1e+00
cases:1.51%
controls:0.85%
cases:1.18%
controls:0.38%
cases:0.80%
controls:0.07%
—
—
cases:0.28%
controls:0.07%
cases:1.24%
controls:0.43%
cases:3.96%
controls:1.36%
32
179
2085
20976
25
80
2092
21075
17
15
2100
21140
—
6
15
2111
21124
26
91
2071
20850
79
268
1916
19485
Noninfective gastroenteritis and colitis, unspecified
K52.9 [45572215]
1.6e+00
1.8e+00
—
—
—
2.4e+00
1.7e+00
cases:0.76%
controls:0.15%
cases:0.28%
controls:0.05%
—
—
—
—
—
—
cases:0.38%
controls:0.03%
cases:1.05%
controls:0.20%
16
32
2101
21123
6
10
2111
21145
—
—
—
8
7
2089
20934
21
39
1974
19714
Hepatitis B virus core IgM Ab [Presence] in Serum
31204-1 [3013527]
8.9e-01
2.2e+00
—
—
—
1.9e+00
1.6e+00
cases:0.38%
controls:0.16%
cases:0.57%
controls:0.07%
—
—
—
—
—
—
cases:0.76%
controls:0.11%
cases:1.95%
controls:0.41%
8
33
2109
21122
12
14
2105
21141
—
—
—
16
23
2081
20918
39
80
1956
19673
Other dorsalgia
M54.8 [45538790]
2.0e+00
2.2e+00
—
—
—
1.8e+00
1.5e+00
cases:0.66%
controls:0.09%
cases:0.47%
controls:0.05%
—
—
—
—
—
—
cases:0.24%
controls:0.04%
cases:1.00%
controls:0.22%
14
20
2103
21135
10
11
2107
21144
—
—
—
5
8
2092
20933
20
44
1975
19709
Mitochondria Ab [Titer] in Serum
20483-4 [3034770]
6.6e-01
9.2e-01
—
—
2.5e+00
1.7e+00
1.5e+00
cases:0.47%
controls:0.25%
cases:0.24%
controls:0.09%
—
—
—
—
cases:0.28%
controls:0.02%
cases:0.48%
controls:0.09%
cases:1.45%
controls:0.34%
10
52
2107
21103
5
20
2112
21135
—
—
6
5
2111
21134
10
18
2087
20923
29
67
1966
19686
Complement C4 [Mass/volume] in Serum or Plasma
4498-2 [3017766]
9.9e-01
1.7e+00
—
—
—
1.7e+00
1.3e+00
cases:0.71%
controls:0.26%
cases:0.57%
controls:0.11%
—
—
—
—
—
—
cases:0.48%
controls:0.09%
cases:1.70%
controls:0.45%
15
56
2102
21099
12
23
2105
21132
—
—
—
10
19
2087
20922
34
89
1961
19664
Borrelia burgdorferi IgG Ab [Units/volume] in Serum
7817-0 [3016888]
1.1e+00
1.9e+00
2.3e+00
—
—
1.6e+00
9.9e-01
cases:1.65%
controls:0.55%
cases:1.13%
controls:0.17%
cases:0.24%
controls:0.02%
—
—
—
—
cases:0.62%
controls:0.12%
cases:2.11%
controls:0.79%
35
116
2082
21039
24
35
2093
21120
5
5
2112
21150
—
—
13
26
2084
20915
42
157
1953
19596
Care involving use of rehabilitation procedure, unspecified
Z50.9 [45595525]
1.1e+00
2.0e+00
—
—
—
2.1e+00
1.5e+00
cases:0.38%
controls:0.13%
cases:0.47%
controls:0.06%
—
—
—
—
—
—
cases:0.57%
controls:0.07%
cases:1.10%
controls:0.24%
8
28
2109
21127
10
13
2107
21142
—
—
—
12
15
2085
20926
22
48
1973
19705
Outpatient Hospital
22 [8756]
5.2e-01
7.8e-01
1.2e+00
—
1.4e+00
9.1e-01
8.3e-01
cases:29.33%
controls:19.80%
cases:11.57%
controls:5.64%
cases:2.08%
controls:0.63%
—
—
cases:2.65%
controls:0.67%
cases:11.78%
controls:5.08%
cases:29.07%
controls:15.18%
621
4189
1496
16966
245
1194
1872
19961
44
134
2073
21021
—
56
141
2061
20998
247
1064
1850
19877
580
2998
1415
16755

LabWAS

↥
OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
1803
8825
7.79
318.15
12.7
6.4
0.04
0.04
e9/l
2.40
1711
7686
1802
8818
7.78
317.98
12.6
6.4
0.56
0.55
e9/l
1.19
1710
7684
450
614
9.02
307.65
1.1
1.1
—
—
—
0
0
1812
9054
7.71
307.61
12.8
6.4
2.05
1.94
e9/l
3.08
1743
8079
1818
9129
7.77
306.31
12.8
6.6
0.18
0.18
e9/l
1.07
1745
8082
1828
9917
6.95
260.58
14.8
10.1
3.91
3.97
e9/l
0.65
1735
8661
820
2537
4.63
243.29
1.6
1.4
400.80
534.27
titre
1.74
199
524
1593
8151
4.79
232.15
13.0
6.6
8.59
8.61
%
0.15
1559
7719
1584
8133
4.70
228.08
12.9
6.4
2.67
2.80
%
1.58
1550
7698
1576
8131
4.61
223.58
13.1
6.5
0.73
0.69
%
2.62
1541
7677
1599
8458
4.57
215.89
12.9
6.4
30.60
28.80
%
11.10
1569
8089
1579
8308
4.48
213.99
12.5
6.3
55.58
56.66
%
3.88
1556
8001
1997
12644
10.28
213.48
11.3
3.7
11.60
10.34
mm/h
4.39
1961
11909
146
63
24.81
204.57
1.6
2.4
9.28
10.37
mg/l
0.80
112
54
1617
9048
4.27
190.84
5.7
3.2
0.00
5.78
estimate
2.07
430
1880
1608
8966
4.24
190.69
5.7
3.2
0.00
0.00
estimate
0.34
430
1869
374
728
6.02
188.47
1.7
2.1
7.04
8.06
iu/ml
0.22
95
161
1618
9106
4.23
188.12
5.8
3.2
0.01
0.18
estimate
0.51
413
1773
1034
4370
3.65
187.37
8.1
4.5
—
—
—
0
0
1944
12796
6.95
176.60
12.6
7.7
72.92
76.87
u/l
5.70
1912
12189
790
2950
3.67
170.45
1.4
1.3
8.27
11.63
u/ml
0.74
342
1251
1347
7175
3.39
159.95
4.8
2.9
6.23
6.18
ph
1.17
718
4158
238
369
7.14
149.23
3.9
3.2
56.68
57.71
%
0.63
238
369
796
3260
3.30
144.20
1.4
1.3
29.39
28.21
iu/ml
0.06
257
978
1255
6913
2.98
130.92
5.7
3.0
0.01
0.10
estimate
0.71
390
1533
471
1468
3.84
129.38
6.2
4.8
0.50
1.04
%
4.21
116
406
105
63
17.48
126.90
2.7
3.3
6.86
9.99
mg/l
2.45
87
51
457
1429
3.80
124.58
6.7
5.1
0.01
0.38
%
0.90
100
330
452
1404
3.82
124.41
5.6
4.6
0.37
0.68
%
1.86
106
393
453
1416
3.79
123.47
6.4
4.9
0.06
0.13
%
1.12
98
355
959
4689
2.90
122.88
6.4
3.3
0.00
0.01
estimate
1.54
417
1761
1343
7895
2.90
120.12
17.7
10.1
0.00
0.00
e9/l
0.23
1190
6467
96
54
18.57
119.61
2.4
2.4
52.21
121.45
au/ml
0.51
13
12
285
676
4.71
112.25
1.4
1.2
1.57
0.90
u/ml
0.31
40
36
562
2167
3.16
108.48
3.3
3.3
3.97
4.43
e9/l
1.26
529
1945
791
3739
2.77
104.55
5.9
3.2
1.02
1.43
kg/l
0.50
520
2419
590
2411
3.00
102.14
3.2
2.6
114.67
112.11
ug/g
0.09
492
1971
186
330
6.08
101.44
1.9
1.6
10788.96
16072.48
e6/l
0.60
137
228
1051
5868
2.56
97.16
4.4
3.4
51.49
95.63
e6/l
1.81
754
3871
605
2572
2.89
96.77
1.5
1.6
—
—
—
0
0
116
133
9.17
93.39
1.8
1.7
57.63
58.38
%
0.06
76
91
690
3195
2.72
93.12
2.8
2.5
4.78
7.15
e6/l
4.30
636
2880
934
5080
2.49
89.33
7.6
6.3
—
—
—
0
0
835
4344
2.52
87.54
3.8
4.1
7.40
7.40
ph
0.99
561
3054
1256
7958
2.41
83.45
3.1
2.3
76.60
75.05
nmol/l
1.27
1199
7426
143
241
6.29
81.91
1.7
1.4
—
—
—
0
0
448
1758
2.96
81.57
1.4
1.5
—
—
—
0
0
97
105
9.63
81.49
1.7
1.5
40.87
35.23
%
0.51
61
67
304
946
3.58
81.43
5.7
3.0
—
—
—
0
0
376
1337
3.20
81.31
2.9
2.9
10.63
10.75
g/l
0.22
348
1244
1119
6838
2.34
79.45
4.9
5.0
36.80
36.51
g/l
1.08
1071
6465
867
4832
2.34
75.32
3.4
2.9
86.90
88.29
e6/l
0.01
720
3543
1168
7436
2.26
73.01
6.3
6.8
1.22
1.21
mmol/l
0.74
998
6453
911
5293
2.26
70.51
4.5
2.7
0.01
0.24
estimate
0.73
390
1471
758
4144
2.29
67.26
3.1
2.8
0.22
0.40
e6/l
3.56
600
2900
759
4186
2.26
65.62
2.3
2.4
312.75
329.07
umol/l
5.17
674
3838
1041
6546
2.15
64.35
5.8
6.2
1.21
1.21
mmol/l
0.06
993
6100
873
5176
2.16
62.26
3.5
2.6
0.00
0.02
—
10
86
2078
17945
7.47
61.03
25.1
11.9
15.32
22.48
mg/l
38.50
1915
14227
61
52
12.05
60.26
1.6
1.4
4.23
1.30
%
—
22
10
755
4293
2.18
59.28
2.4
2.0
143.21
261.12
u/l
2.31
721
4079
290
1057
3.02
59.06
1.8
2.0
1.32
1.50
g/l
0.82
277
989
717
4035
2.17
57.45
2.7
2.2
2.71
2.69
mg/l
0.09
640
3497
700
3917
2.17
56.78
1.6
1.7
—
—
—
0
0
824
4960
2.08
54.74
2.7
2.5
56.87
62.96
u/l
1.06
763
4630
1892
15733
2.81
51.62
26.7
15.1
13.64
13.41
%
13.46
1882
15517
1197
8398
1.97
50.03
5.6
6.6
9.79
11.17
umol/l
2.84
1135
8034
1441
10848
2.02
48.27
5.0
3.7
640.07
1987.57
e6/l
0.80
14
130
497
2569
2.22
48.03
2.5
2.4
13.21
14.09
umol/l
1.85
467
2412
161
469
3.63
46.93
8.5
6.9
—
—
—
0
0
56
61
9.40
46.69
1.2
1.0
—
—
—
0
0
1281
9320
1.94
46.68
3.7
3.0
108.05
99.98
ug/l
0.56
1219
8857
273
1103
2.69
45.34
2.5
2.3
0.24
0.53
e6/l
1.59
237
1045
669
3947
2.01
45.16
1.6
1.5
2.42
2.29
g/l
1.22
483
2636
172
537
3.40
45.04
1.2
1.3
—
—
—
0
0
284
1186
2.61
44.08
2.4
2.3
19.23
19.64
au/ml
0.04
34
177
454
2364
2.17
42.51
2.5
2.4
2.41
2.38
g/l
0.47
424
2205
264
1092
2.62
41.68
1.3
1.3
41.75
50.30
au/ml
0.32
13
78
511
2830
2.06
40.44
3.2
2.6
534.36
536.67
mosm/kgh2o
0.08
458
2459
653
3959
1.94
39.81
1.7
1.6
20.57
20.18
nmol/l
0.26
588
3433
416
2144
2.17
39.72
2.5
2.5
22.83
24.11
%
1.17
389
2013
375
1875
2.21
38.53
1.5
1.4
—
—
—
0
0
461
2499
2.08
38.44
2.6
2.5
0.96
1.21
e6/l
0.48
294
1232
1244
9304
1.81
37.91
4.8
4.6
6.36
6.56
mmol/l
3.26
1185
8689
68
118
5.92
37.66
1.5
1.4
3440.39
71099.46
e6/l
1.50
41
82
303
1411
2.34
36.79
4.9
3.3
—
—
—
0
0
408
2148
2.11
36.60
2.4
2.0
—
—
—
0
0
707
4504
1.85
36.34
1.4
1.3
1.31
1.67
u/ml
0.35
225
1321
202
782
2.75
36.20
2.1
2.3
—
—
—
0
0
330
1610
2.24
35.83
2.4
2.1
347.44
381.65
nmol/l
2.57
316
1515
729
4712
1.83
35.60
1.9
2.0
—
—
—
0
0
924
6441
1.77
34.75
10.9
10.8
1.16
1.17
inr
0.33
783
5323
232
997
2.49
33.55
2.1
2.8
68.29
66.91
g/l
2.08
214
943
604
3773
1.84
32.38
5.1
4.1
—
—
—
0
0
76
167
4.68
32.35
1.6
1.4
—
—
—
0
0
804
5474
1.75
32.16
2.9
3.5
2.35
2.35
mmol/l
0.52
766
5094
46
66
7.10
30.57
2.0
2.0
—
—
—
0
0
103
298
3.58
30.24
1.7
1.8
0.48
0.79
g/l
2.84
73
231
787
5401
1.73
30.10
3.8
2.9
115.91
43.51
ng/l
0.34
483
3070
74
171
4.45
29.60
1.6
1.4
0.40
0.42
g/l
0.18
52
120
74
171
4.45
29.60
1.6
1.4
3.00
3.01
g/l
0.02
53
121
473
2807
1.88
29.46
2.5
2.8
2.43
2.43
mmol/l
0.08
432
2533
74
172
4.42
29.38
1.6
1.4
6.32
6.91
g/l
0.61
53
121
586
3746
1.78
28.49
1.8
1.7
0.90
1.02
mg/l
0.57
453
2815
2086
19347
4.79
28.16
24.1
10.1
26.91
26.59
u/l
0.39
2071
18891
1977
17831
2.51
27.66
17.9
13.1
139.56
139.71
mmol/l
2.52
1954
17435
1981
17891
2.53
27.49
17.9
13.2
3.93
3.94
mmol/l
1.04
1955
17448
1689
14414
1.83
27.46
4.8
4.4
14.69
14.50
pmol/l
3.06
1593
13499
275
1381
2.14
27.38
2.1
2.0
0.00
0.02
estimate
1.06
97
322
144
544
2.77
26.92
1.5
1.2
43.91
42.32
u/ml
—
10
33
914
6671
1.65
26.83
2.2
1.9
96.32
97.44
pmol/l
0.32
523
3645
287
1484
2.08
26.41
2.4
3.0
1.83
1.78
%
0.38
268
1348
647
4344
1.70
25.99
3.3
2.5
—
—
—
0
0
120
423
2.95
25.49
1.5
1.2
41.21
36.49
u/ml
0.10
12
41
366
2087
1.91
25.42
1.8
1.6
1389.68
1135.30
nmol/l
5.69
287
1618
175
752
2.45
25.15
2.1
2.0
0.00
0.02
estimate
0.88
83
246
373
2148
1.89
25.11
1.3
1.2
—
—
—
0
0
140
550
2.65
24.24
1.4
1.3
—
—
—
0
0
850
6214
1.61
24.00
3.6
3.2
32.07
31.87
u/l
0.04
805
5897
131
508
2.68
23.27
1.5
1.3
3.96
8.95
u/ml
0.84
18
69
130
506
2.67
22.92
1.4
1.2
2.28
3.56
u/ml
0.49
12
35
206
988
2.20
22.90
1.4
1.2
—
—
—
0
0
491
3159
1.72
22.57
1.8
1.6
33100661.42
41880450.52
pmol/l
0.13
429
2734
219
1085
2.14
22.42
2.1
3.0
73.31
72.11
e9/l
0.18
161
790
135
548
2.56
21.87
1.3
1.3
79.33
86.46
titre
0.15
15
48
351
2095
1.81
20.77
1.5
1.4
—
—
—
0
0
224
1155
2.05
20.58
4.7
3.6
1.22
1.23
mmol/l
0.81
195
985
124
500
2.57
20.36
2.3
2.1
0.94
2.13
ug/l
1.03
114
452
423
2683
1.72
20.23
3.3
3.2
447.00
548.77
ng/l
0.16
259
1782
516
3454
1.65
20.12
2.8
3.0
986.17
1085.28
ng/l
0.19
444
2885
39
73
5.42
19.98
1.3
1.6
5.31
6.35
u/l
0.70
32
64
1002
7835
1.53
19.81
2.9
2.6
—
—
estimate
—
0
0
54
138
3.99
18.99
1.2
1.2
—
—
—
0
0
1866
16912
1.83
18.74
5.7
5.1
1.67
1.82
mu/l
9.82
1785
15940
308
1858
1.77
17.39
2.0
1.6
—
—
—
0
0
50
129
3.95
17.37
1.2
1.2
—
—
—
0
0
229
1284
1.88
16.39
1.4
1.3
177.38
264.74
u/ml
0.47
218
1192
64
210
3.11
15.47
1.6
1.3
9.47
78.47
u/ml
—
6
12
139
668
2.16
15.32
1.3
1.2
—
—
—
0
0
106
470
2.32
14.20
2.1
2.4
10.65
11.95
mg/l
0.79
101
445
227
1327
1.80
14.15
3.8
3.6
7.39
7.38
ph
0.99
123
755
119
574
2.14
13.01
1.7
2.0
1.48
1.48
g/l
0.01
103
501
349
2337
1.59
13.00
2.9
2.6
3.32
3.29
e6/l
0.01
184
1063
83
351
2.42
12.40
2.7
3.5
50.13
64.96
mg/l
0.29
64
293
64
242
2.70
12.04
1.4
1.7
—
—
—
0
0
82
352
2.38
11.86
2.6
3.5
25.13
75.40
mg/l
0.87
63
297
239
1489
1.68
11.84
7.1
9.0
12.39
13.15
kpa
1.57
234
1438
239
1489
1.68
11.84
7.1
9.0
5.04
5.09
kpa
0.41
234
1439
212
1281
1.73
11.75
4.0
3.6
1.97
1.73
mmol/l
0.50
186
1093
361
2493
1.54
11.66
2.7
3.7
0.81
0.82
mmol/l
0.59
343
2374
132
698
1.95
11.25
5.3
5.8
—
—
—
0
0
128
673
1.96
11.10
2.5
2.2
—
—
—
0
0
284
1884
1.59
10.91
5.1
6.3
1.04
1.04
mmol/l
0.01
265
1772
236
1497
1.65
10.89
7.2
9.0
7.42
7.42
ph
0.77
133
814
82
366
2.29
10.88
1.3
1.2
3.60
3.65
mmol/l
0.18
72
349
325
2228
1.54
10.80
1.9
2.1
29.24
29.31
s
0.09
313
2165
235
1495
1.64
10.71
7.1
8.9
1.09
0.91
mmol/l
0.35
199
1242
47
163
2.93
10.41
1.5
2.3
31.68
32.57
pg
0.55
47
163
100
1899
0.50
10.41
3.6
4.2
33.69
31.79
%
0.76
71
1358
2094
20273
2.95
10.29
36.4
18.5
272.29
258.63
e9/l
18.29
2085
19916
2094
20280
2.93
10.15
36.2
18.4
91.22
90.43
fl
13.53
2089
20099
2094
20281
2.92
10.13
36.1
18.4
30.28
30.18
pg
2.16
2088
20099
2094
20284
2.91
10.07
36.6
18.8
40.46
41.40
%
1.80
2088
20090
2094
20285
2.91
10.04
36.3
18.4
4.48
4.55
e12/l
12.56
2085
19880
72
315
2.33
10.02
2.5
3.2
3.52
3.74
ratio
0.03
34
167
2094
20289
2.90
9.96
36.4
18.5
6.92
6.60
e9/l
7.72
2083
19874
2094
20294
2.88
9.86
36.6
18.5
134.82
136.58
g/l
8.43
2089
20112
670
5341
1.37
9.82
2.9
3.5
7.43
7.90
mmol/l
1.68
588
4668
80
373
2.19
9.59
1.4
1.5
328.17
846.06
e6/l
0.51
66
292
142
814
1.80
9.44
3.9
2.9
129.53
131.75
g/l
0.55
137
790
531
4097
1.39
9.43
4.1
3.8
95.62
93.75
%
1.14
516
4020
1792
16683
1.47
9.33
5.8
5.1
37.47
38.16
mmol/mol
3.13
1727
15888
65
281
2.35
9.32
2.5
3.5
2.60
2.45
mmol/l
0.18
50
179
85
415
2.09
9.08
1.5
1.4
278.38
292.06
ug/g
0.24
52
238
78
369
2.16
9.04
1.4
1.4
16.08
43.24
e6/l
0.67
61
275
281
1939
1.52
8.99
2.1
2.7
5.47
7.85
umol/l
2.89
239
1702
54
219
2.50
8.90
3.3
3.2
1.29
1.47
%
0.11
47
204
29
83
3.53
8.80
1.6
1.6
2834.29
1813.33
titre
—
7
12
1821
17055
1.47
8.71
4.7
4.2
5.74
5.77
mmol/l
0.37
1720
15971
148
884
1.72
8.56
2.5
2.9
76.94
174.18
ng/l
6.69
139
789
221
1470
1.56
8.34
1.4
1.4
23.70
27.04
iu/l
0.82
184
1263
84
425
2.02
8.19
1.3
1.3
501.51
517.94
mg/l
0.12
77
411
219
1467
1.55
8.01
2.5
2.3
0.22
0.22
g/l
0.04
205
1387
80
402
2.03
7.95
5.2
6.9
1.47
1.28
mmol/l
0.48
74
353
161
1006
1.65
7.88
3.5
4.0
85.05
83.66
ng/l
0.08
141
890
223
1515
1.53
7.65
1.2
1.2
—
—
—
0
0
79
407
1.98
7.35
2.4
3.2
1.39
2.26
index
0.74
41
224
86
460
1.91
7.18
1.1
1.1
—
—
—
0
0
585
4755
1.32
7.09
3.7
4.3
8.39
8.54
mg/mmol
0.03
354
3028
574
4662
1.32
6.98
3.0
3.6
51.90
48.34
mg/l
0.13
355
2988
70
353
2.02
6.93
1.2
1.1
—
—
—
0
0
883
7600
1.28
6.85
2.0
1.8
1.45
1.38
mmol/l
1.09
765
6605
42
174
2.44
6.70
1.3
1.4
0.32
0.27
nmol/l
0.12
33
139
196
1340
1.51
6.54
2.4
2.3
12.95
13.12
nmol/l
0.10
187
1251
39
159
2.48
6.44
1.5
3.0
—
—
—
0
0
60
296
2.06
6.34
2.3
3.5
—
—
—
0
0
41
173
2.40
6.30
1.4
1.4
—
—
nmol/l
—
0
0
176
1192
1.52
6.14
7.2
9.5
—
—
—
0
0
40
169
2.39
6.14
1.9
2.3
0.91
0.92
%
0.03
30
106
1719
16182
1.32
5.97
28.9
15.1
331.77
332.80
g/l
5.27
1713
16076
120
751
1.63
5.89
1.2
1.2
—
—
—
0
0
36
148
2.46
5.87
1.2
1.1
33.44
44.56
mg/l
0.99
29
120
142
928
1.57
5.83
2.2
2.0
9.93
8.19
ug/l
0.12
125
829
172
1180
1.50
5.66
1.3
1.2
—
—
—
0
0
26
93
2.82
5.57
1.2
1.1
2.87
4.78
nmol/l
—
8
19
32
128
2.52
5.54
1.1
1.1
1.09
1.05
ratio
0.52
24
109
30
117
2.59
5.47
1.7
1.2
74.03
75.44
umol/l
0.19
30
117
108
672
1.64
5.45
1.3
1.4
13.51
9.89
u/l
1.38
94
546
59
308
1.94
5.37
1.2
1.2
—
—
—
0
0
76
431
1.79
5.36
1.1
1.2
243.93
270.36
u/ml
0.46
42
273
221
2973
0.71
5.29
1.9
1.9
3.46
3.49
ratio
0.14
170
2200
631
5350
1.25
5.21
2.4
2.2
—
—
—
0
0
832
7278
1.23
5.17
2.1
2.0
—
—
—
0
0
79
459
1.75
5.15
1.9
2.3
262.49
471.22
ug/l
0.88
72
432
160
2264
0.68
5.10
1.6
1.7
3.57
3.52
mmol/l
0.20
107
1508
23
81
2.86
5.09
1.4
1.5
—
69.67
%
—
0
12
65
358
1.84
5.06
1.3
1.5
—
—
—
0
0
28
111
2.54
4.96
1.2
1.3
0.52
0.65
ratio
1.33
18
56
215
1582
1.40
4.90
1.3
1.2
68.52
139.65
u/ml
3.11
74
613
185
1326
1.43
4.89
3.4
2.1
6.08
6.09
ph
0.08
131
819
87
531
1.67
4.77
1.1
1.1
4.58
5.70
eliau/ml
—
6
97
120
800
1.53
4.57
3.8
3.6
24.54
24.13
mmol/l
1.02
120
790
71
416
1.73
4.53
1.2
1.4
—
—
—
0
0
13
27
4.84
4.49
1.4
1.4
—
—
—
0
0
68
395
1.75
4.48
2.4
2.5
—
—
—
0
0
18
60
3.02
4.40
1.8
1.7
—
—
—
0
0
9
12
7.53
4.35
1.0
1.1
—
—
titre
—
0
0
31
141
2.22
4.12
1.3
1.4
1.87
1.99
mmol/l
0.54
26
136
154
1103
1.43
4.12
1.9
2.2
1537.25
7185.10
u/l
4.36
47
464
26
110
2.38
4.07
1.2
2.0
0.64
1.97
u/field
1.72
14
65
7
7
10.03
4.01
1.0
1.4
—
—
—
0
0
137
968
1.44
3.95
1.9
1.7
308.48
298.80
mu/l
0.11
126
869
206
1564
1.35
3.90
2.2
2.3
35.91
71.96
u/l
0.62
163
1352
60
352
1.72
3.86
1.1
1.1
—
—
—
0
0
16
54
2.98
3.85
1.4
1.1
17.33
17.09
umol/l
0.06
16
47
106
719
1.50
3.77
1.6
1.7
7.80
13.40
u/ml
1.16
21
225
65
394
1.67
3.73
1.1
1.4
145.88
143.84
au/ml
0.05
16
109
18
67
2.70
3.66
2.4
3.5
22.44
21.31
ug/l
0.12
18
61
40
213
1.89
3.54
1.2
1.3
—
—
—
0
0
48
271
1.79
3.54
2.4
2.8
91.07
90.87
%
0.09
48
263
34
171
2.00
3.54
2.2
2.8
—
—
—
0
0
24
105
2.30
3.52
1.7
2.3
—
—
—
0
0
57
340
1.70
3.49
1.9
2.1
131.98
132.21
g/l
0.03
46
275
25
112
2.25
3.48
1.1
1.1
1650.92
1399.18
miu/ml
0.56
25
112
27
125
2.17
3.48
1.5
1.2
11.37
9.48
mm/h
0.22
27
125
16
58
2.77
3.42
1.1
1.1
10.17
480.29
ng/l
—
6
20
216
2736
0.77
3.42
1.3
1.3
—
—
—
0
0
173
1307
1.35
3.41
3.2
3.6
4.62
4.55
pmol/l
0.29
156
1190
28
133
2.12
3.40
1.1
1.1
—
—
—
0
0
21
88
2.40
3.39
1.2
2.5
2053.33
1863.37
ml
0.36
21
79
5
190
0.26
3.39
31.4
20.0
1258.60
1448.51
nmol/l
—
5
185
16
59
2.72
3.32
1.4
1.6
347.60
111.50
umol/l
—
10
26
59
362
1.65
3.27
1.2
1.1
12.65
14.58
au/ml
0.15
15
117
5
185
0.27
3.25
20.6
15.6
773.00
7818.45
nmol/l
—
5
179
31
156
2.00
3.25
1.2
1.3
0.03
1.34
u/ml
1.90
16
77
53
319
1.68
3.17
2.5
2.9
8.39
8.37
kpa
0.04
53
311
37
202
1.85
3.08
1.7
1.4
62.48
63.97
mmol/l
0.07
31
168
123
895
1.40
3.08
1.3
1.3
283.73
232.11
miu/ml
0.76
55
446
27
132
2.06
3.07
1.3
1.2
314.00
262.22
titre
—
5
27
12
36
3.35
3.01
1.1
1.0
7.55
6.92
mg/g
0.08
12
36
5
5
10.02
2.98
1.4
1.2
68.00
57.00
umol/l
—
5
5
22
101
2.19
2.93
3.6
3.4
420.77
1042.20
u/ml
1.67
22
101
69
454
1.54
2.90
2.0
1.8
204.96
208.25
pmol/l
0.10
69
433
403
3454
1.21
2.83
4.6
4.4
2.04
2.06
ug/l
0.01
379
3150
1437
13629
1.17
2.82
3.5
3.0
46.17
41.73
u/l
1.10
1371
13049
1880
18262
1.25
2.81
4.9
4.4
4.74
4.78
mmol/l
1.05
1807
17442
16
65
2.47
2.79
2.1
1.3
0.00
0.00
estimate
-0.00
16
65
51
316
1.63
2.77
1.1
1.1
—
—
—
0
0
23
111
2.08
2.73
2.8
2.6
727.87
1360.77
mg
1.53
23
111
17
72
2.37
2.72
1.4
2.0
29.94
29.15
%
0.06
17
72
37
211
1.77
2.71
1.6
1.6
—
—
—
0
0
37
211
1.77
2.71
1.6
1.6
—
—
—
0
0
37
211
1.77
2.71
1.6
1.6
—
—
—
0
0
37
211
1.77
2.71
1.6
1.6
—
—
—
0
0
1893
18415
1.25
2.71
5.4
4.8
2.81
2.85
mmol/l
1.26
1811
17509
53
335
1.60
2.67
2.0
2.2
6.53
5.45
umol/l
0.28
38
252
21
99
2.13
2.65
1.1
1.2
—
—
—
0
0
13
49
2.66
2.62
5.0
2.0
—
—
—
0
0
9
25
3.61
2.57
1.2
1.9
2.44
1.76
%
—
9
25
29
156
1.87
2.57
1.1
1.1
—
—
—
0
0
96
696
1.40
2.50
4.3
2.9
1.02
1.02
ratio
1.31
88
616
79
1109
0.70
2.50
1.1
1.1
0.53
0.63
ratio
—
10
119
20
95
2.12
2.49
2.8
2.1
—
—
—
0
0
53
342
1.56
2.47
2.9
2.5
13.27
13.08
%
0.55
53
337
47
726
0.64
2.42
1.6
1.6
—
—
—
0
0
14
58
2.42
2.37
1.1
1.5
87.66
575.57
nmol/24h
0.51
14
58
26
139
1.88
2.36
1.7
2.3
18.17
19.53
nmol/l
0.39
26
132
23
118
1.96
2.35
1.4
1.2
—
—
—
0
0
50
323
1.56
2.33
1.2
1.2
4.37
4.02
u/ml
0.10
19
140
1867
18195
1.21
2.24
4.7
4.4
1.49
1.48
mmol/l
0.12
1785
17286
42
263
1.61
2.24
2.9
2.3
—
—
—
0
0
552
4953
1.15
2.21
3.2
2.9
—
0.75
—
0
12
47
706
0.66
2.16
1.4
1.5
—
—
—
0
0
46
694
0.66
2.16
1.5
1.5
1.28
1.27
mm
0.01
30
488
13
55
2.37
2.12
5.0
1.9
—
—
—
0
0
111
853
1.32
2.05
1.6
1.7
0.23
0.33
mg/l
1.32
59
402
15
69
2.18
2.04
1.1
2.0
7.87
8.62
%
0.15
15
69
12
50
2.41
2.02
1.2
1.4
11.99
9.14
mmol/l
0.56
12
50
87
1153
0.74
1.98
1.1
1.1
1.52
1.54
g/l
0.35
87
1153
157
1272
1.25
1.94
7.3
8.2
8.53
8.50
mmol/l
0.02
151
1222
8
27
2.97
1.93
13.5
5.1
5.75
5.17
kpa
—
8
27
813
8732
0.89
1.92
3.0
2.8
—
—
—
0
0
16
78
2.06
1.91
1.3
1.8
2.10
5.69
u/field
—
10
62
7
22
3.19
1.88
3.7
2.4
—
—
—
0
0
23
129
1.79
1.85
1.3
1.3
163.62
158.85
pmol/l
0.08
23
129
23
129
1.79
1.85
4.0
2.2
24.11
31.91
mg/l
0.49
18
84
335
2935
1.17
1.83
1.5
1.5
—
—
—
0
0
30
184
1.64
1.78
1.2
1.6
—
—
—
0
0
11
47
2.35
1.77
1.0
1.1
—
—
—
0
0
11
47
2.35
1.77
1.0
1.1
—
—
—
0
0
11
47
2.35
1.77
1.0
1.1
—
—
—
0
0
142
1151
1.25
1.77
1.1
1.1
—
—
—
0
0
87
665
1.32
1.71
2.1
1.7
—
—
—
0
0
67
892
0.74
1.62
1.5
1.5
57.48
59.16
ug/l
0.15
56
733
138
1129
1.24
1.60
1.9
2.1
—
—
—
0
0
30
191
1.58
1.57
1.1
1.1
—
—
—
0
0
89
695
1.29
1.53
1.7
1.8
19.92
20.53
s
0.50
74
606
69
521
1.34
1.51
3.3
3.7
271.33
285.52
mg/l
0.07
40
236
61
452
1.36
1.50
2.4
2.7
24.44
25.04
mmol/l
0.65
61
446
6
21
2.86
1.50
1.3
1.6
—
—
—
0
0
136
1120
1.23
1.50
2.0
2.0
—
—
—
0
0
34
227
1.51
1.46
2.4
2.3
—
—
—
0
0
137
1134
1.22
1.45
1.9
2.1
—
—
—
0
0
1764
17239
1.14
1.43
4.0
3.8
1.26
1.26
mmol/l
0.03
1673
16287
137
1140
1.22
1.39
1.9
2.1
—
—
—
0
0
27
174
1.56
1.37
2.5
2.7
1.54
1.52
g/24h
0.01
16
112
9
44
2.05
1.26
1.0
1.2
—
—
—
0
0
5
118
0.42
1.24
1.2
2.7
—
—
—
0
0
49
364
1.35
1.23
1.1
1.1
—
—
—
0
0
5
19
2.64
1.21
1.0
2.2
—
—
—
0
0
26
172
1.52
1.20
1.0
1.2
20.00
15.31
u/ml
—
5
97
124
1042
1.20
1.17
2.0
2.1
—
—
—
0
0
69
544
1.28
1.16
1.4
1.2
—
—
—
0
0
57
438
1.31
1.16
2.9
2.9
—
—
—
0
0
127
1072
1.20
1.15
2.2
3.2
18.58
63.61
u/ml
3.25
122
1038
13
72
1.81
1.15
1.2
1.2
—
—
—
0
0
8
40
2.00
1.12
1.5
1.3
0.07
0.13
u/ml
—
8
40
74
594
1.25
1.09
2.0
2.2
3.56
4.12
iu/l
0.20
31
268
22
144
1.53
1.08
1.1
1.2
—
—
—
0
0
19
120
1.59
1.08
1.2
1.2
—
—
—
0
0
5
22
2.28
1.03
1.0
1.0
—
—
—
0
0
5
22
2.28
1.03
1.2
1.4
—
—
—
0
0
13
75
1.74
1.02
2.2
1.2
192.00
168.25
mmol/24h
0.42
13
75
0
30
0.00
0.97
0.0
1.2
—
60.65
—
0
24
604
5692
1.09
0.96
1.5
1.6
—
—
—
0
0
21
142
1.48
0.92
1.1
1.5
—
—
—
0
0
68
555
1.23
0.90
1.1
1.1
1.03
2.55
u/ml
1.96
36
282
17
110
1.55
0.90
1.8
2.9
43.64
44.07
%
0.06
11
58
42
324
1.30
0.88
2.3
2.7
92.57
95.06
ug/min
0.02
27
200
24
169
1.42
0.87
2.4
3.3
0.82
0.83
nmol/l
0.04
18
142
6
30
2.00
0.87
1.2
1.6
41.74
29.38
pmol/l
—
6
24
49
387
1.27
0.87
1.4
1.4
23.97
25.86
u/l
0.18
44
323
25
178
1.41
0.86
1.0
1.1
—
—
—
0
0
53
424
1.26
0.85
1.8
1.9
—
—
—
0
0
12
73
1.65
0.81
1.5
2.0
99.67
103.43
ng/l
0.07
12
73
58
472
1.24
0.81
1.3
1.5
0.36
0.41
nmol/l
0.33
41
370
308
2846
1.10
0.78
1.7
1.8
—
—
—
0
0
39
305
1.28
0.76
1.2
1.1
—
—
—
0
0
40
314
1.28
0.76
6.7
3.5
—
—
—
0
0
101
874
1.16
0.75
2.2
2.1
—
—
—
0
0
46
369
1.25
0.74
2.9
2.6
62.48
64.09
%
0.16
46
358
5
24
2.09
0.74
1.0
1.3
6.14
5.82
mmol/l
—
5
24
7
38
1.84
0.73
1.0
1.2
—
—
—
0
0
19
135
1.41
0.69
2.4
3.1
43.75
54.68
%
1.00
12
121
13
85
1.53
0.69
1.0
1.3
146.38
129.56
nmol/l
0.94
13
85
99
865
1.15
0.67
3.3
3.2
5.06
5.18
kpa
0.81
92
839
67
567
1.19
0.67
2.4
3.1
1.46
1.36
mg/l
0.39
60
533
21
153
1.38
0.67
2.1
3.2
14.73
13.67
index
0.10
11
108
41
330
1.25
0.66
1.1
1.1
1.32
3.59
eliau/ml
2.44
12
190
18
130
1.39
0.61
1.3
1.1
—
—
—
0
0
129
1434
0.89
0.60
1.7
1.7
—
—
—
0
0
8
52
1.54
0.59
1.0
1.8
—
—
—
0
0
253
2353
1.09
0.59
1.2
1.3
—
—
—
0
0
11
73
1.51
0.56
1.2
1.5
—
—
—
0
0
160
1461
1.10
0.56
3.7
4.7
77.73
42.09
ug/l
0.19
122
1138
16
116
1.38
0.54
1.1
1.3
6.57
6.28
mmol/l
0.18
16
110
26
205
1.27
0.52
1.8
1.6
8.03
7.68
mmol/l
0.43
26
195
94
837
1.13
0.52
3.3
3.2
7.42
7.42
ph
0.32
82
690
51
597
0.85
0.52
3.9
3.2
—
—
—
0
0
139
1523
0.91
0.52
1.6
1.6
1010.38
1019.84
mu/l
0.04
115
1260
49
416
1.18
0.51
1.0
1.1
4.50
3.31
u/ml
0.27
26
202
21
265
0.79
0.45
5.2
6.5
327.24
386.75
umol/l
1.18
21
236
60
525
1.15
0.45
3.9
4.4
43.81
854.27
u/ml
1.74
51
464
39
458
0.85
0.43
4.5
3.3
24.89
24.87
mmol/l
0.02
32
422
0
15
0.00
0.41
0.0
1.4
—
10.83
—
0
6
67
752
0.89
0.41
2.2
1.8
—
—
—
0
0
0
17
0.00
0.40
0.0
1.1
—
—
—
0
0
13
98
1.33
0.37
1.3
1.6
0.62
0.50
e9/l
0.99
13
98
141
1511
0.93
0.36
1.3
1.4
—
—
—
0
0
9
126
0.71
0.35
1.3
1.5
—
—
—
0
0
44
386
1.14
0.34
1.1
1.1
3.14
4.52
u/ml
0.39
20
170
12
91
1.32
0.33
1.0
1.0
—
—
—
0
0
23
191
1.21
0.33
3.0
5.5
225.51
60.68
u/ml
—
8
62
22
264
0.83
0.33
1.5
1.6
—
—
—
0
0
51
457
1.12
0.30
1.1
1.1
1.19
1.89
u/ml
0.65
24
216
7
57
1.23
0.29
1.0
1.9
40.66
41.25
g/l
—
7
57
56
508
1.11
0.28
1.3
1.3
—
—
—
0
0
17
140
1.22
0.27
1.2
1.5
29.38
32.16
g/l
0.37
17
129
15
180
0.83
0.24
1.2
1.2
—
—
—
0
0
19
161
1.18
0.24
1.1
1.1
0.34
3.98
u/ml
—
6
45
5
40
1.25
0.22
1.0
1.2
—
—
—
0
0
15
178
0.84
0.22
1.1
1.5
—
—
—
0
0
0
11
0.00
0.21
0.0
2.1
—
330.45
—
0
11
0
11
0.00
0.21
0.0
1.5
—
0.17
—
0
11
0
11
0.00
0.21
0.0
2.0
—
—
—
0
0
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
0
13
0.00
0.21
0.0
1.0
—
0.23
—
0
8
0
13
0.00
0.21
0.0
12.5
—
136.43
—
0
7
0
13
0.00
0.21
0.0
1.6
—
56.63
—
0
8
10
80
1.25
0.20
1.2
3.1
15.06
16.77
%
—
10
80
0
14
0.00
0.20
0.0
2.1
—
—
—
0
0
6
51
1.18
0.19
1.2
1.2
—
—
—
0
0
59
549
1.08
0.19
1.2
1.1
—
—
—
0
0
18
207
0.87
0.19
1.3
1.2
—
—
—
0
0
24
270
0.89
0.19
1.1
1.3
—
—
—
0
0
10
81
1.24
0.18
1.1
1.0
297.40
353.53
ng/l
—
5
58
130
1358
0.95
0.18
3.8
3.8
7.35
7.36
ph
0.31
101
993
52
486
1.07
0.16
1.2
1.1
—
—
—
0
0
52
487
1.07
0.15
1.2
1.1
—
—
—
0
0
17
190
0.89
0.13
1.4
1.2
—
—
—
0
0
37
345
1.07
0.12
2.9
3.3
19.84
24.36
mg/l
0.47
31
236
13
115
1.13
0.10
1.1
1.2
—
—
—
0
0
5
44
1.14
0.10
1.0
2.8
0.64
0.61
mmol/l
—
5
44
11
97
1.13
0.09
1.6
1.5
1.98
2.27
nmol/l
0.12
11
71
5
62
0.81
0.08
1.0
1.0
—
—
—
0
0
5
62
0.81
0.08
8.0
7.0
11.20
8.39
%
—
5
62
5
62
0.81
0.08
4.0
3.5
39.00
43.03
%
—
5
62
42
401
1.05
0.08
1.6
1.4
6.17
3.96
ug/l
0.30
35
369
7
66
1.06
0.08
1.3
1.2
29.29
29.06
s
—
7
66
214
2106
1.02
0.07
2.8
2.8
0.69
0.73
ug/l
0.25
110
1158
6
73
0.82
0.07
2.7
3.4
—
—
—
0
0
13
118
1.10
0.07
1.2
1.3
—
—
—
0
0
49
478
1.03
0.03
1.1
1.1
0.37
1.30
u/ml
1.53
18
201
16
152
1.05
0.02
1.1
1.2
105.88
116.03
pmol/l
0.60
16
152
10
106
0.94
0.01
1.4
1.4
—
—
—
0
0
11
116
0.95
0.00
1.4
1.4
—
—
—
0
0
33
336
0.98
0.00
1.2
1.1
7.00
1675.52
iu/ml
—
6
79
11
109
1.01
0.00
1.4
1.4
3945.00
28437.88
e6/l
—
6
58
36
359
1.00
0.00
1.1
1.1
0.05
0.26
u/ml
—
10
110
50
497
1.01
0.00
1.1
1.1
3.06
4.91
u/ml
0.71
24
266
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
5
52
0.96
0.00
1.4
2.2
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.2
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.5
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.2
—
—
—
0
0
0
5
0.00
-0.00
0.0
2.0
—
—
—
0
0
7
76
0.92
-0.00
2.1
1.6
—
—
—
0
0
0
9
0.00
-0.00
0.0
1.1
—
0.03
—
0
9
0
9
0.00
-0.00
0.0
1.4
—
—
—
0
0
0
5
0.00
-0.00
0.0
5.4
—
—
—
0
0
7
71
0.99
-0.00
1.0
1.1
—
5.79
—
0
11
8
82
0.98
-0.00
1.4
2.8
7.35
8.85
mmol/l
—
8
82
5
56
0.89
-0.00
1.2
1.9
—
—
—
0
0

Mortality – FinRegistry

↥

Association

Association between endpoint M13_SPONDYLINFLAMNAS and mortality.

Females

Parameter HR [95% CI] p-value
M13_SPONDYLINFLAMNAS 1.224 [1.04, 1.44] 0.014
Birth year 1.0 [0.99, 1.01] 0.97

During the follow-up period (1.1.1998 — 31.12.2019), 297 out of 5780 females with M13_SPONDYLINFLAMNAS died.

Males

Parameter HR [95% CI] p-value
M13_SPONDYLINFLAMNAS 1.518 [1.31, 1.76] < 0.001
Birth year 0.987 [0.98, 1.0] 0.005

During the follow-up period (1.1.1998 — 31.12.2019), 390 out of 3635 males with M13_SPONDYLINFLAMNAS died.

Mortality risk

Mortality risk for people of age

years, who have M13_SPONDYLINFLAMNAS.

N-year risk Females Males
1 0.084% 0.256%
5 0.817% 1.557%
10 2.133% 4.122%
15 4.094% 7.724%
20 7.452% 13.285%

Relationships between endpoints

↥

Index endpoint: M13_SPONDYLINFLAMNAS – Other specified/unspecified inflammatory spondylopathies

GWS hits: 5

Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
rg [CI]
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
loading spinner Loading data